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RESUMEN	  	   Los	  virus	  de	  ARN	  pueden	  infectar	  todo	  tipo	  de	  organismos,	  desde	  los	  procariotas	  a	   los	  eucariotas	  superiores,	  y	  estos	  agentes	  infecciosos	   parecen	   particularmente	   propensos	   a	   causar	  enfermedades	   emergentes	   tanto	   en	  humanos,	   animales,	   como	  en	  plantas.	  Su	  habilidad	  para	  escapar	  del	  sistema	  inmunitario,	  evadir	  estrategias	   antivirales	   o	   infectar	   a	   nuevas	   especies	   son	   aspecto	  más	  de	  su	  rápida	  evolución.	  Por	  lo	  tanto,	  comprender	  los	  procesos	  básicos	  del	   la	  evolución	  de	   los	  virus	  de	  ARN	  podría	  ayudar	  en	  el	  diseño	  de	  nuevas	  estrategias	  antivirales.	  	  Una	  de	   las	  principales	  características	  de	   los	  virus	  de	  ARN	  es	   su	   tasa	   de	   mutación	   extremadamente	   alta.	   De	   hecho,	   la	   alta	  diversidad	  genética	  de	  las	  poblaciones	  virales	  da	  lugar	  a	  una	  nube	  de	   variantes	   que	   interactúan	   y	   contribuyen	   colectivamente,	  conocido	  también	  por	  el	  término	  de	  cuasiespecies,	  y	  que	  permite	  a	  las	   poblaciones	   virales	   adaptarse	   rápidamente	   a	   entornos	  dinámicos.	   Estudios	   anteriores	   han	   demostrado	   que	   la	   tasa	   de	  mutaciones	  espontáneas	  de	   los	  virus	  de	  ARN	  varía	  de	  10-­‐6	  a	  10-­‐4	  sustituciones	  por	  nucleótido	  por	  célula	  infectada	  (s/n/c)	  y	  puede	  variar	  considerablemente,	  incluso	  para	  el	  mismo	  virus,	  aunque	  se	  sabe	   poco	   sobre	   las	   causas	   de	   esta	   variabilidad.	  Consecuentemente,	   el	   conocimiento	   de	   la	   tasa	   de	   mutación	   y	   el	  espectro	  molecular	   de	  mutaciones	   espontáneas	   son	   importantes	  para	   entender	   la	   evolución	   de	   la	   composición	   genética	   de	   las	  poblaciones	  virales.	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En	   los	   virus	   de	   ARN	   las	   tasas	   de	   mutación	   están	  determinadas	   por	   factores	   codificados	   por	   el	   virus,	   como	   la	  fidelidad	   de	   la	   polimerasa	   viral,	   la	   presencia/ausencia	   de	  mecanismos	   correctores,	   o	   el	   modo	   de	   replicación	   viral.	   Sin	  embargo,	   sólo	   unos	   pocos	   estudios	   se	   han	   centrado	   en	   las	  características	  celulares	  que	  podrían	  explicar	  la	  variabilidad	  en	  la	  producción	   de	   la	   diversidad	   genética	   viral,	   o	   si	   esta	   variabilidad	  pudiera	  ser	  distribuida	  heterogéneamente	  entre	  células	  únicas.	  	  En	   este	   estudio,	   se	   propuso	   analizar	   algunos	   de	   los	  factores	  subyacentes	  a	  la	  variabilidad	  en	  las	  tasas	  de	  mutación	  de	  los	  virus	  de	  ARN.	  En	  primer	  lugar,	  se	  estudió	  el	  efecto	  del	  tipo	  de	  célula	  que	   se	   infecta,	   y	   la	  variación	  en	   función	  del	  huésped	  en	  el	  que	   el	   virus	   se	   replica.	   A	   continuación,	   nos	   centramos	   en	   la	  variabilidad	   que	   ocurre	   a	   nivel	   de	   una	   célula	   única,	  mediante	   la	  caracterización	  de	   la	  diversidad	  genética	  de	   los	  virus	   liberados	  a	  partir	   de	   células	   individuales.	   Por	   último,	   nos	   fijamos	   en	   el	  potencial	   efecto	   de	   factores	   celulares	   de	   tipo	  ADAR,	  mediante	   la	  determinación	   del	   tipo	   de	   mutaciones	   espontáneas	   que	   se	  acumulan	  en	  el	  genoma	  de	  un	  norovirus.	  	  	   Se	  utilizó	  la	  prueba	  de	  fluctuación	  de	  Luria-­‐Delbrück	  para	  comprobar	   la	   variabilidad	   en	   la	   tasa	  de	  mutación	  del	   virus	  de	   la	  estomatitis	  vesicular	  (VSV)	  entre	  diferentes	  células	  de	  mamíferos,	  así	  como	  entre	  diferentes	  condiciones	  de	  cultivo.	  Se	  encontró	  una	  tasa	   de	   mutación	   similar	   entre	   las	   células	   BHK-­‐21,	   así	   como	   en	  células	  embrionarias	  de	  ratón	  (MEF),	  células	  MEF	  inmortalizadas	  mediante	  deleción	  del	  gen	  p53,	  células	  de	  cáncer	  de	  colon	  murino	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(CT26)	   y	   de	   neuroblastoma	   (Neuro-­‐2A),	   sugiriendo	   que	   VSV	   se	  replica	  con	  la	  misma	  fidelidad	  en	  estos	  diferentes	  tipos	  de	  células	  de	  mamíferos.	  Por	  otra	  parte,	  debido	  a	  que	  el	  ciclo	  de	  vida	  de	  VSV	  no	   sólo	   implica	   su	   replicación	   en	   mamíferos,	   sino	   también	   en	  insectos,	   comprobamos	   su	   tasa	   de	   mutación	   en	   células	   de	  
Drosophila	  melanogaster	   (S2),	   de	   Spodoptera	   frugiperda	   (sf21)	   y	  del	  mosquito	  Aedes	  albopictus	   (C6/36).	   Curiosamente,	   la	   tasa	   de	  mutación	  de	  VSV	  fue	  cuatro	  veces	  mas	  baja	  en	  células	  de	  insectos	  en	   comparación	   con	   las	   células	   de	   mamíferos	   probadas.	  Curiosamente,	   los	   arbovirus	   parecen	   tener	   una	   evolución	   más	  lenta	   que	   los	   virus	   que	   no	   estan	   transmitidos	   por	   un	   vector,	   y	  nuestros	  resultados	  sugieren	  que	  en	  los	  insectos	  esto	  puede	  ser	  en	  parte	  debido	  a	  una	  tasa	  de	  mutación	  más	  baja.	  	  	   Se	  desarrolló	  un	  enfoque	  que	  combina	  micromanipulación	  y	  secuenciación	  masiva	  para	  estudiar	  la	  diversidad	  genética	  de	  los	  virus	  producidos	  y	  liberados	  por	  células	  únicas,	  usando	  de	  nuevo	  VSV	   como	   sistema	   modelo.	   Demostramos	   que	   el	   virus	   presenta	  gran	  diversidad	  genética	  en	  células	  únicas,	  aunque	  esta	  diversidad	  no	  fue	  homogéneamente	  contribuida	  por	  todas	   las	  células.	  Llama	  la	   atención	   que	   la	   variabilidad	   existente	   en	   el	   inóculo	   viral	  demostró	  que	   la	  unidad	   infecciosa	  mínima	   (PFU)	   también	  puede	  transmitir	  diversidad	  genética	  viral.	  En	  efecto,	  no	  sólo	  se	  observó	  complementación	   genética	   entre	   alelos	   de	   las	   variantes	  albergadas	  dentro	  de	  la	  misma	  PFU,	  sino	  también	  que	  el	  efecto	  de	  una	   mutación	   se	   determinó	   colectivamente	   por	   otras	   variantes	  durante	  su	  co-­‐transmisión,	  un	  proceso	  que	  podría	  seguir	  durante	  varias	   generaciones.	   Esta	   co-­‐transmisión	   de	   diversidad	   genética	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dentro	   de	   la	   misma	   unidad	   infecciosa	   tiene	   implicaciones	  importantes	   para	   la	   evolución	   viral,	   como	   por	   ejemplo	   la	   de	  mantener	  la	  diversidad	  genética	  durante	  fuertes	  cuellos	  de	  botella	  de	   las	   poblaciones	   virales,	   o	   crear	   una	   asociación	   espacial	   entre	  los	   alelos,	   y	   	   sugiere	   que	   la	   selección	   natural	   actúa	   a	   nivel	   de	  conjuntos	   de	   partículas	   virales	   diversas	   en	   lugar	   de	   sobre	  genotipos	  individuales.	  Por	  último,	  hemos	  visto	  que	  la	  variabilidad	  en	   la	   diversidad	   genética	   producida	   entre	   células	   únicas	   estaba	  estrechamente	   asociada	   con	   el	   rendimiento	   viral,	   sugiriendo	   un	  compromiso	   entre	   la	   eficacia	   y	   la	   fidelidad	   de	   la	   replicación	   del	  virus,	   que	   puede	   ser	   determinado	   por	   un	  modelo	   de	   replicación	  geométrica.	  Aunque	  este	  tipo	  de	  replicación	  alimenta	  la	  aparición	  de	   nuevas	  mutaciones,	   también	   aumenta	   la	   carga	   genética.	   Para	  equilibrar	   ambos	   mecanismos,	   hemos	   demostrado	   que	   los	  mutantes	   que	   muestran	   un	   fenotipo	   mutador	   deberían	   ser	  encontrados	  en	  una	  baja	  frecuencia	  en	  las	  poblaciones	  virales.	  	  	   Se	   usó	  un	   clon	   infeccioso	  del	   virus	  Norwalk	   (NV).	   Puesto	  que	  NV	  no	  es	  capaz	  de	  iniciar	  subsiguientes	  ciclos	  de	  infección	  en	  las	   células	   aquí	   utilizadas	   (HEK293T),	   tuvimos	   la	   posibilidad	   de	  observar	   la	   aparición	   de	   mutaciones	   espontáneas	   en	   un	   único	  ciclo,	   descartando	   así	   posibles	   efectos	   de	   la	   selección	   o	   la	  acumulación	   de	   mutaciones	   a	   lo	   largo	   de	   varias	   generaciones.	  	  Obtuvimos	  así	  una	  tasa	  de	  mutación	  de	  9	  ×	  10-­‐5	  s/n/c	  consistente	  con	  las	  estimaciones	  publicadas	  anteriormente	  para	  otros	  virus	  de	  ARN.	  Curiosamente,	  se	  observó	  que	  de	  los	  128	  clones	  moleculares	  secuenciados	  con	  el	  Sanger,	  dos	  	  mostraron	  múltiples	  cambios	  T	  -­‐>	  C.	  Sugerimos	  que	  estas	  hipermutaciones	  podrían	  ser	  el	  resultado	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1.	  Introduction	  to	  RNA	  viruses	   	   By	   the	   end	   of	   the	   19th	   century,	   the	   infectious	   agent	  responsible	   for	  tobacco	  mosaic	  disease,	  able	  to	  go	  through	  filters	  retaining	   bacteria	   was	   discovered	   by	   Adolf	   Mayer	   and	   Dimitri	  Ivanofsky.	   Soon	   after	   this	   discovery,	   the	   existence	   of	   entities	  smaller	  than	  bacteria,	  not	  observable	  with	  a	  light	  microscope	  and	  replicating	   only	   in	   living	   cells	   was	   introduced	   by	   Martinus	  Beijerinck	  (Manrubia	  and	  Lázaro,	  2006).	  Later	  in	  the	  20th	  century,	  these	  infectious	  agents	  were	  named	  viruses,	  and	  the	  first	  isolation	  and	  description	  of	  bacteriophages	  (i.e.	  viruses	  that	  infect	  bacteria)	  and	  animal	  viruses,	  such	  as	  foot-­‐and-­‐mouth	  disease	  virus	  (FMDV)	  (Loeffler	   and	   Frosch,	   1998),	   initiated	   the	   development	   of	   the	  virology	  field.	  	   Although	   all	   cellular	   organisms	   use	   DNA	   to	   store	   genetic	  information,	   viruses	   are	   composed	   either	   of	   a	   DNA	   or	   an	   RNA	  molecule.	   Whereas	   DNA	   viruses	   replicate	   their	   genome	   with	  similar	   enzymes	   as	   the	   host	   cell,	   in	   RNA	   viruses	   the	   genetic	  information	   is	   stored	   in	   an	   RNA	   molecule.	   Therefore,	   to	  reproduce,	   RNA	   viruses	   have	   to	   use	   specific	   replication	  mechanisms,	  which	  are	  characterized	  by	  an	  extremely	  low	  fidelity,	  and	   are	  mainly	   responsible	   for	   their	   high	   rates	   of	  mutation	   and	  highly	   heterogeneous	   populations.	   Indeed,	   a	   key	   feature	   of	   RNA	  viruses	   is	   their	  extremely	  high	  mutation	  rate,	  which	  allows	  them	  to	   evolve	   at	   timescales	   that	   can	   be	   recorded	   by	   human	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observation,	  thus	  making	  them	  an	  ideal	  model	  to	  study	  evolution	  (Holmes,	  2008;	  Holmes,	  2009;	  Biek	  et	  al.,	  2015).	  	  	   RNA	  viruses	  are	  able	  to	  infect	  a	  wide	  range	  of	  hosts,	  from	  prokaryotes	  to	  higher	  eukaryotes,	  and	  are	  well	  situated	  in	  the	  list	  of	   human	   infectious	   diseases.	   Indeed,	   RNA	   viruses	   include	   the	  second	   and	   sixth	   most	   deadly	   pathogens	   worldwide	   (HIV-­‐1	   and	  measles,	   respectively)	   and	   contribute	   significantly	   to	   the	   first	  (lower	  respiratory	  infections)	  and	  third	  (diarrhea)	  biggest	  causes	  of	   mortality	   (World	   Health	   Statistics,	  www.who.int/gho/publication/world-­‐health-­‐statistics/2013).	  Consequently,	   the	   economic	   cost	   of	   antiviral	   treatments,	  vaccination	  campaigns	  and	  epidemiological	   interventions	  against	  RNA	  viruses	  are	  considerable,	  and	  direct	  loss	  of	  productivity	  is	  an	  additional	   concern	   in	   livestock	   breeding	   and	   agriculture.	   For	  instance,	   during	   the	   2002-­‐2003	   severe	   acute	   respiratory	  syndrome	   coronavirus	   (SARS-­‐CoV)	   outbreak,	   only	   8437	   people	  were	   infected,	  813	  died,	   but	   the	  global	   economic	   cost	  was	  about	  US$50	  billion.	  Also,	  the	  2001	  epidemic	  of	  foot-­‐and-­‐mouth	  disease	  in	  the	  UK	  (due	  to	  FMDV)	  resulted	  in	  the	  death	  or	  slaughter	  of	  over	  3.5	   million	   cattle	   and	   a	   total	   cost	   of	   approximately	   $4	   billion	  (Holmes,	  2009).	  	   During	   their	   lifecycle,	  RNA	  viruses	   infect	  different	   tissues	  within	  the	  same	  host,	  different	  hosts	  of	  the	  same	  species,	  but	  also	  jump	   between	   host	   species,	   and	   therefore	   have	   to	   constantly	  adapt	  to	  new	  environments	  (Stern	  et	  al.,	  2014).	  Although	  the	  high	  genetic	  diversity	  of	  RNA	  virus	  populations	  allows	  them	  to	  quickly	  respond	   to	   these	   changing	   environments,	   these	   viruses	   also	  experience	   several	   evolutionary	   constraints.	   As	   a	   consequence,	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RNA	   viruses	   frequently	   cause	   transient	   “spill-­‐over”	   infections	   in	  new	   host	   species,	   where	   only	   a	   single	   individual	   is	   infected,	  because	   they	   can	  not	   sustain	  host-­‐to-­‐host	   transmission	   (Holmes,	  2009).	  	  
2.	   Evolutionary	   mechanisms:	   mutation,	   selection,	   genetic	  
drift	  and	  adaptation	  	   Evolution	   through	   natural	   selection	   necessitates	   the	  generation	   of	   genetic	   diversity	   on	   which	   it	   can	   act.	   For	  riboviruses,	  this	  source	  of	  diversity	  is	  mainly	  a	  consequence	  of	  the	  occurrence	   of	   mutations	   during	   genome	   replication	  within	   their	  host,	  such	  as	  the	  substitution,	  deletion	  or	  insertion	  of	  a	  nucleotide	  into	   the	   nascent	   chain.	   This	   mechanism	   is	   the	   basis	   of	   the	  spontaneous	  mutation	  rate,	  defined	  as	  the	  probability	  of	  a	  genetic	  change	   per	   copied	   nucleotide	   per	   viral	   generation	   (Combe	   and	  Sanjuán,	   2014a),	   and	   must	   be	   distinguished	   from	   the	   mutation	  frequency	   that	   is	   the	   actual	   proportion	   of	   mutations	   in	   a	   given	  population	   (Drake,	   1993;	   Sanjuán	   et	   al.,	   2010).	   Since	   RNA	  replicases	  and	  reverse	  transcriptases	  lack	  proofreading	  activities,	  mutation	  rates	  in	  RNA	  viruses	  are	  order	  of	  magnitude	  higher	  than	  those	  of	  DNA	  viruses,	  and	  are	  close	  to	  1	  mutation	  per	  genome	  per	  replication	   event,	   leading	   to	   highly	   heterogeneous	   populations	  (Domingo	   and	   Holland,	   1997;	   Drake	   and	   Holland,	   1999;	   Drake,	  1993;	  Schrag	  et	  al.,	  1999;	  Duffy	  et	  al.,	  2008).	  	  	   High	   mutation	   rates	   can	   represent	   a	   selective	   advantage	  because	  they	  generate	  a	  huge	  diversity	  of	  variants	  that	  allow	  RNA	  viruses	   to	   divert	   the	   host	   immune	   system,	   adapt	   to	   rapid	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environment	   changes	   (Giraud	   et	   al.,	   2001)	   and	   confront	   vaccine	  and	   antiviral	   drugs	   (Gerrish	   and	   García-­‐Lerma,	   2003).	   However,	  the	   majority	   of	   spontaneous	   mutations	   are	   deleterious,	   as	  demonstrated	   with	   VSV,	   where	   up	   to	   40%	   of	   spontaneous	  mutations	  were	   lethal	  whereas	  29.2%	  were	  deleterious	   (Sanjuán	  et	   al.,	   2004),	   and	  with	  TEV	  where	  40.9%	  were	   lethal	   and	  36.4%	  were	   deleterious	   (Carrasco	   et	   al.,	   2007).	   As	   a	   consequence,	   high	  mutation	   rates	   are	   also	   associated	   to	   increased	   genetic	   load	   and	  fitness	   loss	   (Chao,	   1990;	   Duarte	   et	   al.,	   1992;	   de	   la	   Iglesia	   and	  Elena,	  2007;	  García-­‐Arenal	  et	  al.,	  2001;	  Pybus	  et	  al.,	  2007).	  	  	   The	   evolutionary	   mechanisms	   driving	   high	   riboviral	  mutation	   rates	   have	   also	   been	   interpreted	   in	   terms	   of	   fitness	  trade-­‐offs.	   Indeed,	   it	   has	   been	   proposed	   that	   there	   is	   a	   trade-­‐off	  between	   replication	   speed	   and	   replication	   fidelity,	   such	   that	  selection	   for	   rapid	   replication	   results	   in	   higher	   mutation	   rates	  (Elena	  and	  Sanjuán,	  2005).	  This	   trade-­‐off	  was	  exemplified	  by	  the	  observation	  of	  a	  fitness	  cost	  associated	  with	  increased	  replication	  fidelity	   that	  resulted	   in	   lower	  replication	  rates	   for	  both	  vesicular	  stomatitis	   virus	   (Furió	   et	   al.,	   2005)	  and	   HIV-­‐1	   (Furió	   o	   et	   al.,	  2007).	  Also,	  there	  could	  be	  a	  possible	  trade-­‐off	  between	  the	  rates	  of	   production	   of	   advantageous	   versus	   deleterious	   mutations.	  Although	   natural	   selection	   should	   favor	   lower	  mutation	   rates	   in	  stable	   environments,	   because	   of	   the	   reduced	   load	   of	   deleterious	  mutations	  (Duffy	  et	  al.,	  2008),	  RNA	  viruses	  experience	  constantly	  changing	   environments,	   and	   thus	   high	   error-­‐prone	   RNA	  polymerases	   represent	   a	   selective	   advantage	   (Mansky	   and	  Cunningham,	  2000;	  Vignuzzi	  et	   al.,	   2006).	  However,	  RNA	  viruses	  exist	   close	   to	   their	   maximum	   tolerable	   error	   rates	   (i.e.	   error	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threshold,	  Manrubia	  et	  al.,	  2010)	  and	  slight	  elevations	  in	  mutation	  rate	   lead	   to	   their	   extinction	   because	   the	   fittest	   genotype	   is	   lost	  (Eigen,	  1971;	  Eigen,	  1992).	  This	  has	  been	  illustrated	  with	  studies	  of	   lethal	  mutagenesis,	  where	  artificially	   increased	  mutation	  rates	  using	   a	   chemical	   mutagen,	   such	   as	   5’-­‐fluorouracil	   or	   ribavirin,	  resulted	  in	  important	  fitness	  loss	  but	  also	  extinction	  (Mansky	  and	  Bernard,	  2000;	  Sierra	  et	  al.,	  2000;	  Anderson	  et	  al.,	  2004;	  Domingo	  et	   al.,	   2005;	   Bull	   et	   al.,	   2007).	   Therefore,	   these	   observations	  suggested	   that	   RNA	   virus	   high	  mutation	   rates	  might	   also	   be	   the	  results	   of	   a	   trade-­‐off	   between	   the	   production	   of	   sufficient	  beneficial	   mutations	   to	   rapidly	   adapt	   to	   changing	   environments	  and	   the	   risk	   of	   mutational	   meltdown	   (Sniegowski	   et	   al.,	   2000;	  Duffy	  et	  al.,	  2008;	  Holmes,	  2009).	  	  	   An	   important	   consequence	   of	   the	   idea	   that	   riboviruses	  exist	  at	  the	  limit	  of	  the	  error	  threshold	  is	  that	  it	  might	  also	  have	  an	  upper	   limit	   in	   their	   genome	   sizes,	   described	   as	   Eigen’s	   paradox	  (Holmes,	  2009).	  Under	  the	  same	  rate	  of	  mutation	  per	  nucleotide,	  RNA	  viruses	  with	   larger	  genomes	  will	   suffer	  of	  more	  deleterious	  mutations	   than	   those	   with	   smaller	   genomes	   (Eigen,	   1992).	  However,	   if	   smaller	   genomes	   are	   selected,	   they	   cannot	   package	  the	  additional	  genetic	  material	  needed	  for	  proofreading	  activities	  (Maynard	   Smith	   and	   Szathmáry,	   1995).	   Counterbalancing	   the	  burden	   of	   deleterious	   mutations	   imposed	   by	   their	   quick	  replication	  and	  the	  lack	  of	  proofreading	  mechanisms,	  RNA	  viruses	  exist	  as	  enormous	  population	  sizes.	  For	  instance,	  at	  the	  intra-­‐host	  level,	   it	  has	  been	  estimated	   for	  HIV-­‐1	   that	  up	  to	  107-­‐108	  cells	  can	  be	  infected,	  with	  about	  1010	  virions	  produced	  every	  day	  (Perelson	  et	   al.,	   1996),	  whereas	   in	   the	   case	  of	  HCV,	   the	  daily	  production	   is	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about	  1012	  virions	  (Neumann	  et	  al.,	  1998).	  For	  plant	  viruses,	  there	  may	   also	   be	   up	   to	   1012	   virus	   particles	   produced	   in	   a	   single	   leaf	  (Gibbs	   et	   al.,	   2008).	   Finally,	   for	   poliovirus	   the	  burst	   size	   (i.e.	   the	  number	  of	  infectious	  viruses	  produced	  per	  infected	  cell)	  could	  be	  about	   104	   (Kew	   et	   al.,	   2005).	   Moreover,	   because	   of	   huge	  population	   sizes,	   and	   to	   compensate	   for	   the	   accumulation	   of	  deleterious	   mutations,	   natural	   selection	   may	   also	   favour	  mutational	   robustness	   in	   RNA	   virus	   populations	   (Krakauer	   and	  Plotkin,	  2002;	  Elena	  et	  al.,	  2006;	  Lenski	  et	  al.,	  2006;	  Sanjuán	  et	  al.,	  2007),	  defined	  as	   the	  phenotypic	   constancy	  of	   a	  viral	  population	  in	  the	  face	  of	  genetic	  changes.	  	  	   In	  addition	  to	  selection,	  the	  frequency	  of	  a	  given	  mutation	  in	  a	  viral	  population	  can	  also	  be	   influenced	  by	  genetic	  drift.	  This	  evolutionary	   mechanism	   results	   from	   randon	   changes	   in	   allele	  frequencies	  in	  finite	  populations,	  which	  can	  lead	  to	  the	  stochastic	  fixation	  of	  mutations	   irrespectively	  of	  their	  selective	  value	  (Ohta,	  1992).	   In	   viral	   populations,	   bottleneks	   frequently	   take	   place	  during	   transmission	   from	   one	   individual	   host	   to	   another,	   thus	  increasing	   the	   power	   of	   genetic	   drift.	   Transmission	   bottleneks	  have	  been	  estimated	  in	  several	  animal	  and	  plant	  viruses	  (Wahl	  et	  al.,	   2002;	   Sacristán	   et	   al.,	   2003; Li	   and	   Roossinck,	   2004;	  Betancourt	   et	   al.,	   2008)	   and,	   in	   most	   cases,	   they	   can	   be	  substantial,	  with	  only	  one	  or	  few	  viral	  particles	  being	  transmitted.	  	  	  
3.	  RNA	  virus	  mutation	  rates	  	  
	   The	   rate	   of	   spontaneous	   mutation	   is	   a	   key	   parameter	  determining	   the	   genetic	   structure	   of	   populations	   over	   time.	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However,	   it	   was	   only	   in	   the	   late	   1970´s	   that	   the	   pioneer	   work	  demonstrating	   the	   extremely	   high	   genetic	   diversity	   of	  bacteriophage	   Qβ	   (Domingo	   et	   al.,	   1978)	   allowed	   us	   to	   have	   a	  better	   understanding	   of	   the	   causes	   and	   implications	   of	   viral	  mutation	   rates.	   Afterwards,	  mutation	   rates	   have	   been	  measured	  for	   over	   20	   different	   RNA	   viruses	   (Sanjuán,	   2010),	   although	  quantifying	  these	  rates	  remains	  technically	  difficult.	  For	  instance,	  many	   studies	   are	   limited	   to	   only	   a	   few	   and	   potentially	  unrepresentative	   mutational	   targets,	   and	   estimates	   are	   often	  biased	   by	   the	   action	   of	   purifying	   selection,	   which	   removes	  deleterious	   mutations	   from	   the	   population	   (Sanjuán,	   2010).	   To	  divert	   this	   selection	  bias,	  one	  possibility	   is	   to	  use	  reporter	  genes	  or	   in	   vitro	   biochemical	   assays	   using	   recombinant	   enzymes,	   but	  these	   types	   of	   studies	   do	   not	   accurately	   reflect	   the	   sequence	  context	  and	  the	  cellular	  environment	  of	  viral	  replication	  in	  nature.	  	  Importantly,	   all	   viral	   RNA-­‐dependent	   RNA	   polymerases	  (RdRps),	   except	   those	   of	   coronaviruses,	   and	   all	   reverse	  transcriptases	   (RT)	   studied	   to	   date	   lack	   3´exonuclease	  proofreading	   activity	   and	   incorporate	   mismatches	   into	   the	  nascent	  chain	  relatively	  efficiently	  (Roberts	  et	  al.,	  1988;	  Minskaia	  et	  al.,	  2006).	  	  	   RNA	   virus	   mutation	   rates	   published	   to	   date	   range	   two	  orders	  of	  magnitude,	  from	  10-­‐6	  to	  10–4	  substitutions	  per	  nucleotide	  per	   cell	   infection	   (s/n/c)	  and	  can	  vary	  considerably	  even	   for	   the	  same	  virus	  (Duffy	  et	  al.,	  2008;	  Sanjuán	  et	  al.,	  2010).	  However,	  little	  is	   known	   about	   the	   causes	   of	   this	   variability,	   aside	   from	   pure	  measurement	   errors.	   Since	   slight	   changes	   of	   the	   viral	   mutation	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rate	   can	   have	   important	   implications	   for	   pathogenesis	   (Pfeiffer	  and	  Kirkegaard,	  2005;	  Vignuzzi	  et	  al.,	  2006),	  vaccine	  development	  (Vignuzzi	   et	   al.,	   2008;	   Weeks	   et	   al.,	   2012),	   antiviral	   therapy	  (Anderson	   et	   al.,	   2004;	   Domingo,	   2006),	   and	   epidemiological	  disease	   management	   (Holmes,	   2008;	   Woolhouse	   and	   Gaunt,	  2007),	   it	   is	   necessary	   to	   have	   a	   better	   idea	   of	   the	   factors	  underlying	  the	  variability	  in	  viral	  mutation	  rates.	  
3.1	  Virus-­‐encoded	  factors	  acting	  on	  mutation	  rates	  
	   3.1.1	  Mutation	  rate	  versus	  genome	  size	  	   Among	   DNA	   viruses,	   bacteria,	   and	   also	   unicellular	  eukaryotes,	   mutation	   rates	   have	   been	   shown	   to	   correlate	  inversely	   with	   genome	   size,	   such	   that	   the	   number	   of	   mutations	  per	   genome	   stays	   roughly	   constant	   at	   0.003	   substitutions	   per	  round	  of	   copying	   (Drake,	  1991).	  However,	   this	   rule	  was	   recently	  rejected	   for	   multicellular	   eukaryotes,	   in	   which	   mutation	   rates	  actually	  tend	  to	  increase	  with	  genome	  size	  (Lynch,	  2010).	  Because	  RNA	   virus	   genome	   sizes	   vary	   only	   by	   tenfold,	   as	   opposed	   to	   a	  thousand-­‐fold	  variation	  across	  DNA	  viruses	  and	  microorganisms,	  the	   relationship	   between	   mutation	   rate	   and	   genome	   size	   has	  remained	   less	   clear.	   However,	   a	   negative	   correlation	   between	  RNA	  virus	  mutation	  rates	  and	  genome	  sizes	  was	  first	  suggested	  by	  the	  discovery	  of	  a	  3´exonuclease	  proofreading	  activity	  in	  the	  RdRp	  of	   coronaviruses,	   the	   RNA	   viruses	   with	   the	   largest	   genomes	  (Denison	   et	   al.,	   2011;	   Eckerle	   et	   al.,	   2010;	   Eckerle	   et	   al.,	   2007;	  Ulferts	  and	  Ziebuhr,	  2011;	  Minskaia	  et	  al.,	  2006).	  Moreover,	  there	  is	   a	   negative	   correlation	   between	   RNA	   virus	   genome	   sizes	   and	  evolution	  rates	  (measured	  substitutions	  per	  nucleotide	  per	  year	  in	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Figure	   1.	   Negative	   correlation	   between	   RNA	   virus	   mutation	   rate	   and	  genome	  size	  (bp:	  base-­‐pair).	  The	  least-­‐squares	  regression	  line	  has	  slope	  -­‐2.06	   ±	   0.79	   in	   log-­‐log	   scale	   (Pearson	   r	   =	   -­‐	   0.655,	   p	   =	   0.029).	   Reverse	  transcribing	  viruses	  were	  not	  included	  in	  this	  plot.	  Adapted	  from	  Combe	  and	  Sanjuán	  (2014a).	  	  	   The	  evolutionary	  explanation	  for	  this	  negative	  correlation	  between	   mutation	   rates	   and	   genome	   sizes	   remains	   unclear.	   As	  discussed	  before,	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often	   deleterious	   than	   beneficial,	   and	   to	   reduce	   the	   genetic	   load	  selection	   should	   favour	   lower	   mutation	   rates,	   but	   on	   the	   other	  hand,	   higher	  mutation	   rates	   allow	   adaptation	   (Sniegowski	   et	   al.,	  2000).	  To	  resolve	  this	  situation,	  theory	  predicts	  that	  there	  should	  be	   an	   optimum	   value	   of	   the	   mutation	   rate	   that	   maximizes	  adaptability	  and	  correlates	  inversely	  with	  genome	  size	  (Orr,	  2000;	  Johnson	  and	  Barton,	  2002).	  
3.1.2	  Mutation	  rate	  versus	  genome	  polarity	  	   According	   to	   Baltimore’s	   classification,	   there	   are	   the	  following	  groups	  of	  viruses:	  positive-­‐stranded,	  negative-­‐stranded,	  double	   stranded	   (ds),	   and	   reverse-­‐transcribing	   viruses.	   The	   first	  two	   groups	   of	   viruses	   are	   single-­‐stranded,	   and	   are	   denoted	  ss(+)RNA	  and	  ss(−)RNA,	  respectively.	   In	  ss(+)RNA	  and	  ss(−)RNA	  viruses,	  replication	  occurs	  by	  synthesis	  of	  complementary	  strands,	  which	   are	   used	   as	   templates	   for	   the	   synthesis	   of	   new	   genomic	  RNAs.	   In	   dsRNA	   viruses	   replication	   can	   occur	   either	   through	   a	  positive-­‐strand	   intermediate	   used	   for	   synthesizing	   dsRNA	   (i.e.	  rotaviruses)	   or	   following	   the	   standard	   semi-­‐conservative	  replication	  mode	  of	  cellular	  DNA	  (i.e.	  partitiviruses).	  	  	   Genome	   polarity	   has	   many	   implications	   in	   RNA	   virus	  biology.	   In	   ss(+)RNA	   viruses,	   the	   genomic	   RNA	   acts	   directly	   as	  mRNA,	   whilst	   in	   ss(−)RNA	   and	   dsRNA	   viruses	   it	   needs	   to	   be	  transcribed	  first.	  As	  a	  consequence,	  ss(−)RNA	  and	  dsRNA	  viruses	  have	   to	  package	  a	  RdRp	   in	   the	  virion	  and	  generally	  protect	   their	  genomic	   RNA	   with	   nucleoproteins,	   potentially	   protecting	   them	  from	  RNA	  damaging	  agents	  or	  host-­‐mediated	  editing.	  In	  contrast,	  the	   genome	  of	   ss(+)RNA	  viruses	   and	   retroviruses	   is	  more	  naked	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and	  susceptible	  to	  form	  secondary	  structures,	  thus	  increasing	  the	  probability	  of	  recombination	  and	  frame-­‐shift	  mutation,	  as	  showed	  for	  HIV-­‐1	  (Galetto	  et	  al.,	  2004;	  Simon-­‐Loriere	  et	  al.,	  2009;	  Pathak	  and	  Temin,	  1992).	  	  	   Recently,	   we	   showed	   that	   ss(+)RNA	   viruses	   exhibit	   the	  highest	   variability	   in	   mutation	   rates,	   since	   they	   ranged	   by	   two	  orders	  of	  magnitude	   (Figure	  2).	  However,	   this	  observation	   could	  be	   due	   to	   the	   fact	   that	   there	   are	   (i)	   more	   studies	   for	   ss(+)RNA	  viruses	   compared	   to	   ss(−)RNA	  and	  dsRNA	  viruses,	   (ii)	   estimates	  for	  a	  broader	  host	  range	  in	  ss(+)RNA	  viruses	  (animals,	  plants	  and	  bacteria),	   (iii)	  more	  variable	  genome	  sizes	   in	  ss(+)RNA,	   from	  4.2	  kb	   for	   the	   phage	   Qβ	   to	   31.3	   kb	   for	   the	   murine	   hepatitis	  coronavirus,	  versus	   a	  7.8-­‐15.9	  kb	  range	   for	  all	  other	  RNA	  viruses	  for	  which	  mutation	   rates	   are	  available,	   and	   (iv)	   the	   anomalously	  low	  mutation	  rate	  for	  the	  bacteriophage	  Φ6,	  representing	  the	  only	  estimate	  for	  dsRNA	  viruses	  (Chao	  et	  al.,	  2002).	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Figure	   2.	   Mutation	   rates	   versus	   genome	   polarity.	   Mutation	   rates	   are	  represented	   for	   the	   four	   groups	   of	   RNA	   viruses	   established	   by	   the	  Baltimore	   classification.	  Horizontal	   black	   lines	   represent	   the	   geometric	  mean	   (log-­‐scale	   mean)	   for	   each	   category.	   Adapted	   from	   Combe	   and	  Sanjuán	  (2014a).	  	  
3.1.3	  Viral	  replication	  mode	  Riboviruses	  can	  replicate	  following	  several	  models	  (Figure	  3).	  Under	  the	  stamping	  machine	  (SM)	  model,	  a	  single	  template	   is	  repeatedly	   used	   to	   produce	   all	   progeny	   strands	   within	   a	   cell,	  which	   do	   not	   become	   template	   until	   they	   infect	   another	   cell.	  Therefore	  under	  the	  SM	  model	  due	  to	  the	  complementarity	  of	  the	  RNA,	   there	   are	   only	   two	   rounds	   of	   genome	   copying	   per	   cell,	  allowing	   a	   linear	   accumulation	   of	   the	   progeny	   and	   thus	   low	  mutation	   frequencies	   are	   expected	   (Safari	   and	   Roossinck,	   2014;	  García-­‐Villada	   and	   Drake,	   2012).	   In	   contrast,	   under	   geometric	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replication	  (GR),	  once	  a	  new	  progeny	  strand	  is	  synthesized	  it	  also	  becomes	   template.	   There	   are	   thus	  multiple	   (i.e.	   more	   than	   two)	  rounds	   of	   genome	   copying	   per	   cell,	   leading	   to	   an	   exponential	  growth	  of	  the	  virus	  (Luria,	  1951;	  Sardanyés	  et	  al.,	  2009;	  Thébaud	  et	   al.,	   2010),	   and	   thus	   higher	  mutation	   frequencies	   are	   expected	  (Safari	  and	  Roossinck,	  2014).	  	  	  
	  
Figure	   3.	   Viral	   replication	   modes.	   Under	   the	   stamping	   machine	  replication	  model,	   a	   single	   template	   is	   used	   to	  produce	   all	   the	  progeny	  strands	  within	  a	  cell.	  There	  are	  only	  two	  rounds	  of	  genome	  copying	  per	  cell,	   thus	   progeny	   accumulate	   linearly,	   as	   well	   as	   mutations	   (coloured	  dots).	   In	   contrast,	   under	   geometric	   replication,	   once	   a	   new	   progeny	  strand	  is	  synthesized	  it	  also	  becomes	  template	  within	  the	  same	  cell,	  thus	  there	  are	  multiple	  (i.e.	  more	  than	  two)	  rounds	  of	  genome	  -­‐>	  antigenome	  -­‐>	   genome	   copying	   per	   cell	   and	   progeny	   genomes	   and	   mutations	  accumulate	  exponentially.	  Adapted	  from	  Combe	  and	  Sanjuán	  (2014a).	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Viral	   replication	   under	   the	   stamping	   machine	   or	   the	  geometric	   model	   impact	   differently	   the	   pattern	   of	   intra-­‐cellular	  mutation	   accumulation	   (García-­‐Villada	   and	   Drake,	   2012;	   Schulte	  et	   al.,	   2015),	   and	   the	   mean	   and	   variance	   of	   the	   number	   of	  mutations	   after	   one	   infection	   cycle	   will	   be	   higher	   under	   the	  geometric	   model	   (Combe	   and	   Sanjuán,	   2014a).	   However,	   scarce	  information	  on	  the	  mode	  by	  which	  RNA	  viruses	  replicate	  within	  a	  host	   cell	   is	   available.	   Only	   few	   studies	   published	   to	   date,	  conducted	  with	   the	  bacteriophage	  φ6	  (Chao	  et	  al.,	  2002),	  φX174	  (Denhardt	  and	  Silver,	  1966),	  Qβ	  (García-­‐Villada	  and	  Drake,	  2012)	  and	   the	   ss(+)RNA	   turnip	   mosaic	   virus	   	   (Sardanyés	   et	   al.,	   2011)	  and	   Wheat	   streak	   mosaic	   virus	   (French	   and	   Stenger,	   2003),	  suggested	   that	   riboviruses	   replicate	   following	   the	   stamping	  machine	  model.	  However,	  the	  mutant	  distribution	  for	  φ6	  differed	  from	  the	  expected	  Poisson	  distribution,	  suggesting	  an	  exponential	  component	   of	   the	   replication	   dynamics	   (Chao	   et	   al.,	   2002).	   Also,	  Martínez	   et	   al.	   (2011)	   investigated	   the	   dynamics	   of	   (-­‐)-­‐	   and	   (+)-­‐strands	  RNA	  of	  tobacco	  mosaic	  virus	  in	  the	  protoplast	  of	  Nicotiana	  
benthamiana,	   and	   proposed	   that	   the	   mode	   of	   replication	   of	   this	  virus	   might	   be	   a	   mixed	   strategy	   of	   geometric	   and	   stamping	  machine,	  although	  90%	  of	  the	  synthesized	  genomes	  derived	  from	  the	   stamping	   machine	   model.	   For	   poliovirus,	   a	   recent	   study	  combining	   a	   mathematical	   model	   with	   quantitative	   data	   on	   the	  production	   of	   RNA	   and	   viral	   particles	   showed	   that	   multiple	  generations	   elapsed	   within	   a	   single	   cell	   infection	   (Schulte	   et	   al.,	  2015).	   For	   ss(-­‐)RNA	   viruses,	   although	   it	   has	   been	  proposed	   that	  the	  replication	  mode	  of	  VSV	  might	  be	  mixed	  (Sanjuán	  et	  al.,	  2010),	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the	   high	   ratio	   of	   (-­‐)-­‐	   to	   (+)-­‐strands	   also	   support	   a	   stamping	  machine	  model	  (Safari	  and	  Roossinck,	  2014).	  
3.2	  Host	  factors	  acting	  on	  mutation	  rates	  	   In	   addition	   to	  virus-­‐encoded	   factors,	   such	  as	   the	   intrinsic	  viral	   polymerase	   fidelity	   (Menéndez-­‐Arias,	   2009;	   Pfeiffer	   and	  Kirkegaard,	   2003;	   Arnold	   et	   al.,	   2005;	   Korneeva	   and	   Cameron,	  2007),	   the	   presence/absence	   of	   proofreading	   mechanisms	  (Roberts	  et	  al.,	  1988;	  Steinhauer	  et	  al.,	  1992;	  Denison	  et	  al.,	  2011),	  or	   the	   mode	   of	   replication	   (Chao	   et	   al.,	   2002;	   Sardanyes	   et	   al.,	  2009),	  host	  factors	  may	  also	  determine	  viral	  mutation	  rates.	  
	   3.2.1	  Variability	  at	  the	  cellular	  level	  
	   Viruses	  depend	  on	  intra-­‐cellular	  resources	  for	  nucleic	  acid	  and	  protein	  biosynthesis.	  For	  instance,	  variation	  among	  cell	  types	  of	  the	  total	  intra-­‐cellular	  concentration	  and	  balance	  of	  dNTPs	  may	  affect	   replication	   fidelity	   in	   retroviruses	   (Diamond	   et	   al.,	   2004;	  Bebenek	  et	  al.,	  1992;	   Julias	  and	  Pathak,	  1998).	  The	   impact	  of	  cell	  metabolism	  on	  viral	  mutation	  rates	  has	  also	  been	  exemplified	  in	  a	  study	  showing	  that	  ethanol-­‐derived	  reactive	  oxygen	  species	  (ROS)	  are	  mutagenic	   for	   hepatitis	   C	   virus,	  whereas	   glutathione	   or	   iron	  chelators	  were	  found	  to	  have	  the	  opposite	  effect	  (Seronello	  et	  al.,	  2011).	  Moreover,	  the	  expression	  of	  specific	  cellular	  genes,	  such	  as	  APOBEC3G	   cytidine	   deaminases,	   can	   edit	   and	   produce	   G-­‐to-­‐A	  hypermutation	  in	  retroviruses	  (Harris	  et	  al.,	  2003;	  Lecossier	  et	  al.,	  2003;	  Mangeat	  et	  al.,	  2003;	  Bonnac	  et	  al.,	  2013)	  and	   thus	   impact	  viral	   mutation	   rates.	   Indeed,	   it	   has	   been	   shown	   that	   expression	  levels	   of	   APOBEC3G	   could	   determine	   the	   rate	   at	   which	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hypermutated	  HIV-­‐1	  genomes	  accumulate	   throughout	   the	  course	  of	  an	   infection	  and	   influence	  disease	  progression,	  with	   increased	  hypermutant	  frequency	  associated	  with	  slower	  progression	  rates	  (Land	  et	  al.,	  2008).	  	  	   Cellular	  editing	   is	  not	  restricted	   to	  retroviruses,	   since	   the	  RNA-­‐dependent	  adenosine	  deaminase	  (ADAR)	  has	  been	  shown	  to	  induce	   A-­‐to-­‐G	   hypermutation	   in	   several	   RNA	   viruses,	   including	  measles	  virus	  (Cattaneo	  et	  al.,	  1988;	  Schmid	  et	  al.,	  1992),	  human	  parainfluenza	   virus	   (Murphy	   et	   al.,	   1991),	   respiratory	   syncytial	  virus	   (O’Hara	   et	   al.,	   1984;	  Martinez	   et	   al.,	   1997),	   influenza	   virus	  (tenOever	   et	   al.,	   2007),	   vesicular	   stomatitis	   virus	   (Bass	   et	   al.,	  1989),	   paramyxoviruses	   (Rueda	   et	   al.,	   1994),	   lymphocytic	  choriomeningitis	   virus	   (Zahn	  et	   al.,	   2007),	  Rift	  Valley	   fever	  virus	  (Suspène	  et	   al.,	   2008),	  mumps	  virus	   (Chambers	  et	   al.,	   2009)	  and	  hepatitis	   C	   virus	   (Taylor	   et	   al.,	   2005).	   The	   ADAR	   enzyme,	  expressed	  in	  a	  wide	  variety	  of	  mammalian	  cell	  types,	  is	  a	  double-­‐stranded	  RNA	  (dsRNA)	  binding	  protein	  that	  modifies	  cellular	  and	  viral	  RNA	  sequences	  by	  adenosine	  (A)	  deamination	  to	   inosine	  (I)	  (Nie	   et	   al.,	   2007).	   Inosine	   preferentially	   base	   pair	  with	   cytosine,	  leading	  thus	  to	  the	  replacement	  of	  genome-­‐encoded	  adenosine	  (A)	  by	   guanosine	   (G)	   (Suspène	   et	   al.,	   2008).	   In	   the	   cytoplasm	   of	   the	  host,	   viral	   dsRNAs	   bind	   and	   activate	   cytoplasmic	   viral	   sensor	  proteins	   (Takeuchi	   and	   Akira,	   2010)	   that	   need	   the	   presence	   of	  dsRNA	   ends	   and	   5’	   triphosphates	   to	   discriminate	   virus	   and	  pathogen	   RNAs	   from	   host	   cytoplasmic	   RNAs	   (Mannion	   et	   al.,	  2014).	   The	   stimulation	   of	   these	   sensors	   further	   activate	   the	  cellular	   antiviral	   response	   via	   activation	   of	   (i)	   type	   I	   interferon	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(IFN)	  and	  proinflammatory	  cytokines	  (Geiss	  et	  al.,	  2001)	  and	  (ii)	  dsRNA-­‐activated	   enzymes	   such	   as	   ADAR	   that	   inhibit	   viral	  replication	  (Samuel,	  2001).	  	   Whilst	  the	  formation	  of	  dsRNA	  has	  been	  long	  thought	  to	  be	  a	   common	   feature	   to	   all	   viruses	   (Jacobs	   and	   Langland,	   1996;	  Kumar	  and	  Garmichael,	  1998),	  Weber	  et	  al.	   (2006)	  confirmed	   its	  production	   in	   infected	   cells	   by	   (+)-­‐strand	   RNA	   viruses,	   dsRNA	  viruses	   and	  DNA	  viruses.	   In	   contrast,	   dsRNA	   intermediates	  were	  not	  detected	  for	  (-­‐)-­‐strand	  RNA	  viruses,	  although	  these	  viruses	  are	  able	   to	   induce	   interferon	   synthesis	   (Weber	  et	   al.,	   2004),	   activate	  PKR	  (Bergmann	  et	  al.,	  2000;	  Stojdl	  et	  al.,	  2000;	  Streitenfeld	  et	  al.,	  2003)	   or	   even	   express	   a	   dsRNA-­‐binding	   protein	   (Hatada	   et	   al.,	  1992;	   Lu	   et	   al.,	   1995).	   Alternatively,	   in	   (-­‐)-­‐strand	   RNA	   viruses	  other	  viral	   structures	  may	  play	   the	   role	  of	  dsRNA	  as	  an	  antiviral	  signal	   for	   the	   host	   cell	   (Weber	   et	   al.,	   2006),	   such	   as	   the	  ribonucleoprotein	   particles	   of	   VSV	   and	  measles	   virus	   capable	   of	  triggering	   IFN	   induction	   (tenOever	   et	   al.,	   2002;	   tenOever	   et	   al.,	  2004).	   Because	   ADAR	   is	   induced	   by	   viral	   infection	   and	   IFN	  activation,	   it	   has	   been	   proposed	   to	   play	   a	   role	   in	   host	   defense	  mechanisms	   (Patterson	   et	   al.,	   1995;	   Rabinovici	   et	   al.,	   2001),	  although	   recent	   studies	   have	   demonstrated	   that	   it	   can	   also	  promote	   the	   replication	   of	   many	   RNA	   viruses	   (Gélinas	   et	   al.,	  2011).	   However,	   the	   RNA	   editing	   by	   ADAR	   might	   affect	   the	  outcome	   of	   virus-­‐host	   interactions	   (Samuel,	   2011),	   such	   as	   in	  measles	   infection	   where	   hypermutations	   were	   associated	   with	  changes	  in	  viral	  pathogenesis	  and	  persistent	  infection	  (Cattaneo	  et	  al.,	   1988),	   or	   as	   showed	   for	   human	   hepatitis	   virus	  where	   ADAR	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inhibited	   viral	   replication	   and	   compromised	   virus	   stability	   as	   a	  potential	   antiviral	   mechanism	   (Hartwig	   et	   al.,	   2006;	   Jayan	   and	  Casey,	  2002;	  Taylor	  et	  al.,	  2005).	  	  
	   3.2.2	  Variability	  at	  the	  host	  species	  level	  
	   The	   slower	   evolution	   of	   arthropod-­‐borne	   viruses	  compared	   to	   directly	   transmitted	   viruses	   (Jenkins	   et	   al.,	   2002;	  Woelk	   and	   Holmes,	   2002;	   Hicks	   and	   Duffy,	   2014)	   has	   been	  interpreted	   in	   terms	   of	   fitness	   trade-­‐offs,	   where	   beneficial	  mutations	   in	   one	   host	   can	   be	   costly	   in	   the	   other	   host,	   thus	  restricting	  viral	  adaptation	  in	  the	  long	  term	  (Weaver	  et	  al.,	  1999;	  Coffey	   et	   al.,	   2008).	   This	   trade-­‐off	   has	   been	  well	   documented	   in	  dengue	  virus,	  in	  which	  the	  analysis	  of	  sequence	  diversity	  revealed	  strong	   purifying	   selection	   (Holmes,	   2003;	   Holmes	   and	   Rambaut,	  2004).	   However,	   previous	   work	   has	   not	   tested	   for	   possible	  differences	   between	   the	   rates	   of	   spontaneous	   mutation	   of	  arboviruses	  and	  those	  of	  other	  viruses.	  	  This	  may,	  though,	  offer	  an	  alternative	   explanation	   for	   the	   relatively	   slow	   evolution	   of	  arboviruses.	  Also,	  the	  relatively	  high	  genetic	  homogeneity	  of	  plant	  RNA	  viruses	  may	  be	  explained	  by	  the	  fact	  that	  positive	  selection	  of	  new	   beneficial	   mutations	   is	   weaker	   compared	   to	   their	   animal	  counterpart	  (Hall	  et	  al.,	  2001;	  Rodriguez-­‐Cerezo	  et	  al.,	  1991;	  Kim	  et	  al.,	  2005;	  Marco	  and	  Aranda,	  2005;	  Fraile	  et	  al.,	  1997).	  This	  can	  be	   the	   result	   of	   (i)	   weaker	   immune	   pressure	   than	   in	   animal	  viruses	  (García-­‐Arenal	  et	  al.,	  2001),	  or	  (ii)	  increased	  genetic	  drift,	  relative	   to	   selection,	   during	   population	   bottlenecks	   operating	   in	  leaf-­‐to-­‐leaf	   (Li	   and	  Roossinck,	  2004)	  and	   inter-­‐host	   transmission	  (Ali	   et	   al.,	   2006).	   Moreover,	   it	   has	   been	   proposed	   that	   plant-­‐
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specific	   spatial	   structures	   could	   impose	   a	   limit	   to	   the	   fixation	   of	  beneficial	   mutations	   by	   reducing	   the	   opportunities	   for	  competition	   among	   genetic	   variants	   (Elena	   et	   al.,	   2011).	   Recent	  studies	  showed	  that	  the	  mutation	  rates	  of	  turnip	  mosaic	  virus	  and	  tobacco	   etch	   virus	   were	   slightly	   above	   10-­‐6	   s/n/r	   (Tromas	   and	  Elena,	  2010;	  de	  la	  Iglesia	  et	  al.,	  2012),	  which,	  similar	  to	  the	  rate	  for	  dsRNA	  bacteriophage	  Φ6,	  fall	  in	  the	  lower	  part	  of	  the	  typical	  RNA	  virus	   range	   (Figure	   4).	   In	   support	   of	   this	   finding	   was	   the	  observation	   that	   the	   fidelity	   of	   the	   viral	   replicase	   of	   cucumber	  mosaic	  virus	  (CMV)	  depends	  on	  the	  host	  plant	  in	  which	  the	  virus	  replicates,	   since	   insertions/deletions	   were	   more	   frequent	   in	  pepper	   than	   in	   tobacco	  plants	   (Pita	   et	   al.,	   2007).	  These	  different	  levels	   of	   genetic	   diversity	   between	   host	   plants	   have	   been	  attributed	   to	   either	   differences	   in	   viral	   replicase	   fidelity,	   that	  could	   be	   host-­‐dependent,	   or,	   alternatively,	   to	   host-­‐specific	  selection	   pressures	   and	   bottlenecks	   associated	   to	   cell-­‐to-­‐cell	  movement	   that	   limited	   the	   accumulation	   of	   diversity	   (Schneider	  and	  Roossinck,	  2001).	  


















Figure	  4.	  Animal	  versus	  plant	  RNA	  virus	  mutation	  rates.	  Horizontal	  black	  lines	   represent	   the	  geometric	  mean	  (log-­‐scale	  mean)	   for	  each	  category.	  Adapted	  from	  Combe	  and	  Sanjuán	  (2014a).	  	  
4.	  Experimental	  models	  	  
4.1	  Rhabdovirus:	  Vesicular	  stomatitis	  virus	  	   	  
	   4.1.1	  History	  and	  generalities	  	   Vesicular	  stomatitis	  virus	  (VSV)	  is	  a	  lytic,	  enveloped,	  non-­‐segmented	  RNA	  virus	  of	  negative	  polarity,	  belonging	  to	  the	  order	  
Mononegavirales,	   family	   Rhabdoviridae	   and	   genus	   Vesiculovirus	  (group	  V	  in	  Baltimore’s	  classification).	  The	  virion	  is	  described	  as	  a	  bullet-­‐shaped	  particle	  of	  180	  nm	  in	  length	  and	  75	  nm	  in	  diameter	  	  (Figure	  5).	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Figure	  5.	  Electron	  microscope	  photograph	  of	  VSV	  particles,	  courtesy	  of	  Professor	   FA	   Murphy	   and	   UC	   Davis	  (http://www.vetmed.ucdavis.edu/viruses/download.html).	  	  	   VSV	   is	   the	   causative	   agent	   of	   the	   zoonotic	   vesicular	  stomatitis	  disease	  in	  multiple	  livestock	  species,	  as	  well	  as	  a	  variety	  of	   wild	   animals,	   that	   gives	   rise	   to	   important	   public	   health,	  veterinary	   and	   agricultural	   impacts	   (Kuzmin	   et	   al.,	   2009;	  Reis	   et	  al.,	   2009).	   Although	   rhabdoviruses	   are	   distributed	   worldwide,	  vesiculoviruses	   are	   endemic	   between	   southern	   North	   America	  and	  northern	  South	  America,	  where	  they	  cause	  annual	  outbreaks	  usually	   associated	   with	   the	   change	   between	   rainy	   and	   dry	  seasons.	  Vesicular	  stomatitis	  is	  not	  a	  newly	  emerged	  disease	  since	  outbreaks	   of	   “sore	   tongue”	   in	   horses	   between	   1801-­‐1802,	   and	  then	  in	  1817,	  were	  reported	  in	  the	  easter	  USA,	  that	  were	  followed	  by	   important	   epidemics	   between	   1862-­‐1995	   (Letchworth	   et	   al.,	  1999).	  	   The	   two	   main	   VSV	   serotypes	   are	   the	   Indiana	   serotype	  (VSIV)	   and	   the	   New	   Jersey	   serotype	   (VSNJV),	   which	   account	   for	  80%	  of	  the	  outbreaks	  in	  the	  US	  (Kuzmin	  et	  al.,	  2009).	   In	  infected	  animals,	  the	  clinical	  disease	  signs	  are	  like	  those	  of	  foot-­‐and-­‐mouth	  disease	   and	   are	   characterized	   by	   initial	   vesicular	   formations	   on	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the	   feet	   and	   in	   the	   mouth	   that	   progress	   to	   erosions	   and	  ulcerations	  on	  the	  tongue,	  palate,	  gum,	  lips,	  snout,	  teats,	  prepuce,	  interdigital	   space	   and	   coronary	   band,	   whereas	   in	   humans	  symptoms	   are	   like	   those	   of	   influenza	   (Letchworth	   et	   al.,	   1999).	  The	   incubation	   time	   is	   variable	   but	   usually	   vesicles	   are	   visible	  within	   24-­‐72	   h	   after	   viral	   infection,	   and	   recovery	   occurs	   within	  two	  to	  three	  weeks	  of	  vesicle	  formation	  (Reis	  et	  al.,	  2009).	  	  
	   4.1.2	  VSV	  host	  range	  and	  lifecycle	  	   VSV	  has	  a	  wide	  host	  range	  since	   it	  can	   infect	  a	  very	   large	  number	   of	   mammal	   species	   including	   livestock	   (cattle,	   horse,	  swine,	  goats,	  etc.)	  and	  wild	  animals	  (rodents,	  bear,	  lynx,	  bats,	  etc.),	  and	   also	   infects	   insects	   (sandflies,	   blackflies,	   mosquitoes,	   etc.)	  (Letchworth	   et	   al.,	   1999;	   Kuzmin	   et	   al.,	   2009)	   which	   act	   as	  transmission	  vectors	  (Comer	  et	  al.,	  1990;	  Mead	  et	  al.,	  2004;	  Tesh	  et	  al.,	  1972).	  Indeed,	  VSV	  is	  an	  arthropod-­‐borne	  virus	  (arbovirus)	  and	   its	   lifecycle	   involves	  horizontal	   transmission	   from	   insects	   to	  mammals	   during	   blood	   meals	   (Comer	   et	   al.,	   1990;	   Mead	   et	   al.,	  2004;	   Mead	   et	   al.,	   1999)	   and	   vertical	   (i.e.	   transovarian)	  transmission	  from	  infected	  female	  insects	  to	  their	  offspring	  (Tesh	  et	   al.,	   1972)	   (Figure	   6).	   Although	   transovarian	   transmission	   in	  insects	   can	   be	  maintained	   for	   several	   generations,	   the	   virus	   can	  also	   be	   lost.	   Therefore,	   replication	   in	   both	   arthropods	   and	  vertebrates	  is	  necessary	  in	  the	  lifecycle	  of	  arboviruses,	  explaining	  the	  necessity	  of	  mammalian	  infections	  (Zárate	  and	  Novella,	  2004).	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Figure	   6.	  Natural	   life	   cycle	   of	   VSV.	  Within	   the	   insect	   reservoir,	   arrows	  indicate	   vertical	   (i.e.	   transovarian)	   transmission	   of	   the	   virus	   from	  infected	   female	   insects	   to	   their	   offspring.	   Horizontal	   arrows	   indicate	  transmission	   of	   the	   virus	   between	   insects	   and	   mammals	   (wild	   and	  domestic	  animals)	  during	  blood	  meals.	  In	  mammals,	  VSV	  can	  transmit	  by	  contact	   between	   an	   infected	   and	   a	   non-­‐infected	   animal,	   although	   the	  mechanisms	  of	  transmission	  are	  unknown.	  	  	  
	  	   4.1.3	  VSV	  genome	  organization	  	   The	   VSV	   RNA	   genome	   has	   11,161	   nucleotides	   in	   length	  and	  packaged	  in	  the	  form	  of	  an	  internal	  ribonucleoprotein	  (RNP)	  complex.	  The	  genome	  comprises	  five	  genes,	  a	  leader	  and	  a	  trailer	  regulatory	  sequences	  organized	   in	  the	   following	  order	  3’-­‐le,	  N,	  P,	  M,	  G,	  L,	  tr	  -­‐5’	  (Abraham	  and	  Banerjee,	  1976,	  Ball	  and	  White,	  1976)	  (Figure	  7).	  The	  genome	  is	  never	  found	  as	  a	  naked	  RNA	  during	  the	  replication	   cycle	   in	   the	   cytoplasm	   of	   infected	   cells,	   but	   rather	   is	  always	   packaged	   by	   the	   nucleocapsid	   (N)	   protein	   to	   form	   a	  nuclease-­‐resistant	  helical	  core,	   that	   is	   the	   functional	   template	   for	  RNA	   synthesis	   (Barr	   et	   al.,	   2002).	   Because	   negative-­‐sense	   RNA	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viral	  genomes	  cannot	  be	  used	  as	  mRNA,	  and	  host	  cells	  do	  not	  have	  appropriate	   enzymes	   to	   catalyze	   transcription	   (Lichty	   et	   al.,	  2004),	   initiation	   of	   the	   infection	   cycle	   relies	   on	   a	   viral	   RNA-­‐dependent	   RNA-­‐polymerase	   (RdRp),	   composed	   by	   the	   large	   (L)	  protein	   and	   a	   phosphoprotein	   (P),	  which	   are	   both	   bound	   to	   and	  interact	   with	   the	   RNP	   core	   to	   perform	   viral	   transcription	   and	  replication.	  The	  remaining	  two	  components	  of	  the	  VSV	  virion,	  the	  matrix	  (M)	  protein	  and	  the	  glycoprotein	  (G)	  are	  not	  essential	   for	  RNA	  synthesis.	  Nevertheless,	  M	  protein	  serves	  as	  condensation	  of	  the	  RNP	  core	  during	  assembly	  and	  participates	   in	  the	  budding	  of	  the	   virion	   from	   the	   cell	   membrane,	   while	   the	   G	   protein	   is	   the	  functional	   unit	   for	   both	   assembly	   into	   virions	   and	   virus	   binding	  and	  entry	  via	  host	  cell	  receptors	  (Kuzmin	  et	  al.,	  2009).	  Also,	  the	  M	  protein	   has	   a	   crucial	   role	   in	   the	   early	   phases	   of	   viral	   infection	  since	   it	   avoids	   the	   cellular	   antiviral	   programs	   by	   interrupting	  cellular	  transcription	  and	  blocking	  mRNA	  export	  from	  the	  nucleus	  (Lichty	  et	  al.,	  2004;	  Kuzmin	  et	  al.,	  2009).	  	  	  
	  
	  
Figure	  7.	  Vesicular	  stomatitis	  virus	  genome	  organization.	  The	  ss(-­‐)RNA	  genome	   is	   composed	   of	   five	   structural	   genes,	   plus	   leader	   and	   trailer	  regulatory	   sequences:	   3’-­‐(leader),	   the	   nucleoprotein	   (N),	   the	  phosphoprotein	   (P),	   the	   matrix	   protein	   (M),	   the	   glycoprotein	   (G),	   the	  large	  polymerase	  protein	  (L),	  and	  (trailer)-­‐5’.	  From	  Lichty	  et	  al.	  (2004).	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   4.1.4	  VSV	  genome	  replication	  	   The	  replication	  cycle	  of	  the	  VSV	  genome	  is	  similar	  to	  those	  of	   most	   negative-­‐stranded	   RNA	   viruses	   and	   requires	   both	  transcription	   and	   replication	   of	   the	   (-­‐)-­‐strand	   RNA	   molecule.	  Intra-­‐cellular	   replication	   involves	   the	   synthesis	   of	   a	   full-­‐length	  (+)-­‐strand	   RNA,	   which	   then	   serves	   as	   the	   template	   for	   the	  production	  of	  progeny	  (-­‐)-­‐strand	  RNA	  (Peluso	  and	  Moyer,	  2002).	  	  	   The	   adsorption	   of	   VSV	   to	   the	   cell	  membrane	   is	  mediated	  by	   the	  G	  protein	  using	  nonspecific	  electrostatic	  and	  hydrophobic	  interactions.	   VSV	   penetration	   uses	   clathrin-­‐dependent	  endocystosis	  into	  coated	  vesicles,	  which	  become	  an	  endosome	  1-­‐2	  min	  after	  adsorption.	  Then,	  a	  pH	  drops	  below	  6.5	  allows	  the	  fusion	  of	   the	  endosome	  membrane	  with	   the	  viral	  envelope	  (Letchworth	  et	  al.,	  1999).	  Following	  attachment,	  penetration	  and	  uncoating,	  the	  genome	   is	   delivered	   into	   the	   cytoplasm,	   where	   RNA	   synthesis	  occurs	   (Follett	   et	   al.,	   1974).	   This	   process	   starts	   by	   a	   primary	  transcription,	   where	   the	   virion	   polymerase	   responds	   to	   specific	  signals	   to	   transcribe	   six	   discrete	   RNAs:	   a	   47-­‐nucleotide	   leader	  RNA	   that	   is	   neither	   capped	  nor	   polyadenylated,	   and	   five	  mRNAs	  that	  are	  capped	  and	  methylated	  at	   the	  5’end	  and	  polyadenylated	  at	   the	   3’	   end.	   Following	   translation	   of	   the	  mRNAs	   into	   sufficient	  yield	  of	  viral	  proteins,	  genome	  replication	  starts.	  The	  RdRp	  binds	  to	  the	  3’	  end	  of	  the	  genome,	  ignores	  all	  the	  signals	  for	  production	  of	   discrete	   monocistronic	   mRNAs,	   and	   synthesizes	   a	   full-­‐length	  complementary	   antigenome.	   This	   antigenomic	   RNA	   serves	   as	  template	  for	  synthesis	  of	  a	  45-­‐nucleotide	  minus	  sense	  leader	  RNA,	  and	  also	  for	  synthesis	  of	  full-­‐length	  progeny	  genomes.	  These	  new	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ss(-­‐)RNA	   progeny	   genomes	   can	   be	   then	   used	   as	   templates	   for	  secondary	   transcription,	   or	   assembled	   into	   infectious	   particles	  and	  exit	  the	  cell	  (Figure	  8)	  (Barr	  et	  al.,	  2002).	  	  	   The	   early	   events	   of	   the	   replication	   cycle	   (i.e.	   attachment,	  penetration,	   uncoating	   and	   primary	   transcription)	   take	   place	  within	  the	  first	  hours	  postinfection,	  whereas	  the	  remaining	  steps	  (i.e.	   genome	   replication,	   secondary	   transcription	   and	   assembly)	  occur	   within	   12-­‐18	   hours	   (Reis	   et	   al.,	   2009).	   At	   the	   end	   of	   the	  cycle,	   transcription	   and	   replication	   are	   inhibited,	   the	   RNP	  becomes	   intensively	   condensed	  and	   is	   subsequently	  delivered	   to	  the	   cell	   membrane,	   where	   the	   virion	   acquires	   the	   glycoprotein	  and	  lipid	  envelope	  for	  self-­‐assembly	  (Kuzmin	  et	  al.,	  2009).	  	  
	  	  
Figure	   8.	   Vesicular	   stomatitis	   virus	   genome	   replication.	   Following	  attachment,	  penetration	  and	  uncoating,	  the	  genome	  is	  delivered	  into	  the	  cytoplasm	  of	  the	  infected	  cell	  where	  the	  RNA	  synthesis	  occurs.	  At	  the	  end	  of	  the	  replication	  cycle,	   the	  virion	  is	  delivered	  to	  the	  cell	  membrane	  for	  self-­‐assembly	  and	  exits	  the	  cell	  by	  lysis.	  From	  Lichty	  et	  al.	  (2004).	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   4.1.5	  VSV	  as	  a	  model	  for	  experimental	  evolution	  	   Vesicular	   stomatitis	   virus	   is	   one	   of	   the	  most	  widely	   used	  systems	   for	   the	   experimental	   study	  of	   viral	   evolution	  because	  of	  its	  relatively	  simple	  and	  well	  characterized	  genome	  organization,	  fast	   replication,	   and	   its	   high	   adaptability	   and	   capacity	   to	   spread	  between	   infected	   cells	   (Letchworth	   et	   al.,	   1999;	   Novella,	   2003).	  Also,	   since	   the	   virion	   attaches	   to	   some	   ubiquitous	   cell	   surface	  receptor	   it	  can	  productively	   infect	  mammalian	  cells	   from	  various	  origins	  (Whelan,	  2008),	  as	  well	  as	  insect	  cells	  (Novella,	  2003).	  	  
4.2	  Calicivirus:	  Norwalk	  virus	  	  
	   4.2.1	  History	  and	  generalities	  	   Norwalk	   virus	   (NV)	   is	   a	   small,	   non-­‐enveloped,	   non-­‐segmented	   RNA	   virus	   of	   positive	   polarity,	   and	   is	   the	   prototype	  strain	  of	  the	  Norovirus	  genus	  in	  the	  family	  Caliciviridae	  (group	  IV	  in	  Baltimore’s	  classification).	  The	  virion	  particle	  is	  about	  38	  nm	  in	  diameter	  (Figure	  9).	  
	  
Figure	   9.	  Electron	  microscope	  photograph	  of	  Norwalk	  virus	   from	  stool	  sample	   from	   an	   individual	   with	   gastroenteritis,	   F.	   P.	   Williams,	   U.S.	  Environmental	  Protection	  Agency	  (http://pathmicro.med.sc.edu/).	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   Noroviruses	   are	   human	   pathogens	   responsible	   for	   more	  than	   90%	   of	   outbreaks	   of	   non-­‐bacterial	   gastroenteritis	   in	  developed	   countries,	   and	   as	   many	   as	   23	   million	   cases	   of	  gastroenteritis	  in	  the	  United	  States	  each	  year	  are	  caused	  by	  these	  infectious	   agent	   (Fankhauser	   et	   al.,	   1998;	   Mead	   et	   al.,	   1999).	  Outbreaks	   are	   typically	   associated	  with	  winter	   seasonality	   (Guix	  et	  al.,	  2007;	  Allen	  et	  al.,	  2008)	  and	  are	  mainly	  reported	  in	  hospitals	  and	  elderly	  care	  homes,	  but	  have	  also	  been	  associated	  with	  other	  semi-­‐closed	   environments	   such	   as	   schools,	   restaurants,	   cruise	  ships	   and	   hotels	   (Lopman	   et	   al.,	   2003;	  Mounts	   et	   al.,	   2000).	   The	  clinical	   features	   of	   norovirus	   infections	   consist	   of	   an	   incubation	  period	   of	   12-­‐48	   h	   characterized	   by	   acute	   onset	   of	   nausea,	  vomiting,	   abdominal	   cramps	   and	   diarrhea	   that	   generally	   last	   for	  about	   48	   h	   (Nilsson	   et	   al.,	   2003).	   However,	   due	   to	   their	   short	  incubation	   time,	   low	   infectious	   dose,	   efficient	   transmission	   and	  the	   short	   duration	   of	   protective	   immunity,	   noroviruses	   cause	  important	   morbidity	   in	   the	   human	   population	   and	   impose	   a	  significant	  economic	  burden	  on	  national	  health	  services	  (Lopman	  et	   al.,	   2003;	   Lopman	   et	   al.,	   2004).	   The	   majority	   of	   human	  noroviruses	   are	  divided	   in	   two	  genogroups,	  GI	   and	  GII,	   the	  most	  frequently	   detected	   noroviruses	   associated	   with	   outbreaks	  belonging	  to	  genogroup	  GII-­‐4	  (Gallimore	  et	  al.,	  2007).	  
	   4.2.2	  NV	  lifecycle	  	   The	   transmission	   route	   of	   noroviruses	   is	   fecal-­‐oral	   via	  aerosols,	   fomites,	   food,	  or	  water	  (Dingle,	  2004).	  Although	  human	  noroviruses	  were	  originally	  identified	  more	  than	  30	  years	  ago,	  our	  understanding	   of	   their	   replication	   cycle	   and	   mechanisms	   of	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pathogenecity	   has	   been	   limited	   because	   these	   viruses	   are	  noncultivable	   in	   established	   cell	   lines	   and	   an	   animal	   model	   to	  study	  viral	   infection	  is	  not	  available	  (Duizer	  et	  al.,	  2004).	   Indeed,	  the	   factors	   that	   block	   norovirus	   replication	   in	   standard	   cell	  cultures	   remain	   unknown.	   Therefore,	   features	   of	   their	   lifecycle	  have	   been	   essentially	   inferred	   from	   studies	   using	   other	   animal	  caliciviruses	   sustained	   by	   mammalian	   cell	   cultures	   (Guix	   et	   al.,	  2007).	   It	   has	   been	   only	   recently	   discovered	   a	  murine	   norovirus	  that	   is	   able	   to	   replicate	   in	   a	   murine	   macrophage-­‐like	   cell	   line	  (Wobus	  et	  al.,	  2014).	  Also,	  transfection	  of	  a	  full-­‐lenght	  cDNA	  clone	  of	   the	   NV	   genome	   into	   modified	   vaccinia	   Ankara	   (MVA)-­‐T7	  infected	   cells	   allowed	   the	   expression	   of	   viral	   proteins	   and	  subsequent	  RNA	  replication	  (Asanaka	  et	  al.,	  2005).	  
	   4.2.3	  NV	  genome	  organization	  and	  replication	  	   The	   single-­‐stranded,	   positive	   sense	   RNA	   genome	   of	  approximately	   7.7	   kb	   in	   length	   encodes	   the	   viral	   structural	   and	  non-­‐structural	   proteins	   in	   three	   open	   reading	   frames	   (ORF)	  (Figure	  10).	  The	  genomic	  RNA	  is	  protein-­‐capped	  at	  the	  5’	  end	  and	  polyadenylated	   at	   the	   3’	   end	   (Hardy,	   2005).	   ORF1	   encodes	   a	  polyprotein	   that	   is	   post-­‐translationally	   cleaved	   by	   the	   viral	  protease	   into	   the	   non-­‐structural	   proteins	   including	   VPg-­‐like	  protein,	   viral	   protease	   and	   an	   RdRp.	   ORF2	   encodes	   the	   major	  structural	   protein	   VP1,	  which	   is	   organized	   into	   distinct	   domains	  (Prasad	   et	   al.,	   1999),	   including	   a	   conserved	   shell	   (S)	   domain,	  which	  forms	  the	  contiguous	  shell	  of	  the	  virus,	  and	  a	  protruding	  (P)	  domain	  that	  extends	  away	  from	  the	  capsid	  (Cao	  et	  al.,	  2007).	  The	  P	  domain	  is	  organised	  into	  a	  highly	  variable	  P2	  region,	  flanked	  on	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either	   side	  by	  more	   conserved	  P1-­‐1	  and	  P1-­‐2	  domains.	  Whereas	  P1	  is	  more	   interior,	  P2	   is	   located	  at	  the	  outer	  surface,	  suggesting	  that	   receptor	   binding	   function	   and	   antigenic	   properties	   of	   the	  capsid	  are	  localised	  in	  this	  region	  (Tan	  and	  Jiang,	  2005;	  Lochridge	  et	   al.,	   2005).	   Therefore,	   P2	   might	   be	   responsible	   for	   host	  attachment	   and	   recognition	   by	   the	   host	   immune	   system	   (Cao	   et	  al.,	  2007;	  Prasad	  et	  al.,	  1999).	  Finally,	  ORF3	  encodes	  a	  small	  basic	  protein	   believed	   to	   be	   involved	   in	   the	   assembly	   of	   progeny	  particles	   (Jiang	   et	   al.,	   1993;	   Glass	   et	   al.,	   2000;	   Bertolotti	   et	   al.,	  2003).	   	  	  
	  
Figure	   10.	   Norwalk	   virus	   genome	   organization.	   Are	   indicated,	   the	  location	  of	   the	  nonstructural	  proteins	  within	   the	  ORF1	  polyprotein,	   the	  viral	   structural	   proteins	   VP1	   and	   VP2	   encoded	   by	   ORF2	   and	   ORF3,	  respectively,	   and	   the	   5’	   and	   3’	   untranslated	   regions.	   Within	   VP1,	  conserved	  (P1)	  and	  hypervariable	  (P2)	  domains	  are	  represented	  and	  the	  colors	   correspond	   to	   the	   ribbon	   structure.	   The	   small	   N-­‐terminal	   (in	  green)	   faces	  the	   interior	  of	   the	  particle.	  The	  shell	   (S)	  domain	   is	  colored	  yellow	   and	   extends	   from	   amino	   acid	   50-­‐225.	   The	   P1	   subdomains	   are	  colored	   red	   and	   comprise	   amino	   acids	   226-­‐278	   and	   residues	   406-­‐520.	  The	  P2	  domain	   (blue)	   is	   an	   insertion	   in	   the	  P1	  domain	   and	   consists	   of	  amino	  acids	  279-­‐405.	  Adapted	   from	  Asanaka	  et	   al.	   (2005),	  Hardy	  et	   al.	  (2005)	  and	  Prasad	  et	  al.	  (1999).	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   Upon	   infection	   of	   cells,	   nonstructural	   proteins	   are	  expressed	   from	   genomic	   RNA	   and	   form	   an	   RNA	   replication	  complex,	  which	  generates	  new	  genomic	  RNA	  molecules	  as	  well	  as	  subgenomic	  RNAs	  encoding	  VP1	  and	  VP2.	  After	  expression	  of	  the	  structural	   proteins	   from	   these	   subgenomic	   RNA	   molecules,	   the	  capsid	  is	  assembled	  and	  viral	  RNA	  encapsidates	  prior	  to	  progeny	  release	  (Guix	  et	  al.,	  2007).	  	  
5.	  Objectives	  	   The	  objective	  of	  this	  PhD	  thesis	  is	  to	  investigate	  some	  host	  factors	   underlying	   the	   variability	   in	   RNA	   virus	   mutation	   rates.	  First,	  we	  studied	  the	  effect	  of	  the	  cell	  type	  being	  infected,	  and	  the	  variation	   depending	   on	   the	   host	   species	   in	   which	   the	   virus	  replicates.	   Then,	   we	   focused	   on	   the	   variability	   occuring	   at	   the	  single-­‐cell	   level,	  by	  characterizing	  the	  genetic	  diversity	  of	  viruses	  released	   from	   individual	   cells.	   Finally,	   we	   investigated	   the	  potential	  effect	  of	  the	  RNA	  editing	  of	  host	  enzymes,	  such	  as	  ADAR,	  by	   determining	   the	   type	   of	   spontaneous	   mutations	   occuring	   in	  noroviruses.	  
	  
 

















MATERIALS	  AND	  METHODS	  	  
1.	  Viruses 
1.1	  Vesicular	  stomatitis	  virus	  Viruses	  were	   obtained	   from	   an	   infectious	   cDNA	   clone	   by	  transfecting	   baby	   hamster	   kidney	   (BHK-­‐21)	   cells,	   purified	   by	  filtration	   (0.22	   µm),	   and	   stored	   at	   -­‐70ºC	   in	   aliquots	   until	   use.	  Briefly,	   as	   described	   in	   Sanjuán	   et	   al.	   (2004),	   confluent	   (approx.	  104	   cells/mm2)	   BHK-­‐21	   cells	   were	   infected	   with	   a	   recombinant	  vaccinia	   virus	   vTF7-­‐3	   (American	   Type	   Culture	   Collection)	   that	  expressed	   bacteriophage	   T7	   RNA	   polymerase.	   After	   1	   h	  incubation,	  BHK-­‐21	  cells	  were	  transfected	  with	  a	  full-­‐length	  cDNA	  clone	   (provided	   by	   G.	   T.	   W.	   Wertz,	   University	   of	   Alabama	   at	  Birmingham,	   Birmingham)	   and	   three	   helper	   plasmids	   encoding	  the	  N,	  P,	  and	  L	  proteins	  of	  VSV	  (Whelan	  et	  al.,	  1995).	  Transfections	  were	  performed	  by	  using	  Lipofectamine	  supplemented	  with	  Plus	  Reagent	  (Invitrogen)	  and,	  to	  inhibit	  vaccinia	  replication,	  25	  µg/mL	  1-­‐β-­‐D-­‐arabinofuranosylcytosine	   (AraC)	   were	   added	   6	   h	   post-­‐inoculation	   (hpi).	   The	   supernatant	   was	   harvested	   96	   hpi,	   and	  residual	   vaccinia	   was	   removed	   by	   filtering	   the	   supernatant	  through	   0.22	   µm	   membranes	   (Millipore).	   Dilutions	   of	   the	  supernatant	   (102-­‐	   to	   104-­‐fold)	   were	   used	   for	   plaque	   assays	   that	  allowed	   to	   score	   for	   the	   presence	   of	   plaque-­‐forming	   units	   (PFU)	  24	   hpi,	   indicating	   the	   successful	   recovery	   of	   infectious	   VSV	  particles.	   The	   sequence	   of	   this	   virus	   was	   identical	   to	   GenBank	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accession	   number	   AM690336,	   except	   for	   six	   point	   substitutions	  (A3351G,	  C6190A,	  A6523G,	  A7421C,	  U9532C,	  U11136A).	  
1.2	  Norwalk	  virus	  The	   cDNA	   clone	   of	   Norwalk	   virus	   (NV)	   was	   provided	   by	  Dr.	   M.	   K.	   Estes	   (Departments	   of	   Molecular	   Virology	   and	  Microbiology	  and	  Medicine,	  Baylor	  College	  of	  Medicine,	  Houston).	  As	   described	   by	   Asanaka	   et	   al.	   (2005),	   the	   construction	   of	  subgenomic	   NV	   cDNA	  was	   based	   on	   the	   nucleotide	   sequence	   of	  subgenomic	  RNA	  found	  in	  animal	  caliciviruses	  (Green	  et	  al.,	  2001).	  The	   infectious	   cDNA	   was	   cloned	   in	   our	   laboratory	   by	   bacterial	  transformation	   (XL10-­‐Gold	   ultracompetent	   cells,	   Agilent	  Technologies),	   under	   heat	   shock	   conditions	   (42°C	   for	   45	   sec	  followed	  by	  2	  min	  in	  ice).	  A	  colony-­‐forming-­‐unit	  (CFU)	  was	  picked	  and	  amplified	  overnight	  in	  Luria	  Broth	  (LB)	  media	  supplemented	  with	   Ampicilin	   (Amp).	   The	   cDNA	   was	   purified	   using	   midiprep	  (PureLink®	  HiPure	  Plasmid	  Midiprep	  kit,	   InvitrogenTM)	  and	  then	  stored	  in	  aliquots	  at	  -­‐20°C	  until	  use.	  	  Tranfections	   were	   performed	   using	   Lipofectamine®	   LTX	  Reagent	   (InvitrogenTM).	   The	   day	   before	   transfection,	   1	   ×	   105	  HEK293T	   cells	   were	   split	   in	   a	   24-­‐well	   microplate	   in	   500	   µL	   of	  media	   in	   order	   to	   reach	   a	   cell	   density	   of	   50-­‐80%	   the	   day	   of	  transfection.	   The	   NV	   cDNA	   was	   transfected	   into	   HEK293T	   cells	  previously	   infected	   with	   the	   recombinant	   vaccinia	   vTF7-­‐3	   virus	  (see	  section	  1.1)	  at	  a	  MOI	  10	  for	  1	  h,	  which	  initiated	  the	  primary	  transcription	   of	  NV	   cDNA	   to	  RNA.	  Once	  RNA	  was	   synthesized,	   it	  replicated	  by	  itself	  into	  the	  cytoplasm	  of	  the	  cells,	  and	  the	  activity	  of	   T7	   RNA	   polymerase	   was	   blocked	   by	   adding	   AraC	   (1-­‐β-­‐D-­‐
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arabinofuranosylcytosine)	  to	  the	  culture.	  To	  do	  so,	  for	  each	  well	  to	  be	  transfected,	  0.5	  µg	  of	  plasmid	  were	  diluted	  in	  100	  µL	  of	  DMEM,	  to	  which	  1.75	  µL	  of	  Lipofectamine®	  LTX	  Reagent	  were	  added.	  The	  solution	   was	   mixed	   gently	   and	   incubated	   for	   30	   min	   at	   room	  temperature	   to	   form	   the	   DNA-­‐Lipofectamine®	   LTX	   Reagent	  complexes.	  After	  1	  h	  incubation	  at	  37°C	  (shaking	  at	  30	  min)	  cells	  were	  washed	  two	  times	  with	  0.2	  mL	  DMEM	  and	  a	  third	  time	  with	  0.15	   mL	   DMEM.	   After	   30	   min	   incubation,	   100	   µL	   of	   the	   DNA-­‐Lipofectamine®	  LTX	  Reagent	  complexes	  were	  added	  to	  each	  well	  to	   be	   transfected	   and	   mixed	   gently	   by	   rocking	   the	   plate.	   Then,	  after	  5	  h	  incubation	  at	  37°C,	  250	  µL	  of	  AraC	  (1	  mg/mL)	  diluted	  in	  DMEM	  supplemented	  with	  2%	  FBS	  were	  added	   to	  each	  well	   and	  the	   plate	   was	   incubated	   for	   48	   h.	   As	   control	   for	   transfection	  efficiency,	   a	   VSV	   plasmid	   harboring	   a	   green-­‐fluorescent-­‐protein	  (GFP)	  was	  also	  transfected	  under	  the	  same	  conditions.	  	  
2.	  Cells	  
2.1	  Mammalian	  cells	  
	   2.1.1	  BHK-­‐21	  cells	  Baby	  hamster	  kidney	  (BHK-­‐21)	  cells	  are	  originally	  derived	  from	   fibroblasts	   of	   a	   1-­‐day-­‐old	   hamster,	   Mesocricetus	   auratus.	  BHK-­‐21	   cells	   were	   obtained	   from	   the	   American	   Tissue	   Culture	  Collection	   (ATCC®	   CCL-­‐10TM)	   and	   were	   cultured	   in	   DMEM	  (Dulbecco’s	   modified	   Eagle	   medium)	   supplemented	   with	   10%	  fetal	   bovine	   serum	   (FBS),	   0.02	   mM	   L-­‐Glutamine,	   a	   mix	   of	   non-­‐essential	   amino-­‐acids,	   100	   µg/mL	   streptomycin,	   60	   µg/mL	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penicillin,	   and	   2	   µg/mL	   fungizone.	   Since	   BHK-­‐21	   cells	   are	  adherent,	   confluent	   cells.	   Confluent	   cultures	   were	   washed	   with	  phosphate-­‐buffered	   saline	   (PBS),	  detached	  with	   trypsin,	   split	  1:6	  every	  two	  days	  and	  incubated	  at	  37ºC	  under	  5%	  CO2	  (Figure	  11A).	  
	   2.1.2	  HEK293T	  cells	  Human	   embryonic	   kidney	   (HEK293T)	   cells	   are	   originally	  derived	  from	  293	  cells	  that	  were	  immortalized	  with	  adenovirus	  5	  (strain	   F2853-­‐5b)	   and	   transformed	   with	   the	   temperature	  sensitive	  simian	  virus	  (SV40)	  large	  T	  antigen.	  HEK293T	  cells	  were	  obtained	   from	   the	   American	   Tissue	   Culture	   Collection	   (ATCC®	  CRL-­‐11268TM)	   and	   were	   cultured	   in	   DMEM	   F12	   (Dulbecco’s	  modified	   Eagle	   medium)	   supplemented	   with	   10%	   FBS	   and	  antibiotics.	   Adherent	   HEK293T	   cells	   were	   washed	   with	   PBS,	  detached	   with	   trypsin	   and	   split	   1:10	   twice	   a	   week.	   Cells	   were	  incubated	  at	  37°C	  under	  5%	  CO2	  (Figure	  11B).	  
	   2.1.3	  MEFs	  and	  MEF	  p53-­‐/-­‐	  cells	  Mouse	   embryonic	   fibroblast	   (MEF)	   cells	   and	   their	   p53-­‐/-­‐	  derivative	  were	  obtained	  from	  Dr.	  Carmen	  Rivas	  (Centro	  Nacional	  de	   Biotecnología,	   Madrid)	   and	   cultured	   in	   DMEM	   supplemented	  with	   12%	   FBS,	   0.02	   mM	   L-­‐Glutamine,	   a	   mix	   of	   non-­‐essential	  amino-­‐acids,	  100	  µg/mL	  streptomycin,	  60	  µg/mL	  penicillin,	  and	  2	  µg/mL	  fungizone.	  Adherent	  cells	  were	  washed	  with	  PBS,	  detached	  with	   trypsin,	   split	   1:3	   every	   three	   days	   and	   incubated	   at	   37ºC	  under	  5%	  CO2	  (Figure	  11C).	  	  	   The	   p53	   tumor	   suppressor	   gene	   is	   a	   regulator	   of	   normal	  cell	   proliferation	   and	   is	   mutated	   in	   several	   human	   cancers,	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including	   tumors	   of	   colon,	   breast,	   lung	   and	   brain	   (Jacks	   et	   al.,	  1994).	  The	  MEF	  p53-­‐/-­‐	  cell	  line	  was	  also	  provided	  by	  Dr.	  Rivas.	  	  	  
	   2.1.4	  Neuro-­‐2a	  cells	  Mouse	   neuroblastoma	   (Neuro-­‐2a)	   cell	   line	  was	   originally	  established	  from	  a	  spontaneous	  tumor	  of	  a	  strain	  A	  albino	  mouse,	  
Mus	   musculus.	   Neuro-­‐2a	   cells	   were	   obtained	   from	   Prof.	   José	   M.	  García-­‐Verdugo	   (Department	   of	   Cell	   Biology,	   University	   of	  Valencia)	   and	   cultured	   in	   MEM	   (Eagle’s	   minimum	   essential	  medium)	   supplemented	   with	   2	   mM	   L-­‐Glutamine,	   1	   mM	   sodium	  pyruvate,	   10%	   FBS,	   non-­‐essential	   amino	   acids	   and	   antibiotics.	  Adherent	   Neuro-­‐2a	   cells	   were	   washed	   with	   PBS,	   detached	   with	  trypsin	   and	   split	   in	   a	   ratio	   1:3	   every	   three	   days.	   Cells	   were	  incubated	  at	  37ºC	  under	  5%	  CO2	  (Figure	  11D).	  
	   2.1.5	  CT26	  cells	  Colon	  cancer	  CT26	  cells	  originate	  from	  an	  undifferentiated	  grade	  IV	  colon	  adenocarcinoma,	   induced	  by	   intrarectal	   injections	  of	   N-­‐nitrous	   N-­‐methylurethamine	   into	   a	   BALB/c	   female	   mouse	  (Corbett	  et	  al.,	  1975).	  CT26	  cells	  were	  obtained	  from	  the	  American	  Tissue	  Culture	  Collection	  (ATCC®	  CRL-­‐2638TM)	  and	  were	  cultured	  in	  DMEM	  supplemented	  with	  10%	  FBS,	  2	  mM	  L-­‐Glutamine,	  10	  mM	  HEPES	   and	   antibiotics.	   Adherent	   cells	   were	   washed	   with	   PBS,	  detached	   with	   trypsin,	   split	   1:8	   twice	   a	   week,	   and	   incubated	   at	  37ºC	  under	  5%	  CO2	  (Figure	  11E).	  
2.2	  Insect	  cells	  
	   2.2.1	  S2	  cells	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Drosophila	  S2	  cells	  were	  originally	  derived	  from	  a	  primary	  culture	   of	   late-­‐stage	   (20-­‐24	   hours	   old)	   Drosophila	  melanogaster	  embryos	   (Schneider,	   1972).	   S2	   cells	   were	   obtained	   from	   Dr.	  Rubén	   Artero	   (Department	   of	   Genetics,	   University	   of	   Valencia)	  and	   cultured	   in	   Schneider’s	   medium	   (SDM)	   supplemented	   with	  10%	   FBS	   and	   antibiotics.	   S2	   cells	   are	   semi-­‐adherent	   and	   were	  therefore	  detached	  by	  slapping	  the	  flask	  by	  hand.	  Cells	  were	  split	  1:5	  once	  a	  week,	  and	  incubated	  at	  25ºC	  in	  the	  absence	  of	  CO2.	  Cells	  were	  infected	  at	  28ºC	  (Figure	  11F).	  
	   2.2.2	  Sf21	  cells	  The	   sf21	   cell	   line,	   cloned	   from	   ovaries	   of	   the	   Fall	   Army	  worm	   Spodoptera	   frugiperda,	   was	   originally	   developed	   at	   the	  Henry	   A.	   Wallace	   Beltsville	   Agricultural	   Research	   Center	   (USA).	  Sf21	  cells	  were	  obtained	  from	  Dr.	  Salvador	  Herrero	  (Department	  of	  Genetics,	  University	   of	  Valencia)	   and	  were	   cultured	   in	  Grace’s	  insect	   medium	   supplemented	   with	   10%	   FBS	   and	   antibiotics.	  Adherent	  sf21	  cells	  were	  detached	  by	  hand	  slapping,	  split	  1:6	  once	  a	  week,	  and	  incubated	  at	  28ºC	  in	  the	  absence	  of	  CO2	  (Figure	  11G).	  
2.3	  Mosquito	  cells	  
	   2.3.1	  C6/36	  cells	  The	   C6/36	   cell	   line	   was	   originally	   derived	   from	   Aedes	  
albopictus	  whole	  larvae	  cells.	  C6/36	  cells	  were	  obtained	  from	  the	  American	   Tissue	   Culture	   Collection	   (ATCC®	   CRL-­‐1660TM)	   and	  were	   cultured	   in	   DMEM	   supplemented	   with	   10%	   FBS,	   2	   mM	   L-­‐glutamine,	  non-­‐essential	  amino	  acids,	  1	  mM	  sodium	  pyruvate	  and	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antibiotics.	  C6/36	  cells	  are	  non-­‐adherent	  	  and	  were	  split	  1:8	  twice	  per	  week,	  and	  incubated	  at	  28°C	  under	  5%	  CO2	  (Figure	  11H).	  	  
	  
Figure	  11.	  Cell	  lines.	  Mammalian	  cells:	  A,	  BHK-­‐21;	  B,	  HEK293T;	  C,	  MEFs	  and	   MEFs	   p53-­‐/-­‐;	   D,	   Neuro-­‐2a;	   E,	   CT26.	   Insect	   cells:	   F,	   S2;	   G,	   sf21.	  Mosquito	  cells:	  H,	  C6/36	  (http://www.lgcstandards-­‐atcc.org).	  	  
2.4	  Cell	  culture	  under	  hypoxia	  Hypoxia	  (1%	  O2)	  was	  achieved	  by	  displacing	  oxygen	  with	  nitrogen,	  using	  a	  Galaxy	  170R	  incubator	  (Eppendorf).	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infectious	   particles	   produced	   per	   cell),	   for	   plaque	   titration	   and	  also	   to	   isolate	   individual	   plaques	   for	   sequencing.	   Viruses	   were	  conveniently	  diluted	  and	  used	   to	   inoculate	  confluent	  monolayers	  of	  BHK-­‐21	  cells	  in	  60	  mm	  dishes,	  which	  were	  incubated	  for	  24	  h	  in	  DMEM	   semi-­‐solidified	   supplemented	   with	   0.4%	   agarose	  containing	   2%	   FBS.	   Monolayers	   were	   either	   used	   to	   aspirate	  indidivual	   plaques,	   or	   fixed	  with	   10%	   formaldehyde	   and	   stained	  with	  2%	  crystal	  violet	  to	  count	  PFUs	  (particle-­‐forming-­‐units).	  	  	  
4.	  Mutation	  rate	  estimation	  using	  Luria–Delbrück	  fluctuation	  
tests	  
4.1	  Rationale	  and	  design	  of	  the	  test	  
	  	   The	   Luria-­‐Delbrück	   fluctuation	   test	   was	   originally	  proposed	   by	   Luria	   and	   Delbrück	   (1943)	   in	   order	   to	   determine	  whether	   phage-­‐resistant	   bacteria	   arose	   from	   spontaneous	  mutations	  during	   the	   growth	  of	   the	  bacterial	   culture,	   or	   through	  mutations	  induced	  by	  interactions	  with	  the	  phages	  present	  in	  the	  environment	   (Sarkar,	  1991;	  Sarkar	  et	   al.,	   1992).	  The	  principle	  of	  this	  test	  was	  based	  on	  the	  growth	  of	  several	  independent	  cultures	  of	  bacteria	  that	  mutated	  with	  cell	  division	  and	  gave	  rise	  to	  clones	  of	  mutants.	  After	   the	   growth	  period,	   the	   cells	  were	  plated	   in	   the	  presence	   of	   phage	   to	   score	   resistant	   cells	   (Stewart,	   1994).	   Luria	  and	   Delbrück	   focused	   their	   attention	   on	   the	   first	   generation	   of	  resistant	  bacteria	  (i.e.	  bacteria	  that	  survived	  immediately	  after	  the	  addition	   of	   the	   virus)	   and	  hypothesized	   that	   they	  were	   resistant	  before	   the	   addition	   of	   the	   virus,	   suggesting	   that	   mutations	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occurred	   independently	   of	   the	   virus.	   Under	   this	   hypothesis,	  mutants	   that	   arose	   early	   in	   the	   culture	   would	   increase	  exponentially	   through	   the	   cell	   division	   whereas	   many	   cultures	  would	   show	   no	   mutations	   at	   all	   or	   only	   one	   in	   the	   last	   few	  generation.	   Therefore,	   there	   should	   be	   a	   large	   variation	   in	   the	  number	   of	   resistant	   bacteria	   among	   cultures.	   Their	   results	  confirmed	   that	   the	   number	   of	   phage	   resistant	   colonies	   arose	  through	  spontaneous	  mutations	  before	  the	  bacteria	  were	  exposed	  to	   the	   phage,	   and	   that	   mutants	   increased	   in	   numbers	   as	   the	  cultures	   grew	   (Stewart	   et	   al.,	   1989).	   Then,	   the	   Luria-­‐Delbrück	  fluctuation	   test	   was	   applied	   to	   viruses	   and	   became	   a	   standard	  estimation	  method	   used	   for	   several	   viruses,	   including	   poliovirus	  (Sedivy	  et	  al.,	  1987),	  vesicular	  stomatitis	  virus	  (Furió	  et	  al.,	  2005),	  influenza	  A	  virus	  (Suárez	  et	  al.,	  1992),	  measles	  virus	  (Schrag	  et	  al.,	  1999),	   turnip	   mosaic	   virus	   (de	   la	   Iglesia	   et	   al.,	   2012),	   and	  bacteriophages	  φ6	  (Chao	  et	  al.,	  2002)	  and	  Qβ	  (García-­‐Villada	  and	  Drake,	   2012).	   The	  method	   has	   the	   advantage	   of	   being	   relatively	  insensitive	   to	   selection	   and	   the	   viral	   replication	  mode,	   provided	  that	   the	   null-­‐class	  method	   is	   used	   (see	   below).	   Here,	   fluctuation	  tests	   were	   used	   to	   measure	   the	   mutation	   rate	   of	   VSV	   in	  mammalian,	  insect	  and	  mosquito	  cells,	  and	  were	  performed	  under	  different	   experimental	   conditions,	   such	   as	   BHK-­‐21,	   MEF,	   MEF	  p53-­‐/-­‐,	  Neuro-­‐2a,	  CT26,	  BHK-­‐21	  under	  hypoxia	  (1%	  O2),	  BHK-­‐21	  at	  28ºC,	  and	  S2,	  sf21,	  and	  C6/36	  cell	  cultures.	  	   In	  each	  fluctuation	  test,	  we	  inoculated	  32	  identical	  cultures	  each	   containing	   104	   confluent	   cells	   with	   approximately	   300	  pfu/well	  (Ni)	  each	  and	  incubated	  them	  until	  approximately	  3	  ×	  104	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pfu/well	  were	   produced	   (Nf	  )	   (Table	   1).	   After	   a	   round	   of	   freeze-­‐thawing	   to	   release	   intracellular	   particles,	  we	   used	   eight	   cultures	  for	   titration	   (Nf	  )	   and	   24	   for	   plating	   the	   entire	   undiluted	   volume	  (100	   µL)	   in	   the	   presence	   of	   a	   monoclonal	   antibody	   against	   the	  surface	   glycoprotein	   G	   at	   a	   concentration	   that	   neutralizes	  completely	   the	  wild-­‐type	   virus	   and	   selects	   for	  MAR	   (monoclonal	  antibody	  resistant)	  mutants	  (Figure	  12).	  The	  antibody,	  in	  the	  form	  of	   a	   hybridoma	   supernatant,	   was	   added	   to	   the	   plating	   medium	  (25%	  v:v)	  to	  avoid	  phenotypic	  masking	  (Holland	  et	  al.,	  1989).	  	  	  
Table	  1.	  Incubation	  time	  for	  each	  cell	  type	  tested.	  Cultures	  were	  infected	  with	  approximately	  300	  pfu/well	  (Ni)	  and	  incubated	  until	  approximately	  3	  ×	  104	  pfu/well	  were	  produced	  (Nf	  ).	  	  
Cell	  type	   Incubation	  time	  (hpi)	  BHK-­‐21	  at	  37°C	   7h	  40	  min	  BHK-­‐21	  at	  28°C	   7h	  BHK-­‐21	  under	  1%	  O2	   9h	  MEF	   10h	  20min	  MEF	  p53-­‐/-­‐	   10h	  40	  min	  CT26	   15h	  Neuro-­‐2a	   8h	  S2	   24h	  Sf21	   15h	  C6/36	   20h	  	  	  	   Assuming	   that	  mutation	   is	   a	   rare	   and	   random	   event,	   the	  number	  of	  mutations	  per	   culture	   is	   expected	   to	   follow	  a	  Poisson	  distribution	   of	   parameter	   𝜆 = 𝑚 𝑁! − 𝑁! 	  and	   therefore	   the	  probability	   of	   observing	   no	   mutants	   in	   a	   culture	   is	  𝑃! = 𝑒!! !!!!! ,	  where	  m	  is	  the	  mutation	  rate	  from	  the	  wild-­‐type	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to	   the	   MAR	   phenotype	   (null-­‐class	   method).	   However,	   if	   there	   is	  incomplete	   plating,	   some	   cultures	   may	   contain	   undetected	   MAR	  mutants.	   If	  we	  define	  z	  as	   the	  plating	  efficiency	  (relative	  to	  BHK-­‐21	   cells),	   the	   probability	   of	   observing	   no	   mutants	   can	   be	  expressed	  as	  𝑃! = 𝑄!(1 − 𝑧)!! ,	  where	  𝑄! 	  is	   the	  probability	  of	  k	  actual	   mutants	   in	   a	   culture.	   Using	   a	   Poisson	   distribution	   of	  parameter	  𝜆 = 𝑚 𝑁! − 𝑁! 	  for	   k,	   we	   numerically	   solved	  Q0	   given	  
P0,	  Ni,	  Nf,	  and	  z	  and	  calculated	  the	  mutation	  rate	  as	  𝑚 = −ln  (𝑄!)/𝑁! − 𝑁! .	   This	   gave	   a	  mutation	   rate	   (m)	   to	   the	  MAR	   phenotype	  per	  round	  of	  copying,	  which	  was	  converted	  to	  per	  nucleotide	  units	  as	  𝜇 = 3𝑚/𝑇,	  where	  T	   is	   the	  set	  of	  observable	  mutations	   leading	  to	   the	   phenotype	   (i.e.	   mutation	   target)	   and	   three	   stands	   for	   the	  number	   of	   possible	   nucleotide	   substitutions	   per	   site	   (Sanjuán	   et	  al.,	   2010).	   Therefore,	   mutation	   rates	   were	   expressed	   as	  substitution	  per	  nucleotide	  per	  round	  of	  copying	  (s/n/r).	  	  	  	  
	  




Figure	   12.	   Luria-­‐Delbrück	   fluctuation	   test.	   Confluent	   cells	   are	   infected	  with	  a	  small	  viral	  inoculum	  (Ni)	  under	  standard	  growth	  conditions,	  and,	  after	   a	   final	   number	   of	   viral	   particles	   (Nf)	   produced,	   the	   entire	  supernatant	  is	  plated	  in	  the	  presence	  of	  a	  monoclonal	  antibody	  to	  score	  MARMs.	   The	   mutation	   rate	   from	   antibody	   sensitivity	   to	   the	   MAR	  phenotype	   (m)	   can	   be	   calculated	   using	   the	   null-­‐class	   method,	   which	  consists	  of	  counting	  the	  fraction	  of	  cultures	  with	  zero	  mutants	  (𝑃!).	  	  
4.2	  Plating	  efficiency	  in	  fluctuation	  tests	  For	  each	  cell	  type	  tested,	  the	  plaque	  assay	  for	  scoring	  MAR	  mutants	   was	   done	   on	   confluent	  monolayers	   of	   BHK-­‐21	   cells	   for	  technical	   feasibility	   and	   also	   to	   control	   for	   differences	   in	   plating	  efficiency	  among	  cells.	  However,	  since	  plaque	  assays	  to	  score	  MAR	  mutants	   were	   done	   with	   undiluted	   supernatants,	   antiviral	  cytokines	  or	  other	  compounds	  released	  from	  the	  cells	  in	  which	  the	  virus	   was	   grown	   could	   modify	   plating	   efficiency.	   In	   contrast,	  plaque	   assays	   for	   determining	   the	   number	   of	   viruses	   produced	  (Nf)	  were	  done	  at	   a	   roughly	  1/100	  dilution	  and	   thus	  were	  much	  less	   affected	   by	   this	   problem.	   For	   instance,	   BHK-­‐21	   cells	   are	  partially	   responsive	   to	   interferon	   (Lin	   et	   al.,	   2004),	   potentially	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inhibiting	   growth	   of	   MAR	   mutants	   and	   biasing	   mutant	   counts	  down.	  To	  calibrate	  this	  effect,	  we	  titrated	  a	  MAR	  clone	  obtained	  by	  site-­‐directed	   mutagenesis	   (substitution	   D259A	   in	   the	   surface	  glycoprotein	   G)	   in	   the	   presence	   of	   undiluted	   supernatants	  harvested	   from	  cells	  previously	   infected	  with	   the	  wild-­‐type	  virus	  (Ni	  ≈	   300	   pfu	   and	  Nf	   ≈	   104	   pfu,	   similar	   to	   fluctuation	   tests),	   and	  adding	  monoclonal	  antibody	  to	  the	  plates	  to	  observe	  MAR	  plaques	  only.	  The	  wild-­‐type	   infections	  were	  performed	  under	  each	  of	   the	  experimental	  conditions	  (BHK-­‐21,	  MEF,	  MEF	  p53-­‐/-­‐,	  CT26,	  Neuro-­‐2a,	   BHK-­‐21	   under	   1%	   O2,	   BHK-­‐21	   at	   28°C,	   S2,	   Sf21	   and	   C6/36	  cells).	   Based	   on	   this,	   the	   plating	   efficiency	   for	   each	   of	   the	   other	  conditions,	  based	  on	  at	   least	   six	   independent	  plaque	  assays,	  was	  adjusted	  relative	  to	  BHK-­‐21	  cells	  (Supplementary	  1).	  	  
4.3	  Mutational	  target	  size	  in	  fluctuation	  tests	  To	  ascertain	  the	  number	  of	  possible	  mutations	  conferring	  the	  MAR	   phenotype	   (T),	   we	   sequenced	   individual	   MAR	   plaques.	  Viral	  RNA	  was	  purified	  (Macherey-­‐Nagel	  NucleoSpin®	  Viral	  RNA	  isolation)	  and	   reverse-­‐transcribed	  using	  AccuScript	  High	  Fidelity	  Reverse	   Transcriptase	   (Agilent	   Technologies)	   and	   specific	  primers	   (3’-­‐ACATTCCATCCGATCCTTCAC-­‐5’).	   The	  retrotranscription	   conditions	   used	   were	   25°C	   10	   min,	   42°C	   30	  min,	   70°C	   15	   min.	   Then,	   the	   cDNA	   was	   PCR-­‐amplified	   using	  Phusion	   High	   Fidelity	   DNA	   polymerase	   (New	   England	   Biolabs),	  which	   presents	   an	   error	   rate	   of	   4.4	   ×	   10-­‐7	   errors	   per	   nucleotide	  per	  round	  of	  replication,	  as	  provided	  by	  the	  manufacturer.	  Specific	  primers	   (forward	   3’-­‐ACATTCCATCCGATCCTTCAC-­‐5’	   and	   reverse	  5’-­‐CGGAGAACCAAGAATAGTCCAATG-­‐3’)	  were	  used	  to	  amplify	  and	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sequence	  a	  region	  of	  the	  G	  protein	  (genome	  sites	  3361	  to	  4501	  in	  GenBank	   accession	   number	   EF197793)	   controlling	   the	   MAR	  phenotype	   (Holland	   et	   al.,	   1991).	   The	   PCR	   conditions	   used	  were	  98°C	  2	  min,	  35	  cycles	  of	  98°C	  5	  sec,	  66°C	  30	  sec,	  72°C	  30	  sec,	  and	  a	  final	  extension	  step	  of	  72°C	  5	  min.	  PCR	   products	   were	   purified	   (Macherey-­‐Nagel	  NucleoFast®	  96	  PCR	  plates)	   and	   sequenced	  by	  Sanger	   (Genomic	  Core	   Facility	   S.C.S.I.E.,	   University	   of	   Valencia).	   Sequences	   were	  cleaned,	  assembled	  and	   then	  analyzed	   for	  SNPs	  using	   the	  Staden	  software	  (http://staden.sourceforge.net).	  	  	  
5.	  Mutation	  rate	  estimation	  using	  molecular	  clone	  sequencing	  
5.1	  Limiting	  dilution	  In	   order	   to	   ascertain	   the	   reliability	   of	   the	   estimates	  obtained	   by	   the	   Luria-­‐Delbrück	   fluctuation	   test,	   we	   used	   a	  molecular	   clone	   sequencing	   approach.	   To	   do	   so,	   a	   96-­‐well	   plate	  containing	   104	   BHK-­‐21	   cells	   per	   well	   was	   inoculated	   with	   a	  limiting	   dilution	   of	   the	   viral	   VSV	   stock,	   such	   that	   approximately	  10%	   of	  wells	  were	   infected	  with	   a	   single	   infectious	   particle	   (i.e.	  plaque	  forming	  units,	  pfu).	  Plates	  were	  incubated	  at	  37°C	  for	  24	  h,	  inspected	   under	   the	   microscope	   to	   determine	   wells	   showing	  cytopathic	  effects	  (i.e.	  positive	  wells),	  and	  freeze-­‐thawed	  to	  allow	  release	   of	   intracellular	   viruses.	   The	   resulting	   viral	   bursts	   (Nf)	  were	  purified	  (Macherey-­‐Nagel	  NucleoSpin®	  Viral	  RNA	  isolation)	  from	   the	   supernatant	   of	   each	   of	   five	   positive	   wells,	   reverse-­‐transcribed	  and	  PCR-­‐amplified	  (same	  conditions	  as	  in	  section	  4.3)	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using	  specific	  primers	  located	  in	  the	  P	  (genome	  sites	  1339-­‐1899),	  G	   (genome	   sites	   3858-­‐4347)	   and	   L	   (genome	   sites	   6974-­‐7462)	  genes	   (Supplementary	   2).	   To	   obtain	   the	   mutation	   frequency	   (f),	  the	   number	   of	   observed	   mutations	   was	   divided	   by	   the	   total	  number	  of	  bases	  sequenced.	  Then,	  the	  per-­‐generation	  increase	  in	  mutations	  frequency	  was	  calculated	  as	  f	  /	  c,	  where	  c	  is	  the	  number	  of	   infection	   cycles	   (i.e.	   viral	   generations)	   elapsed.	   This	   number	  was	   calculated	  𝑐 = !"!!!"! ,	   and	   where	   B	   is	   the	   per-­‐cell	   burst	   size	  (BS).	  	  
5.2	  Molecular	  cloning	  	  PCR	   products	   were	   gel-­‐purified	   (Zymoclean™	   Gel	   DNA	  Recovery	   Kit)	   and	   cloned	   with	   CloneJETTM	   PCR	   cloning	   kit	  (Thermo	   Scientific),	   using	   the	   linearized	   cloning	   vector	  pJET1.2/blunt,	   and	   T4	   DNA	   ligase.	   Purified	   PCR	   products	   were	  ligated	  with	  the	  vector	  in	  5	  min	  and	  the	  mixture	  was	  directly	  used	  for	  bacterial	  transformation	  under	  heat	  shock	  conditions	  (42°C	  for	  45	  sec	   followed	  by	  2	  min	   in	   ice).	  Colonies	  were	  picked	  and	  PCR-­‐amplified	   using	   Taq	   DNA	   polymerase	   (VWR)	   and	   CloneJETTM	  primers	   (forward	   primer	   5’-­‐CGACTCACTATAGGGAGAGCGGC-­‐3’	  and	   reverse	   primer	   5’-­‐AAGAACATCGATTTTCCATGGCAG-­‐3’).	   The	  PCR	   conditions	   used	  were	   95°C	  5	  min,	   35	   cycles	   of	   95°C	   30	   sec,	  60°C	  30	  sec,	  72°C	  2	  min,	  and	  a	  final	  extension	  step	  of	  72°C	  5	  min.	  	  
5.3	  Effect	  of	  selection	  on	  mutation	  frequency	  To	   correct	   for	   the	   effect	   of	   selection	   on	   mutation	  frequency,	  we	   used	   the	   empirically	   characterized	   distribution	   of	  mutational	   fitness	   effects	   of	   random	   single-­‐nucleotide	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substitutions	   in	   VSV.	   We	   did	   so	   numerically	   by	   simulating	   the	  combined	   effects	   of	   mutation	   and	   selection.	   The	   statistical	  distribution	   of	   fitness	   effects	   (s)	   for	   viable	   substitutions	   can	   be	  roughly	   captured	   using	   an	   exponential	   distribution	   truncated	   at	  
1=s 	  (lethality)	  plus	  a	   class	  of	   lethals	  occurring	  with	  probability	  
pL:	  𝑃 𝑠 = (1 − 𝑝!) !!!!"!!!!! 	  if	   0	   <	   s	   <	   1,	  𝑃 𝑠 = 𝑝! 	  if	   s	   =	   1,	   and	  𝑃 𝑠 = 0	  otherwise.	  In	  a	  previous	  work	  using	  the	  same	  VSV	  strain	  as	  here,	   it	  was	   estimated	   that	  pL	   =	  0.40	   and	   that	  E 𝑠 = !! = 0.13	  (Sanjuán	   et	   al.,	   2004;	   Sanjuán,	   2010).	   Fitness	   effects	   were	  measured	   as	   growth	   rate	   ratios,	  𝑠! = 1 − 𝑟!/𝑟! ,	   where	   r	   is	   the	  exponential	  growth	  rate	  and	  subscripts	  i	  and	  0	  refer	  to	  the	  mutant	  and	  wild-­‐type,	   respectively	   (Sanjuán	  et	   al.,	   2004).	  These	   s-­‐values	  were	   transformed	   to	   per	   cell	   infection	   units	   as	  𝑠!´ = 1 − !!!!!!!!!! ,	  where	  B	  is	  the	  burst	  size.	  After	  simulating	  fitness	  effects	  using	  the	  truncated	   exponential	   plus	   lethal	   distribution	   and	   applying	   the	  per	  cell	  infection	  transformation,	  selection	  was	  applied	  by	  picking	  individuals	   for	   the	   next	   cell	   infection	   cycle	   with	   weighted	  probability	  1	  –	  s´,	  and	  the	  process	  was	  iterated.	  This	  provided	  an	  expected	   mutation	   frequency	   f	   and	   therefore	   a	   relationship	  between	   µ	   and	   f.	   Genetic	   drift	   was	   ignored	   since	   it	   should	   not	  modify	  the	  expected	  value	  of	  f.	  Also,	  for	  simplicity,	  mutations	  were	  assumed	   to	   have	   independent	   fitness	   effects	   (no	   epistasis)	   and	  back	   mutations	   were	   ignored,	   which	   seems	   reasonable	   in	   the	  short-­‐term,	   because	   single	   forward	   mutations	   will	   greatly	  outnumber	   secondary	   and	   back	   mutations.	   Simulations	   were	  performed	   using	   Wolfram	   Mathematica	   and	   Excel.	   A	   graphical	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representation	   of	   this	   correction	   can	   be	   found	   in	   the	   paper	   of	  Sanjuán	  et	  al.	  (2010).	  	  
6.	  Analysis	  of	  published	  molecular	  evolutionary	  rates	  In	   a	   previous	   meta-­‐analysis,	   our	   group	   collected	  evolutionary	  rate	  estimates	   for	  RNA	  viruses,	   that	  were	  originally	  inferred	   from	   field	   isolates	   using	   Bayesian	   analysis	   of	   dated	  sequences	  after	  validation	  of	  the	  molecular	  clock	  (Sanjuán,	  2012).	  Here,	  we	  used	  170	  of	   these	  estimates,	  which	  corresponded	  to	  62	  different	   riboviruses.	  We	   sought	   to	   compare	   viruses	   transmitted	  directly	   through	   respiratory	   secretions,	   blood,	   sexual	   contact,	  feces,	  or	  animal	  bites	  (n	  =	  113)	  against	  arboviruses	  (n	  =	  57).	   	  We	  used	   a	   two-­‐way	   ANOVA	   in	   which	   the	   following	   factors	   were	  included:	   transmission	   mode	   (fixed),	   viral	   family	   (random)	   to	  account	   for	   phylogenetic	   relatedness,	   and	   sampling	   timespan	  (covariate)	   to	   account	   for	   the	   known	   time-­‐dependency	   of	  evolution	   rate	   estimates	   (Jenkins	   et	   al.,	   2002;	   Ho	   et	   al.,	   2011).	  Since	   rates	   ranged	   several	   orders	   of	  magnitude	   log-­‐transformed	  data	  were	  used.	  	  
7.	  	  Genetic	  diversity	  released	  by	  single	  infected	  cells	  
7.1	  Viral	  infection	  and	  single	  cell	  isolation	  BHK-­‐21	   cells	   were	   grown	   to	   a	   confluent	   adherent	  monolayer	   (approx.	   106	   cells/mL),	   and	   were	   then	   washed	   with	  PBS	   and	   detached	   with	   trypsin.	   Cells	   were	   resuspended	   in	  infection	   media	   (i.e.	   culture	   media	   with	   2%	   FBS),	   infected	   with	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VSV	   at	   an	   expected	   multiplicity	   of	   infection	   (MOI)	   0.5	   (approx.	  5.105	   pfu/mL),	   and	   incubated	   for	   45	   min	   at	   37ºC	   to	   allow	   viral	  adsorption.	  Infected	  cells	  were	  then	  diluted	  1/20	  in	  a	  60	  mm	  dish	  to	  isolate	  individual	  cells.	  The	  physical	  retrieval	  of	  single	  cells	  was	  performed	  with	  a	  glass	  capillary	  (NARISHIGE,	  Glass	  Capillary	  G-­‐1),	  previously	  home	  made	  to	  fit	  the	  diameter	  of	  BHK-­‐21	  cells	  and	  set	  onto	   a	   micromanipulator	   (NARISHIGE,	   MN-­‐151),	   under	   an	  inverted	   microscope.	   Individual	   cell	   were	   focused	   at	   ×	   100	  magnification,	  aspirated	  in	  the	  glass	  capillary,	  and	  immediately	  re-­‐injected	   in	   a	   drop	   of	   10	   µL	   of	   DMEM	   using	   an	   O2-­‐supplied	  microinjector	  (NARISHIGE,	  IM-­‐300).	  Drops	  containing	  a	  single	  cell	  was	   pipetted	   and	   released	   into	   100	   µL	   of	   infection	  media	   in	   an	  assigned	  well	  of	  a	  96-­‐well	  microplate,	  and	  cells	  were	  incubated	  for	  24	   h	   at	   37ºC	   to	   allow	   for	   viral	   replication	   and	   progeny	   release.	  Aliquots	  of	  the	  supernatant	  were	  then	  stored	  at	  -­‐70ºC.	  
7.2	  Matrix	  design	  and	  library	  construction	  For	   each	   single	   cell,	   10	   individual	   plaques	   were	   picked	  from	  distinct	  60	  mm	  dishes	  to	  avoid	  cross-­‐contamination	  by	  viral	  diffusion	   in	   the	   agar	   monolayer.	   Plaques	   were	   inoculated	   in	  DMEM	   in	   1.5	   mL	   Eppendorf	   tubes,	   homogeneized	   by	   vortexing,	  stored	  in	  multiple	  aliquots	  at	  -­‐70ºC,	  and	  titrated	  by	  plaque	  assays	  in	   triplicates.	   Individual	   plaques	   were	   equalized	   to	   105	   pfu/mL.	  Given	   the	   large	   number	   of	   plaques	   (881),	   pools	   of	   7-­‐10	   plaques	  were	  made	  for	  reasons	  of	  tractability	  before	  RNA	  extraction,	  such	  that	  each	  plaque	  should	  be	  represented	  at	  roughly	  10%	  frequency	  in	   each	   pool.	   To	   do	   so,	   matrices	   were	   constructed	   by	   allocating	  each	  plaque	  to	  a	  unique	  pair	  of	  	  “Mix”	  and	  “Pool”	  (Table	  2).	  A	  “Mix”	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contained	  all	  plaques	  from	  the	  same	  cell,	  and	  a	  “Pools”	  contained	  plaques	  from	  different	  cells.	  This	  design	  allowed	  for	  plaque	  calling	  after	  sequencing.	  	  
Table	   2.	   Matrix	   design.	   For	   each	   single	   infected	   cell,	   10	   individual	  plaques	  were	  pooled	  in	  equal	  ratio	  in	  a	  “Mix”	  and	  in	  a	  “Pool”.	  “Mix	  1”	  to	  “Mix	  10”	  represent	  the	  within	  cell	  plaque	  pooling,	  from	  cell	  1	  to	  cell	  10.	  “Pool	   1”	   to	   “Pool	   10”	   represent	   the	   between	   cell	   plaque	   pooling,	   from	  plaque	  1	  (1.1,	  2.1	  …	  10.1)	  to	  plaque	  10	  (1.10,	  2.10	  …	  10.10).	  	  
	  	  Viral	   RNA	   from	   each	   “Mix”	   and	   “Pool”	   was	   purified	  (Macherey-­‐Nagel	   NucleoSpin®Viral	   RNA	   isolation	   kit)	   without	  freeze	   thawing	   of	   the	   supernatant,	   and	   was	   reverse-­‐transcribed	  using	   Accuscript	   High	   Fidelity	   Reverse	   Transcriptase	   (Agilent	  Technologies).	   The	   reverse	   transcription	   conditions	   used	   were	  42°C	   60	   min,	   70°C	   15	   min.	   The	   cDNA	   was	   PCR-­‐amplified	   with	  Phusion	  High	  Fidelity	  DNA	  polymerase	  (New	  England	  Biolabs)	  by	  using	  4	  PCR	  fragments	  of	  approx.	  3	  kb	  length	  (Supplementary	  3).	  The	  PCR	  conditions	  used	  were	  98°C	  2	  min,	  35	  cycles	  of	  98°C	  5	  sec,	  58-­‐70°C	  30	  sec,	  72°C	  30	  sec,	  and	  a	   final	  extension	  step	  of	  72°C	  5	  min.	   PCR	   products	   were	   purified	   (Macherey-­‐Nagel	   NucleoFast®	  96	   PCR	   plate)	   and	   quantified	   (Qubit®	   dsDNA	   HS	   Assay	   Kit,	  
Mix	  1 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 1.10
Mix	  2 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10
Mix	  3 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10
Mix	  4 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 4.10
Mix	  5 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 5.9 5.10
Mix	  6 6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 6.9 6.10
Mix	  7 7.1 7.2 7.3 7.4 7.5 7.6 7.7 7.8 7.9 7.10
Mix	  8 8.1 8.2 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10
Mix	  9 9.1 9.2 9.3 9.4 9.5 9.6 9.7 9.8 9.9 9.10
Mix	  10 10.1 10.2 10.3 10.4 10.5 10.6 10.7 10.8 10.9 10.10
Pool	  1 Pool	  2 Pool	  3 Pool	  4 Pool	  5 Pool	  6 Pool	  7 Pool	  8 Pool	  9 Pool	  10
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Invitrogen),	   and	   the	   four	   PCR	   fragments	   corresponding	   to	   the	  same	  “Mix”	  and	  “Pool”	  were	  mixed	  in	  equimolar	  ratios,	  leading	  to	  a	  PCR	  pool.	  Then,	  each	  PCR	  pool	  was	  combined	  to	  another	  one	  to	  constitute	  pairs	  of	  PCR	  used	  to	  build	  90	  tagged	  libraries	  using	  the	  Library	   Builder™	   Fragment	   Core	   Kit	   (Applied	   Biosystems®).	  Consequently,	   the	   final	   frequency	  of	  each	  plaque	  within	  a	   library	  was	   expected	   to	   be	   5%,	   with	   each	   individual	   plaque	   being	  allocated	  to	  a	  unique	  pair	  of	  libraries.	  Sequencing	  was	  performed	  using	   the	   SOLID	   5500	   XL	   machine	   (Life	   Technologies,	   Genomic	  Core	  Facility	  S.C.S.I.E.,	  University	  of	  Valencia),	  which	  is	  as	  efficient	  as	   Illumina	   or	   454	   in	   detecting	   single	   nucleotide	   polymorphism	  (SNP)	  (Ratan	  et	  al.,	  2013).	  The	  schematic	  representation	  of	  the	  full	  experimental	  protocol	  is	  provided	  in	  Figure	  13.	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Figure	  13.	  Experimental	  protocol	  of	  the	  single-­‐cell	  approach	  to	  estimate	  viral	  mutation	   rates.	   BHK-­‐21	   cell	   cultures	  were	   infected	  with	   VSV	   at	   a	  MOI	   0.5,	   and	   after	   incubation	   to	   allow	   for	   viral	   adsorption,	   single	   cells	  were	   retrieved	   with	   a	   micromanipulator	   and	   transferred	   into	   a	   multi-­‐well	  plate.	  After	  incubation	  (24	  h)	  plaque	  assays	  allowed	  us	  to	  determine	  which	   wells	   produced	   single-­‐cell	   viral	   bursts.	   Individual	   viral	   plaques	  were	   isolated	   and	   their	   titer	   was	   determined.	   Plaques	   were	   pooled	   in	  equal	  titer	  ratios	  to	  construct	  matrices	  for	  sequening.	  	  	  
7.3	  Analysis	  of	  SOLID	  data	  and	  SNPs	  calling	  Raw	  sequence	  data	  were	  converted	  to	  FASTQ	  format	  using	  using	   the	  SOLID™	  System	  XSQ	  Tools,	  where	  5'-­‐end	  adapters	  were	  removed	   using	   CutAdapt	   (v1.6)	   (Martin,	   2012)	   and	   sequences	  were	   trimmed	   75	   base	   length	   reads	   using	   the	   FASTXTookit	  (v0.014)	   (http://hannonlab.cshl.edu/fastx-­‐toolkit/index.html).	  Then,	  FASTQ	  files	  were	  cleaned	  to	  remove	  PCR	  primer	  sequences	  using	   CutAdapt,	   with	   the	   specific	   settings	   of	   trimming	   the	  anchored	   5'-­‐end	   primer	   sequence	   and	   keeping	   reads	   ≥	   25	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nucleotide	   length	   after	   the	   clip.	   PRINSEQ	   (v0.20.4)	  was	   used	   for	  dereplication	   (exact	   duplicates	   and	   exact	   reverse	   complement	  duplicates,	  derep	  14),	  selection	  of	  reads	  with	  25-­‐50	  bases	  length,	  trimming	  sequences	  from	  the	  5'-­‐end	  with	  base	  quality	  score	  <	  20,	  and	  removal	  of	  sequences	  with	  ambiguous	  bases	  (Schmieder	  and	  Edwards,	   2011;	   http://prinseq.sourceforge.net/manual.html).	  Filtered	   reads	   were	   mapped	   onto	   the	   reference	   VSV	   sequence	  (GenBank	   accession	   number	   AM690336)	   using	   the	   local	   aligner	  Bowtie	  2	  (input	  Phred	  quality	  “Phred+33”;	  Langmead	  et	  al.,	  2009;	  http://bowtie-­‐bio.sourceforge.net/).	   Mapped	   files	   were	   then	  converted	   into	   binary	   format	   (BAM),	   sorted	   and	   indexed	   in	  SAMtools	  (Kuiken	  et	  al.,	  2005).	  Base	  coverage	  across	  the	  genome	  was	   computed	   with	   BEDTools	   (Quinlan	   and	   Hall,	   2010).	   The	  average	  per-­‐library	  coverage	  was	  (1791	  ±	  1020),	  with	  a	  minimum	  coverage	   >	   100	   in	   99.65%	   of	   the	   genome	   (Supplementary	   4).	  Then,	  by	  converting	  post-­‐alignment	  BAM	  files	  into	  mpileup	  format	  in	   SAMtools,	   SNPs	   were	   called	   in	   VarScan	   (v2.3.7)	   using	   the	  “pileup2snp”	   and	   “pileup2indel”	   commands.	   To	   stringently	   rule	  out	  sequencing	  errors,	  only	  SNPs	  with	  ≥	  10	  supporting	  reads	  at	  a	  position	   (Koboldt	   et	   al.,	   2009;	   DePristo	   et	   al.,	   2011)	  (http://varscan.sourceforge.net/),	   >	  2%	   frequency	   in	   the	   library,	  and	   equal	   ratios	   in	   plus	   and	  minus	   orientation	   (Fisher	   test:	   p	   >	  0.005)	  were	  considered.	  The	  entire	  pipeline	  was	  repeated	  for	  each	  library.	  	  This	   protocol	   provided	   a	   conservative	   list	   of	   SNPs,	   since	  although	   their	   expected	   frequency	   in	   each	   library	   was	   5%	   (for	  those	  appearing	  in	  a	  single	  plaque)	  or	  higher	  (for	  those	  appearing	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in	  several	  plaques),	  their	  actual	  frequency	  may	  be	  lower	  than	  2%	  as	  a	   result	  of	   experimental	   errors.	  Moreover,	   some	  SNPs	  may	  be	  real	   despite	   the	   plus/minus	   orientation	   bias.	   These	   SNPs	   were	  assigned	   to	   libraries	   according	   to	   their	   tagging,	   and	   since	   each	  individual	   plaque	  was	   allocated	   to	   a	   unique	  pair	   of	   libraries,	   the	  presence	   of	   a	   given	   SNP	   in	   a	   specific	   pair	   allowed	   for	   its	  unambiguous	   assignation	   to	   an	   individual	   plaque.	   Some	   SNPs	  appeared	   in	  only	  one	  plaque	   (scSNPs),	  whereas	  others	   appeared	  in	  multiple	  plaques	  within	  a	  cell,	  or	  in	  multiple	  plaques	  in	  various	  cells	  (preSNPs).	  Therefore,	  we	  restricted	  the	  maximum	  copies	  of	  a	  SNP	  such	  that	  the	  maximal	  allowed	  number	  was	  1	  for	  SNPs	  with	  <	  5%	   frequency,	   2	   for	   SNPs	   <	   10%	   frequency,	   and	   so	   on.	   Finally,	  additional	   copies	   of	   the	   identified	   SNPs	  within	   a	   given	   cell	  were	  probed	   by	   lowering	   the	   frequency	   cut	   to	   1%	   and	   relaxing	   the	  requirement	  for	  equal	  ratios	  in	  plus	  and	  minus	  orientation	  reads.	  	  	  
8.	  	  Norwalk	  virus	  virion	  recovery	  and	  sequence	  analysis	  
8.1	  Virus	  recovery	  After	   transfection	   of	   NV	   cDNA	   into	   HEK293T	   cells	   (see	  section	   1.2	   in	   “Materials	   and	  Methods”),	   viruses	  were	   recovered	  from	   supernatants	   and	   from	   cells.	   The	   supernatant	   of	   each	  well	  was	  harvested	   and	   centrifuged	  15	  min	   at	   16,000	  ×	   g	   and	   at	   4°C.	  Then,	  the	  supernatant	  was	  transferred	  in	  a	  new	  1.5	  mL	  Eppendorf	  tube	  and	  viral	  RNA	  was	  extracted	  (Macherey-­‐Nagel	  NucleoSpin®	  Viral	  RNA	  isolation).	  In	  parallel,	  virions	  were	  recovered	  from	  cells	  using	  TRIzol®	  Reagent	   (Invitrogen).	   Briefly,	   adherent	   cells	  were	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lysed	  with	   0.2	  mL	   of	   TRIzol®	  Reagent,	   and	  RNA	  were	   extracted	  with	   chloroform	   and	   isopropanol	   (100%	   v/v)	   and	   were	   then	  washed	   with	   ethanol	   (75%	   v/v).	   To	   eliminate	   any	   remaining	  template	  DNA	  that	  could	  contaminate	  RNA,	  samples	  were	  treated	  with	   DNase	   I,	   RNase-­‐free	   endonuclease	   (Thermo	   Scientific)	   that	  digests	   single-­‐	   and	   double	   stranded	   DNA.	   Briefly,	   1U	   of	   DNase	   I	  was	   mixed	   to	   each	   µg	   of	   RNA	   with	   reaction	   buffer	   containing	  MgCl2	   and	   samples	  were	   incubated	   for	   30	  min	   at	   37°C.	   Then,	   to	  inactivate	   DNase	   I,	   samples	   were	   incubated	   for	   10	   min	   at	   65°C	  with	  EDTA,	   as	   recommended	  by	   the	  manufacturer	   and	  RNA	  was	  column-­‐purified	   using	   NucleoSpin®	   RNA	   Clean-­‐up	   XS	   kit	  (MACHEREY-­‐NAGEL).	  	  
8.2	  RT-­‐PCR	  amplification	  and	  Sanger	  sequencing	  RNA	   was	   reverse-­‐transcribed	   with	   Accuscript	   High	  Fidelity	  Reverse	  Transcriptase	  (Agilent	  Technologies)	  and	  strand-­‐specific	  primers;	   the	  RT	  was	  performed	  with	  the	   forward	  primer	  (5’-­‐ATTACTCTCTGTGCACTGTCTG-­‐3’)	   in	   order	   to	   selectively	  amplify	  (-­‐)-­‐strands	  RNA,	  which	  might	  be	  synthesized	  by	  the	  RdRp	  of	   the	  virus.	   In	  order	   to	  correct	   for	  T7-­‐induced	  mutations	  during	  the	   primary	   transcription	   of	   the	   cDNA	   to	   RNA,	   a	   RT	   was	   also	  performed	   with	   the	   reverse	   primer	   (3’-­‐CAGTGTAGAAGAGGCTGTTGAA-­‐5’)	   allowing	   the	   selective	  amplification	   of	   (+)-­‐strands	   RNA.	   The	   reverse	   transcription	  conditions	   used	  were	   42°C	   60	  min,	   70°C	   15	  min.	   The	   cDNA	  was	  PCR-­‐amplified	  with	  Phusion	  High	  Fidelity	  DNA	  polymerase	  (New	  England	   Biolabs)	   and	   specific	   primers	   (forward	   primer	   5’-­‐AAATGTATGTCCCAGGATGGC-­‐3’	   and	   reverse	   primer	   3’-­‐
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CCCAATCATTTCCCTGTCAT-­‐5’)	   to	   amplify	   the	   full	   VP1	   gene	   of	  Norwalk	  virus	   (GenBank	  accession	  number	  NC001959).	  The	  PCR	  conditions	  used	  were	  98°C	  30	  sec,	  35	  cycles	  of	  98°C	  10	  sec,	  59°C	  30	   sec,	   72°C	   1	   min,	   and	   a	   final	   extension	   step	   of	   72°C	   10	   min.	  Purified	  PCR	  products	  were	  cloned	  and	  colony-­‐PCR	  were	  used	  for	  sequencing	  (see	  sections	  4.3	  and	  5.2	  in	  “Materials	  and	  Methods”).	  	  
8.3.	   Amplification	   of	   hypermutated	   sequences	   and	   454	   high-­‐
throughput	  sequencing	  	   The	  primary	  PCR	  of	  each	  transfection	  samples	  was	  used	  to	  perform	  a	  secondary	  PCR	  that	  increased	  sensitivity	  and	  specificity	  using	  degenerated	  primers.	   In	   the	   forward	  primer,	  T	  nucleotides	  are	   degenerated	   for	   Y	   nucleotides	   to	   amplify	   A-­‐to-­‐G	  hypermutations,	  whereas	  in	  the	  reverse	  primer	  A	  nucleotides	  are	  degenerated	   for	   R	   nucleotides	   and	   amplify	   specifically	   T-­‐to-­‐C	  hypermutations	   (Suspène	   et	   al.,	   2008).	   Two	   distinct	   regions	  within	  the	  VP1	  gene	  were	  amplified:	  region	  1	  composed	  of	  266	  bp	  in	   length,	   using	   forward	   5’-­‐GACGCyACAyCAAGCGyGG-­‐3’	   and	  reverse	   3’-­‐CTCrTGTTrCCrrCCCrrCC-­‐5’primers,	   and	   region	   2	  composed	   of	   405	   bp	   in	   length,	   with	   forward	   5’-­‐CyCyGyCyAACyCACGyGCC-­‐3’	   and	   reverse	   3-­‐CrrCTTGGGrGCCrGrCGG-­‐5’	   primers.	   Purified	   PCR	   products	   were	  used	   for	   molecular	   cloning	   and	   massive	   sequencing	   was	  performed	  with	  the	  454	  GS	  Junior	  machine	  (Genomic	  Core	  Facility	  S.C.S.I.E.,	   University	   of	   Valencia)	   that	   generates	   reads	   of	   approx.	  400	  bp	  in	  length.	  	   Reads	   were	   cleaned	   by	   removing	   adapters	   as	   well	   as	  primer	  sequences	  and	  low	  quality	  regions	  and	  reads	  shorter	  than	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100	   bp	   were	   removed	   with	   the	   PRINSEQ	   software.	   Pair-­‐wise	  alignments	  between	  libraries	  and	  the	  NV	  reference	  sequence	  were	  performed	  using	  454	  Sequencing	   System	  Software	   (Roche).	  Only	  reads	   showing	   at	   least	   one	   SNP	   (excluding	   indels)	   compared	   to	  the	   reference	   sequence	   were	   used	   for	   the	   mapping	   with	   BWA	  software	   (http://bio-­‐bwa.sourceforge.net/).	   SAM	   files	   were	  converted	  into	  aligned	  FASTA	  files.	  For	  each	  read,	  the	  type	  and	  the	  number	   of	   SNPs	   were	   reported	   using	   bioinformatic	   tools	   and	  home-­‐made	  scripts.	  	  
9.	  Statistics	  	  Statistical	   analyses	   were	   performed	   using	   SPSS	   Statistics	  (V.20)	   (http://www-­‐01.ibm.com)	   and	   R	   (v3.1.2)	   softwares	  (http://www.r-­‐project.org).
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RESULTS	  AND	  DISCUSSION	  	  
Chapter	  1.	  Variation	  in	  RNA	  virus	  mutation	  rates	  across	  host	  	  	  
cells	  
	   Although	   host	   factors	   might	   affect	   viral	   mutation	   rates,	  nearly	   all	   estimates	   for	   animal	   viruses	   have	   been	   obtained	   in	  standard	  laboratory	  cell	   lines,	  which	  are	  usually	   immortalized	  or	  cancerous	   and	   thus	   show	   aberrant	   mitotic/metabolic	   and	   gene	  expression	  patterns.	  Furthermore,	   all	   viral	  mutation	   rate	   studies	  have	   been	   conducted	   under	   atmospheric	   oxygen	   levels	   that	   are	  substantially	   higer	   than	   those	   found	   in	  most	   tissues	   (Carreau	   et	  al.,	  2011),	  but	   the	   impact	  of	   this	   type	  of	  environmental	  stress	  on	  the	  estimates	  is	  unknown.	  	  	   Here,	  we	  investigated	  the	  impact	  of	  the	  cell	  type	  and	  host	  species	   on	   the	   variability	   in	   the	   mutation	   rate	   of	   VSV.	   Since	   in	  nature	   this	   virus	   infects	   a	   very	   large	   number	   of	  mammals,	   wild	  animals	   but	   also	   insects,	   it	   replicates	   in	   very	   different	   cellular	  environments	  and	  thus	  represented	  a	  good	  experimental	  model	  to	  investigate	  the	  impact	  of	  this	  cellular	  heterogeneity.	  	  
1.1	   Fluctuation	   tests	   in	   BHK-­‐21	   cells	   and	   validation	   by	  molecular	  
clone	  sequencing	  To	  study	  the	  variability	  in	  the	  mutation	  rate	  of	  VSV	  across	  host	   cells,	   we	   performed	   Luria-­‐Delbrück	   fluctuation	   tests.	   To	  score	   mutants,	   we	   used	   a	   monoclonal	   antibody	   against	   the	  envelope	   glycoprotein	   G	   and	   determined	   the	   probability	   of	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appearance	   of	   monoclonal	   antibody	   resistant	   (MAR)	  mutants	   in	  independent	   cultures	   (null-­‐class	  method).	  To	   set	  up	   the	  method,	  we	  first	  performed	  six	  independent	  tests	  in	  baby	  hamster	  kidney	  cells	  (BHK-­‐21),	  for	  which	  we	  had	  previous	  estimates	  (Furió	  et	  al.,	  2005).	   The	   results	   of	   the	   fluctuation	   test	   gave	   an	   average	  mutation	  rate	   to	   the	  MAR	  phenotype	  of	  m	  =	  (1.64	  ±	  0.27)	  ×	  10–5	  per	   round	  of	   copying	   (Table	  3).	  This	   rate	  was	   then	   converted	   to	  per-­‐nucleotide	  units	  as	  𝜇 = 3𝑚/𝑇,	  where	  the	  mutational	   target	  T	  was	  determined	  by	   sequencing	   the	   glycoprotein	  G	   gene	   from	  15	  MAR	   plaques	   (see	   section	   4.3	   in	   “Materials	   and	   Methods”).	   We	  identified	   four	   different	   nucleotide	   substitutions	   conferring	   the	  MAR	  phenotype,	  which	  led	  to	  amino	  acid	  changes	  D257N,	  D259A,	  D259N,	   and	   S273T.	   Since	   previous	   work	   reported	   the	   same	  substitutions	  at	  position	  259	  of	  the	  G	  glycoprotein,	  in	  addition	  to	  substitutions	   D257G,	   D257V,	   D257Y	   and	   A263E	   (Holland	   et	   al.,	  1991),	  we	  used	  T	  =	  8	  and	  found	  a	  mutation	  rate	  of	  VSV	  in	  BHK-­‐21	  cells	  of	  µ	  =	  6.15	  ×	  10–6	  substitutions	  per	  nucleotide	  per	  round	  of	  copying	  (s/n/r).	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In	   order	   to	   ascertain	   the	   reliability	   of	   the	   estimate	  obtained	   by	   the	   Luria-­‐Delbrück	   fluctuation	   test,	   we	   used	   a	  molecular	   clone	   sequencing	   approach.	   This	   allowed	   us	   to	   score	  mutations	  more	  directly	  than	  in	  fluctuation	  tests	  and	  to	  analyze	  a	  wider	   genome	   region,	   although	   the	   interpretation	   of	   the	   data	   is	  complicated	  by	   the	   fact	   that	   the	  observed	  mutation	   frequency	   is	  dependent	  on	  selection	  or	  the	  viral	  replication	  mode	  (i.e.	  number	  of	   rounds	   of	   genome	   copying).	   Using	   limiting	   dilutions	   (see	  section	   5.1	   in	   “Materials	   and	   Methods”),	   BHK-­‐21	   cells	   were	  infected	  with	  a	  single	  infectious	  unit	  and	  the	  resulting	  viral	  bursts	  (i.e.	  1.55	  ×	  107	  final	  PFU	  on	  average)	  were	  used	  to	  sequence	  three	  genome	  regions	  mapping	  to	  genes	  P,	  G,	  and	  L.	  Among	  the	  77,500	  bases	   analyzed,	   we	   found	   four	   single-­‐nucleotide	   substitutions,	  giving	  a	  mutation	  frequency	  of	  f	  =	  5.16	  ×	  10–5	  (Table	  4).	  Assuming	  a	  per-­‐cell	  burst	  size	  of	  B	  =	  1250	  (Furió	  et	  al.,	  2005),	  the	  number	  of	  infection	  cycles	  (i.e.	  viral	  generations)	  elapsed	  were	  estimated	  to	  be	  𝑐 = !" !.!!×!"!!" !"#$ = 2.3.	   Therefore,	   the	  per-­‐generation	   increase	   in	  mutation	   frequency	  was	   f	   /	  c	   =	  2.24	  ×	  10–5.	  Then,	   to	  account	   for	  the	   effect	   of	   selection,	   we	   used	   the	   previously	   characterized	  distribution	   of	   mutational	   fitness	   effects	   (see	   section	   5.3	   in	  “Materials	  and	  Methods”).	  Based	  on	  this	  distribution,	  the	  expected	  fraction	   of	   observable	  mutations	   after	   2.3	   generations	  was	   53%	  and,	  thus,	  the	  estimated	  per-­‐cell	  mutation	  rate	  was  𝜇! = !!" =  4.23	  ×	   10–5.	   Although	   the	   exact	   number	   of	   round	   of	   genome	   copying	  per	   cell	   was	   unknown,	   a	   previous	   work	   suggested	   rC	   =	   5.8	  rounds/cell,	   implying	  that	  µ	  =	  7.30	  ×	  10–6	  s/n/r.	  Therefore,	  since	  this	   estimate	   was	   fully	   consistent	   with	   the	   above	   results	   of	   the	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Luria-­‐Delbrück	   fluctuation	   test,	   subsequent	   experiments	   in	  mammalian	  and	  insect	  cell	  lines	  were	  done	  using	  fluctuation	  tests	  only	  because	  they	  provided	  a	  faster	  and	  simpler	  approach.	  
	  
	  
Table	  4.	  Molecular	  clone	  sequencing	  of	  VSV	  from	  BHK-­‐21	  cells.	  
	  
1.2	  Constant	  mutation	  rate	  of	  VSV	  in	  different	  mammalian	  cells	  Altough	   VSV	   replicates	   in	   widely	   different	   intra-­‐cellular	  and	   host	   environments,	   mutation	   rates	   published	   to	   data	   have	  been	  measured	  in	  BHK-­‐21	  cells	  only	  (Sanjuán	  et	  al.,	  2010;	  Furió	  et	  al.,	  2005;	  Holland	  et	  al,	  1989),	  which	  are	  immortalized	  or	  tumoral	  as	   opposed	   to	   those	   typically	   encountered	   by	   the	   virus	   in	   vivo.	  Furthermore,	   VSV	   has	   a	   tropism	   for	   neural	   cells,	   and	   kidney	  fibroblasts	  are	  thus	  not	  a	  natural	  target	  of	  this	  virus.	  	  To	  address	   the	  potential	   effect	  of	   cell	   immortalization	  on	  the	  viral	  mutation	  rate,	  we	  performed	  fluctuation	  tests	  in	  primary	  mouse	  embryonic	  fibroblasts	  (MEFs)	  and	  isogenic,	  p53	  knock-­‐out,	  
Gene	   P	   G	   L	  Genome	  sites	   1339-­‐1899	   3858-­‐4347	   6974-­‐7462	  Clones	  	   50	   50	   50	  Total	  bases	  	   28050	   25000	   24450	  Mutations	   A1821C	  (Lys	  →Thr)	  G1640A	  (Gly→Arg)	   A3983G	  (Glu	  →Glu)	  T3937A	  (Leu→His)	   None	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MEFs.	  The	  average	  rates	  were	  similar	  in	  both	  cell	  types,	  since	  we	  found	  m	  =	  1.27	  ×	  10–5	  in	  normal	  MEFs	  and	  m	  =	  0.82	  ×	  10–5	  in	  p53	  knock-­‐out	   MEFs,	   thus	   revealing	   no	   significant	   effect	   of	   cellular	  immortalization	   (Figure	   14;	   Student’s	   t-­‐test:	   p	   =	   0.232,	   n	   =	   6;	  Supplementary	  1).	  However,	  many	   tumoral	  cell	   lines	  show	  other	  genetic	  and	  metabolic	  alterations	   in	  addition	  to	  p53	   inactivation.	  To	   check	   the	   potential	   effects	   of	   these	   changes,	   we	   performed	  fluctuation	   tests	   in	  CT26	   cells	   from	  an	  undifferentiated	   grade	   IV	  colon	  adenocarcinoma	  of	  a	  BALB/c	  mouse	   (Corbett	  et	  al.,	  1975).	  We	  found	  m	  =	  1.18	  ×	  10–5,	  a	  value	  not	  significantly	  different	  from	  that	  of	  primary	  MEFs	  (Student’s	  t-­‐test:	  p	  =	  0.885,	  n	  =	  6).	  Of	  note,	  BHK-­‐21	   are	   also	   tumor-­‐forming	   cells,	   and	   the	   mutation	   rate	   in	  these	  cells	  was	  similar	  to	  the	  rate	  observed	  in	  MEFs	  or	  CT26	  cells	  (one-­‐way	   ANOVA:	   p	   =	   0.293,	   n	   =	   12).	   Because	   metabolic	   and	  mitotic	  activity	  should	  alter	  the	  availability	  of	  intra-­‐cellular	  dNTPs	  (Bray	   and	   Brent,	   1972)	   and	   could	   potentially	   impact	   RNA	  replication	   fidelity,	   this	   homogeneity	   in	   the	   VSV	   mutation	   rate	  was	  not	  an	  obvious	  expectation	  (although	  this	  virus	  replicates	   in	  the	   cytoplasm	   and	   may	   not	   be	   strongly	   affected	   by	   these	  alterations).	  This	  finding	  has	  implications	  for	  the	  field	  of	  oncolytic	  virotherapy	  (Russell	  et	  al.,	  2012),	   since	   it	   is	  critical	   to	  assess	   the	  genetic	   stability	   of	   these	   therapeutic	   viruses	   during	   large-­‐scale	  manufacturing	  and	  clinical	  use.	  In	  particular,	  CT26	  cells	  have	  been	  used	   in	  mice	   as	   a	  model	   for	   testing	   the	  oncolytic	   activity	   of	   VSV	  (Breitbach	  et	  al.,	  2011).	  	  Although	  these	  results	  suggested	  that	  VSV	  replicated	  with	  similar	   fidelity	   in	   different	   cell	   types,	  we	   sought	   to	   test	  whether	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this	   would	   also	   hold	   for	   neural	   cells.	   We	   therefore	   performed	  fluctuation	   tests	   in	   Neuro-­‐2a	   cells	   from	   a	  mouse	   neuroblastoma	  (Klebe	   and	  Ruddle,	   1969).	  Again,	  we	   found	  an	   average	  mutation	  rate	  of	  m	  =	  1.06	  ×	  10–5,	  which	  did	  not	  significantly	  differ	  from	  the	  rate	  obtained	  in	  BHK-­‐21	  cells	  (Student’s	  t-­‐test:	  p	  =	  0.461,	  n	  =	  9).	  	  All	   viral	   mutation	   rate	   estimates	   available	   to	   date	   have	  been	   conducted	   in	   vitro	   under	   atmospheric	   oxygen	   levels	   (i.e.	  20%	   O2).	   However,	   these	   levels	   are	   substantially	   higher	   than	  those	  found	  in	  vivo	  in	  most	  tissues,	  which	  range	  between	  11%	  and	  1%	   O2	   (Carreau	   et	   al.,	   2011).	   For	   instance,	   oxygen	   delivery	   is	  dependent	  on	  the	  metabolic	  requirements	  and	  functional	  status	  of	  each	   organ,	   and	   hypoxia	   (1%	   oxygen)	   is	   marked	   during	   cancer	  formation.	   Therefore,	   to	   test	   for	   the	   impact	   of	   this	   type	   of	  environmental	   stress	   on	   viral	   mutation	   rates,	   we	   performed	  fluctuation	   tests	   in	   BHK-­‐21	   cells	   varying	   oxygen	   levels.	   The	  VSV	  mutation	  rate	   in	  BHK-­‐21	  cells	  cultured	  under	  hypoxic	  conditions	  was	  m	   =	   2.71	   ×	   10–5,	   thus	   slightly	   higher	   but	   not	   significantly	  different	   from	   the	   rate	   obtained	   under	   standard	   conditions	  (Student’s	   t-­‐test:	   p	   =	   0.122,	   n	   =	   9).	   Although	   oxidative	   stress	  should	  lead	  to	  the	  release	  of	  reactive	  oxygen	  species	  (ROS),	  which	  have	  been	  previously	  shown	  to	  be	  mutagenic	  for	  hepatitis	  C	  virus	  (Seronello	   et	   al.,	   2011),	   our	   results	   suggested	   that	   VSV	  was	   not	  sensitive	   to	   oxidation	   levels.	   We	   proposed	   that	   this	   might	   be	  related	  to	  the	  fact	  that	  the	  nucleocapsid	  of	  mononegavirales	  forms	  a	   tunnel-­‐like	   structure	  which	  wraps	   the	   viral	   genomic	   RNA	   and	  remains	   assembled	   during	   the	   entire	   infection	   cycle	   (Ge	   et	   al.,	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2010;	   Green	   et	   al.,	   2006),	   effectively	   isolating	   the	   viral	   RNA	  (Ostertag	  et	  al.,	  2007).	  	  
	  
	  
Figure	   14.	  VSV	  mutation	   rate	   to	   the	  MAR	  phenotype	  estimated	  by	   the	  Luria-­‐Delbrück	  fluctuation	  test	  in	  different	  cellular	  environments.	   	  Each	  dot	   represents	   an	   independent	   estimate	   (n	   =	   3	   for	   all	   except	  n	   =	   6	   for	  BHK-­‐21	   and	   n	   =	   4	   for	   BHK-­‐21	   at	   28°C).	   Horizontal	   bars	   indicate	   the	  mean	   rate.	   Detailed	   information	   for	   each	   test	   is	   provided	   in	  Supplementary	  1.	  Adapted	  from	  Combe	  and	  Sanjuán	  (2014b).	  	  
1.3	  Lower	  mutation	  rate	  in	  insect	  cells	  	   Since	   the	   natural	   lifecycle	   of	   VSV	   alternates	   between	  mammalian	   and	   insect	   hosts,	   we	   sought	   to	   estimate	   the	   viral	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mutation	  rate	  in	  insect	  cells.	  First,	  we	  measured	  the	  mutation	  rate	  of	   VSV	   in	   S2	   cells	   from	   Drosophila	   melanogaster	   embryos.	   The	  average	  estimate	  from	  three	  independent	  fluctuation	  tests	  was	  m	  =	   4.08	   ×	   10–6,	   representing	   a	   fourfold	   decrease	   compared	   with	  BHK-­‐21	  cells	  (Figure	  14,	  Student’s	  t-­‐test:	  p	  =	  0.009,	  n	  =	  9).	  Then,	  to	   further	   investigate	   this	   potential	   decrease	   in	   viral	   mutation	  rate	   in	   insect	   cells,	   we	   selected	   two	   additional	   insect	   cell	   lines,	  such	   as	   sf21	   ovarian	   cells	   from	   the	  moth	  Spodoptera	   frugiperda,	  and	  C6/36	  cells	  from	  Aedes	  albopictus	  mosquito	  larvae	  and	  found	  mutation	  rates	  of	  m	  =	  5.9	  ×	  10–6	  and	  m	  =	  8.14	  ×	  10–6,	  respectively	  (Supplementary	  1).	  Also,	   since	   insect	   cells	  were	   infected	  at	  28°C	  and	  mammalian	  cells	  at	  37°C,	  we	  performed	  four	  additional	  tests	  in	   BHK-­‐21	   at	   28°C	   to	   control	   for	   the	   effect	   of	   the	   incubation	  temperature.	   In	   order	   to	   test	   for	   the	   effects	   of	   host	   type	   and	  temperature	   (fixed	   factors),	   we	   used	   estimates	   obtained	   in	  mammalian	   (BHK-­‐21,	   BHK-­‐21	   at	   28°C,	   MEF,	   MEF	   p53-­‐/-­‐,	   CT26,	  and	  Neuro-­‐2a)	   and	   insect/mosquito	   cells	   (S2,	   Sf-­‐21,	   and	   C6/36)	  and	   performed	   a	   two-­‐way	  ANOVA	   in	  which	   the	   specific	   cell	   line	  was	   treated	   as	   a	   random	   factor	   nested	   within	   host	   type.	   The	  results	  confirmed	  that	  VSV	  showed	  a	  lower	  mutation	  rate	  in	  insect	  cells	  compared	  to	  mammalian	  cells	  (ANOVA:	  p	  <	  0.001),	  and	  also	  that	   temperature	   did	   not	   account	   for	   this	   result	   because	   the	  estimates	   in	   BHK-­‐21	   cells	   were	   actually	   higher	   at	   28°C	   than	   at	  37°C	  (p	  =	  0.001).	  In	  log10-­‐transformed	  data	  (used	  for	  all	  statistical	  comparisons),	   the	   estimated	   effect	   size	   of	   the	   host	   type	   in	   the	  above	  model	  was	  0.590	  ±	  0.205,	  which	  corresponds	  to	  a	  3.9-­‐fold	  mutation	  rate	  decrease	  in	  insect	  cells.	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   We	   also	   observed	   lower	   viral	   yields	   in	   C6/36	   mosquito	  cells	   (Supplementary	   1),	   confirming	   previous	   observations	  (Schloemer	   and	  Wagner,	   1975).	   In	   a	   similar	   study,	   chikungunya	  (CHIKV)	  and	  West	  Nile	  (WNV)	  virus	  variants	  with	  lower	  mutation	  frequencies	   showed	   replication	   defects	   (reduced	   viral	   yield)	   in	  mosquito	   cells	   compared	   to	   mammalian	   cells	   (Rozen-­‐Gagnon	   et	  al.,	   2014).	   However,	   in	   agreement	   with	   our	   results,	   all	   studies	  discarded	   the	   effect	   of	   the	   incubation	   temperature	   as	   a	   possible	  explanation	   for	   the	   differences	   in	   virus	   production	   between	  mammalian	  and	  insect	  cells.	  However,	  we	  wondered	  whether	  the	  observed	  differences	  may	  result	  from	  differences	  in	  the	  sensitivity	  to	  detect	  MAR	  mutants	  in	  mammalian	  and	  insect	  cells.	  To	  address	  this	   potential	   bias,	   we	   first	   verified	   that	   MAR	   plating	   efficiency	  was	   similar	   in	   regardless	   of	   viruses	  were	   grown	   in	   BHK-­‐21,	   S2,	  Sf21,	   and	   C6/36	   (Supplementary	   1).	   Then,	   we	   tested	   for	  differences	   in	   the	   mutation	   target	   size	   (T)	   by	   sampling	   15	  individual	   MAR	   plaques	   from	   fluctuation	   tests	   performed	   in	   S2	  cells	   and	   sequenced	   the	   region	   of	   the	   G	   protein	   controlling	   this	  phenotype	  (see	  section	  4.3	  in	  “Materials	  and	  Methods”).	  We	  found	  the	   same	   amino	   acid	   replacements	   as	   in	   fluctuation	   tests	  performed	  in	  BHK-­‐21	  cells	  (D257N,	  D259N,	  S273T,	  see	  section	  1.1	  above)	   except	   for	  D259A.	  However,	   because	   the	  D259	  mutant	   is	  viable	  in	  insect	  cells	  (Novella	  et	  al.,	  1999),	  failure	  to	  detect	  it	  was	  probably	   just	   due	   to	   insufficient	   sampling	   depth.	  We	   also	   found	  substitution	   A263E,	   which	   was	   reported	   previously	   in	   BHK-­‐21	  cells	  (Holland	  et	  al.,	  1991).	  Since	  viruses	  grown	  in	  S2	  and	  BHK-­‐21	  cells	  shared	  similar	  mutational	  repertoires	  and	  plating	  efficiencies	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our	  results	  supported	  the	  reliability	  of	  the	  observed	  mutation	  rate	  differences	  between	  insect	  and	  mammalian	  cells.	  	  
1.4	   Comparison	   of	   evolutionary	   rates	   between	   arboviruses	   and	  
directly	  transmitted	  viruses	  Interestingly,	   since	   arboviruses	   such	   as	   VSV	   have	   to	  replicate	   in	   disparate	   hosts,	   they	   are	   subjected	   to	   different	  selective	  pressures	   (Coffey	  et	  al.,	  2011)	  and	   tend	   to	  evolve	  more	  slowly	  than	  directly	  transmitted	  viruses	  due	  to	  these	  evolutionary	  constraints	  (Hanada	  et	  al.,	  2004;	  Jenkins	  et	  al.,	  2002;	  Rodriguez	  et	  al.,	   1996).	   For	   instance,	   for	   alphaviruses,	   it	   has	  been	   shown	   that	  viral	   diversity	   is	   more	   restricted	   in	   the	   insect	   host	   because	   of	  more	   stringent	   population	   bottlenecks	   and	   selective	   pressures	  (Rozen-­‐Cagnon	  et	  al.,	  2014).	  Here	  we	  performed	  a	  meta-­‐analysis	  using	   170	   previously	   published	   evolutionary	   rates	   which	  confirmed	  that,	  after	  accounting	  for	  phylogenetic	  relatedness	  and	  the	   timespan	   of	   sequence	   sampling,	   arboviruses	   showed	   a	  significantly	   lower	   evolution	   rate	   than	   directly	   transmitted	  viruses	   (Figure	   15;	   two-­‐way	   ANOVA:	   p	   =	   0.006),	   the	   geometric	  mean	  rates	  being	  5.7	  ×	  10–4	  substitutions	  per	  site	  per	  year	  (s/s/y)	  and	   1.3	   ×	   10–3	   s/s/y,	   respectively.	   Lower	   evolution	   rates	   in	  arboviruses	  have	  been	  often	  interpreted	  in	  terms	  of	  fitness	  trade-­‐offs,	  whereby	  neutral	  or	  beneficial	  mutations	  in	  mammals	  can	  be	  deleterious	   in	   insects,	   and	   vice	   versa,	   thus	   restricting	   viral	  evolution.	  Indeed,	  previous	  studies	  where	  one	  host	  was	  artificially	  removed	  from	  the	  alternate	  cycling	  revealed	  that	  host	  alternation	  constrains	   the	   adapatibility	   of	   arboviruses	   (Coffey	   et	   al.,	   2011).	  Our	   results	   provide	   an	   alternative	   explanation	   for	   the	   slower	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evolution	   of	   arboviruses,	   based	   on	   lower	   mutation	   rates	   in	   the	  insect	  host	  compared	  to	  mammalian	  host.	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Chapter	  2.	  Genetic	  diversity	  of	  an	  RNA	  virus	  at	  the	  single-­‐cell	  
level	  	   It	   has	   been	   traditionally	   assumed	   that	   cell	   cultures	  represent	   homogeneous	   environments.	   However,	   it	   has	   been	  recently	   shown	   that	   cells	   exhibit	   important	   variability	   in	   their	  metabolism	  and	  physiological	  status,	  as	  well	  as	  in	  gene	  expression	  patterns	  (Yoshimoto	  et	  al.,	  2013;	  Kurimoto	  et	  al.,	  2007;	  Wang	  and	  Bodovitz,	  2010;	  Narsinh	  et	  al.,	  2011).	  These	  cell-­‐to-­‐cell	  variations	  might	  have	  major	   implications	   for	   the	  outcome	  of	   viral	   infection	  (Pathak	   and	   Temin,	   1990;	   Monk	   et	   al.,	   1992).	   For	   instance,	  analysis	   of	   individual	   cells	   helped	   to	   clarify	   how	   viruses	  antagonize	  the	  interferon	  response,	  which	  has	  a	  stochastic	  nature	  and	  varies	  from	  cell	  to	  cell	  (Rand	  et	  al.,	  2014).	  For	  animal	  viruses,	  the	  study	  of	  the	  differences	  in	  viral	  yield	  between	  single	  cells	  has	  provided	   important	   clues	   to	   viral	   lifecycle	   aspects	   such	   as	   the	  intra-­‐cellular	  determinants	  of	  viral	  fitness,	  or	  the	  viral	  replication	  mode	   (Schulte	   and	  Andino,	  2014;	  Zhu	  et	   al.,	   2009;	   Schulte	   et	   al.,	  2015;	   Timm	   and	   Yin,	   2012).	   In	   addition	   to	   determining	   host-­‐to-­‐host	  transmission,	  viral	  replication	  also	  governs	  the	  production	  of	  genetic	   diversity	   through	   the	   appearance	   of	   spontaneous	  mutations.	   However,	   the	   rate	   at	   which	  mutations	   accumulate	   in	  viral	   populations	   should	   also	   be	   variable	   (Schubert	   et	   al.	   1984,	  Ninio,	   1991,	   Drake	   et	   al.,	   2005),	   as	   demonstrated	   for	   Spleen	  Necrosis	  Virus	  (SNV)	  where	  a	  single	  provirus	  had	  a	  mutation	  rate	  1,000-­‐fold	   higher	   than	   the	   rate	   determined	   for	   the	   virus	  population	   because	   of	   the	   presence	   of	   multiple	  mutations	   in	   its	  genome	   (Pathak	   and	   Temin,	   1990).	   Although	   there	   are	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fundamental	   gaps	   in	   our	   knowledge	   of	   the	   mutational	   process,	  characterizing	  such	  processes	  underlying	  the	  genetic	  diversity	  of	  viruses	  is	  critical	  in	  order	  to	  understand	  their	  evolution,	  as	  well	  as	  immune	   escape,	   vaccine	   failure,	   drug	   resistance,	   or	   disease	  emergence	   (Duffy	   et	   al.,	   2008;	   Elde	   et	   al.,	   2012;	   Holmes,	   2009;	  Lauring	  et	  al.,	  2013).	  Recent	   advances	   in	   deep	   sequencing	   have	   improved	   our	  knowledge	   of	   viral	   genetic	   diversity,	   but	   these	   studies	   did	   not	  reach	  the	  single-­‐cell	  level	  (Acevedo	  et	  al.,	  2014).	  However,	  single-­‐cell	  analyses	  are	  necessary	  to	  clarify	  whether	  the	  genetic	  diversity	  is	  produced	  homogeneously	  among	  cells,	  or	  tends	  to	  be	  allocated	  to	   a	   subset	   of	   cells,	   as	   previously	   proposed	   (García-­‐Villada	   and	  Drake,	   2012).	   Here,	   by	   combining	   single-­‐cell	   micromanipulation	  with	  deep	  sequencing,	  we	  measured	  the	  accumulation	  of	  SNPs	  for	  hundreds	   of	   full-­‐length	   VSV	   plaques	   released	   from	   individual	  cells.	  
2.1	  Infected	  cells	  and	  MOI	  	   Following	   infection	   of	   confluent	   BHK-­‐21	   cells,	  micromanipulation	   was	   used	   to	   isolate	   350	   single	   cells	   and	  transfer	  them	  to	  separate	  wells	  within	  2	  h	  post	  inoculation	  (hpi),	  such	  that	  no	  viral	  progeny	  could	  be	  released	  before	  cell	   isolation	  (Timm	  and	  Yin,	  2012).	  After	  24	  h	  incubation,	  culture	  media	  were	  plated	  to	  measure	  the	  viral	  yield	  per	  cell	  by	  enumeration	  of	  PFUs.	  Since,	  theorically,	  approx.	  5	  ×	  105	  PFU/ml	  were	  used	  to	  infect	  cell	  cultures	   that	   were	   then	   diluted	   1/20,	   we	   estimated	   that	   the	  proportion	  of	   free	  particles	   that	  might	  have	  been	  aspirated	  with	  the	   cell	   (i.e.	   2-­‐4	   µl	   of	   media	   aspirated)	   should	   be	   around	   2.5-­‐5	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PFUs.	  This	   suggested	   that	   the	   fraction	  of	   free	  PFUs	  mixed	   to	   the	  progeny	  of	  an	  infected	  cell	  accounted	  for	  a	  very	  small	  proportion	  of	   the	   plaques	   that	   were	   sequenced.	   In	   addition,	   a	   pilot	  experiment	   allowed	   us	   to	   establish	   an	   arbitrarily	   threshold	   to	  discriminate	   the	   proportion	   of	   infected-­‐	   and	   non-­‐infected	   cells	  since,	   after	   plaque	   assay	   of	   the	   supernatant,	   wells	   contained	  either	   less	   than	   7	   PFUs	   (between	   0-­‐6)	   or	   more	   than	   34	   PFUs	  (Figure	   16).	   Therefore,	   when	   less	   than	   10	   PFUs	   per	   well	   were	  observed,	   the	   cell	   was	   considered	   as	   non-­‐infected	   and	   was	  discarded	   from	   the	   analysis,	   whereas	   when	  more	   than	   10	   PFUs	  per	  well	  were	  scored	  the	  cell	  was	  considered	  as	  infected.	  	  	   Among	  the	  350	  single	  cells	   isolated	  we	   found	  95	   infected	  cells,	  which	   represents	  27%	  of	   the	   total.	  Therefore,	   according	   to	  the	  Poisson	  distribution,	  we	  calculated	  the	  MOI	  as	  follows:	  –	  ln	  (1-­‐95/350)	   =	   0.32	   PFU/cell,	   such	   that	   85%	   of	   the	   cells	   should	   be	  infected	   by	   a	   single	   infectious	   particle,	   whereas	   15%	   by	   two	   or	  more	  units.	  Although	  95	  cells	  were	  productively	  infected,	  we	  used	  plaques	  from	  90	  cells	  to	  construct	  libraries	  because	  plaques	  from	  the	  remaining	  5	  cells	  did	  not	  have	  enough	  titer	  to	  allow	  for	  their	  equimolar	  pooling.	  	  





















Figure	   16.	   Number	   of	   PFUs	   per	   well.	   In	   a	   pilot	   experiment,	   60	   wells	  were	   inoculated	   with	   a	   single	   infected	   cell	   each.	   After	   incubation,	   the	  supernatant	  was	  used	  for	  plaque	  assays	  and	  we	  scored	  48	  wells	  showing	  between	  0-­‐6	  PFUs,	  whereas	  12	  wells	  had	  >	  34	  PFUs.	  	  
2.2	  VSV	  mutational	  spectrum	  	   To	   analyse	   the	   genetic	   diversity	   of	   viruses	   released	   from	  single-­‐cells,	   we	   picked	   7-­‐10	   plaques	   for	   each	   of	   these	   90	   cells,	  such	   that	   a	   total	   of	   881	   full-­‐length	   individual	   plaques	   (approx.	  11.2	   kb	   each),	   corresponding	   to	   9	   Mb	   sequenced	   by	   the	   SOLID	  technology.	  Since	  a	  previous	  study	  showed	  that	  viruses	  with	  up	  to	  90%	   reduction	   in	   fitness,	   compared	   to	   the	   wild-­‐type	   VSV	   used	  here,	  can	  form	  visible	  plaques	  (Sanjuán	  et	  al.,	  2004),	  a	  priori	  our	  experimental	   protocol	   allowed	   the	   sampling	   of	  most	   of	   the	   non-­‐lethal	  mutations	  present	   in	   these	  90	   single-­‐cells.	  Mapping	  of	   the	  sequences	  of	  these	  881	  plaques	  to	  a	  common	  reference	  sequence	  gave	  a	  total	  of	  285	  SNPs	  (Figure	  17,	  Supplementary	  5).	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   Of	   these	  285	   SNPs,	   264	  were	   coding	  mutations	  with	  155	  synonymous	   substitutions	   and	   109	   nonsynonymous	  substitutions,	  including	  13	  stop	  codons	  (Table	  5).	  	  
	  	  










	   92	  
Table	  5.	  VSV	  mutational	  spectrum	  at	  the	  single-­‐cell	  level.	  For	  each	  type	  of	   mutation	   the	   counts	   are	   reported,	   as	   well	   as	   the	   nucleotide	  substitution	  matrix.	  	  	  
Mutation	  type	   Count	   	   SNPs	  type	  	   	  Total	  mutations	   285	   	   A	   U	   G	   C	  Base	  substitutions	   285	   A	   -­‐	   5	   62	   25	  Indels	   0	   U	   11	   -­‐	   20	   44	  Transitions	   180	   G	   41	   17	   -­‐	   0	  Transversions	   105	   C	   26	   33	   1	   -­‐	  Coding	   264	   	   	   	   	   	  Non-­‐coding	   21	   	   	   	   	   	  Synonymous	   155	   	   	   	   	   	  Nonsynonymous	   109	   	   	   	   	   	  Stop-­‐codon	   13	   	   	   	   	   	  	  	  	   The	   mutational	   spectrum	   was	   dominated	   by	   transitions,	  representing	   63.2%	   of	   all	   SNPs,	   against	   36.8%	   of	   transversions.	  Finally,	   among	   transversions	   the	   nucleotide	   changes	   A	   -­‐>	   C	  (23.8%),	  C	  -­‐>	  A	  (24.8%)	  and	  their	  respective	  complementary	  U	  -­‐>	  G	   (19%)	   and	   G	   -­‐>	   U	   (16.2%)	   were	   significantly	   more	   frequent	  than	  A	  -­‐>	  U	  (4.8%),	  U	  -­‐>	  A	  (10.5%),	  C	  -­‐>	  G	  (0.9%)	  and	  G	  -­‐>	  C	  (0%)	  changes	   (Fisher’s	   exact	   test,	   p	   =	   2.5	   ×	   10-­‐9).	   These	   nucleotide	  changes	  were	   consistent	  with	   the	  mutational	   spectrum	   found	   in	  sequences	   from	   natural	   isolates	   of	   VSV	   (Figure	   18,	   Spearman’s	  correlation,	  ρ	  =	  0.918,	  P	  <	  0.001),	  suggesting	  thus	  their	  relevance	  to	  natural	  diversity.	  




Figure	   18.	   Correlation	  between	  SNPs	   spectra	   in	   viruses	   released	   from	  single-­‐cells	  and	  in	  sequences	  from	  natural	  isolates	  of	  VSV.	  The	  frequency	  of	   each	   type	   of	   SNP	   in	   single-­‐cells	   was	   taken	   from	   Table	   5.	   Blue	   dots	  indicate	   transitions	   and	   red	   dots	   transversions.	   For	   natural	   isolates	   of	  VSV,	   1033	   SNPs	   were	   extracted	   from	   the	   following	   available	   genome	  sequences	   of	   the	   Indiana	   VSV	   serotype:	   EU849003	   (Mudd-­‐Summers	  strain)	  which	  was	  used	  as	  reference,	  AF473865	  (isolated	   from	  cattle	   in	  Colombia,	   1985),	   AF473866	   (isolated	   from	   cattle	   in	   Guatemala,	   1994),	  AF473864	   (isolated	   from	   horse	   in	   Colorado,	   1998),	   EF197793	  (unknown	   host),	   J02428	   (unknown	   host),	   and	   NC_001560	   (unknown	  host).	  The	  dots	  indicate	  the	  percentage	  of	  total	  SNPs	  of	  each	  type	  (A	  -­‐>	  G,	  U	   -­‐>	  C,	   and	   so	  on),	   in	   log-­‐scale.	   The	  G	   -­‐>	  C	  data	  point	   does	  not	   appear	  because	  it	  showed	  0%	  frequency	  in	  single	  cells;	  its	  abundance	  in	  natural	  isolates	  was	  0.4%.	  Adapted	  from	  Combe	  et	  al.	  (submitted).	  	  
2.3	  SNP	  distribution	  between	  and	  within	  single-­‐cells	  	   Of	   the	   90	   cells	   examined,	   85	   contained	   at	   least	   one	   SNP	  whereas	  5	  cells	  had	  no	  SNP.	  The	  number	  of	  SNPs	  varied	  between	  0-­‐11	  depending	  on	  the	  cell	  (Figure	  19A),	  with	  on	  average	  4.3	  SNPs	  per	   cell	   (including	   SNPs	   found	   in	   multiple-­‐copies	   as	   a	   single	  mutation	   event).	   Despite	   this	   ample	   variation	   in	   the	   number	   of	  SNPs	  between	  cells,	  we	  could	  not	  discard	  the	  null	  hypothesis	  that	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the	   number	   of	  mutations	   per	   cell	   followed	   a	   Poisson	  distibution	  (p-­‐value	   after	   applying	   the	   Dunn-­‐Sidâk	   correction	   for	   multiple	  tests,	  p	  >	  5.7	  ×	  10–4).	  	  	   The	   copy	   number	   of	   any	   given	   SNP	   within	   a	   cell	   varied	  also.	  Whereas	   90	   SNPs	   occurred	   in	   only	   1	   plaque	   (scSNPs),	   195	  SNPs	   were	   scored	   in	   multiple-­‐copy	   (Figure	   19B).	   The	   latter	  scenario	   indicates	   intra-­‐cellular	  amplification	  of	  SNPs	  as	  a	   result	  of	   viral	   replication.	   These	  multiple-­‐copy	   SNPs	   probably	   occured	  early	   during	   viral	   replication	   and	   were	   then	   copied	   to	   more	  progeny	  molecules	  under	  a	  geometric	  replication	  model.	  Although	  this	  latter	  strategy	  of	  replication	  has	  been	  recently	  demonstrated	  for	  poliovirus	  (Schulte	  et	  al.,	  2015)	  we	  were	  not	  able	   to	   test	   this	  scenario,	  as	  shown	  below.	  	  	   Finally,	   the	  number	  of	  SNPs	  per	   individual	  plaque	  ranged	  between	   0-­‐9,	   with	   1404	   SNP	   copies	   scored	   among	   the	   881	  plaques	  sequenced,	  leading	  to	  an	  average	  of	  1.59	  SNPs	  per	  plaque	  (Figure	  19C).	  	  	  
	  
	  
Figure	   19.	   Distribution	   of	   the	   number	   of	   SNPs	   between	   and	   within	  single-­‐cells.	  A,	  number	  of	  SNPs	  per	  cell;	  B,	  number	  of	   intra-­‐cellular	  SNP	  copies	  for	  each	  SNP;	  C,	  number	  of	  SNPs	  per	  plaque.	  Adapted	  from	  Combe	  et	  al.	  (submitted).	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2.4	  Pre-­‐existing	  variability	  
	   Interestingly,	  of	  the	  285	  SNPs	  62	  were	  observed	  in	  several	  (2-­‐12)	   cells	   (Supplementary	   5).	   Because	   it	   is	   unlikely	   that	   the	  exact	  same	  point	  mutation	  appeared	  de	  novo	  and	  simultaneously	  in	   multiple	   cells,	   we	   attributed	   these	   62	   SNPs	   to	   pre-­‐existing	  variability	   (preSNPs).	   Consequently,	   these	   mutations	   were	  obviously	   present	   in	   the	   viral	   stock	   and	   thus	   delivered	   to	   cells	  during	  the	  infection	  process.	  Then,	  because	  85%	  of	  the	  cells	  might	  have	   been	   infected	   by	   a	   single	   PFU	   (see	   section	   2.1	   above),	   one	  could	   thought	   that	   each	   cell	   should	   contained	   only	   one	   of	   these	  preSNPs.	   In	   contrast,	   among	   the	   64	   cells	  with	   preSNPs,	   44	   cells	  had	  more	   than	   2	   preSNPs,	  with	   an	   average	   of	   2.56	   preSNPs	   per	  cell.	  Because	  of	  this	  result,	  we	  hypothesized	  that	  single	  PFU	  could	  have	  delivered	  pools	  of	  genetically	  diverse	   infectious	  particles	  to	  each	  single-­‐cell.	  
	   2.4.1	  Spatial	  aggregation	  of	  SNPs	  within	  the	  same	  PFUs	  
	   To	   test	   the	  above	  hypothesis,	  we	  compared	   the	  observed	  distribution	   of	   preSNPs	   for	   all	   single-­‐cells	   isolated	   (350	   single-­‐cells)	  under	  a	  Poisson	  and	  under	  a	  negative	  binomial	  model.	  The	  Poisson	  model	  assumes	  random	  spatial	  distribution	  of	   infectious	  particles,	   whereas	   the	   negative	   binomial	   model	   accommodates	  putative	   aggregation	   of	   virions	   within	   PFUs.	   The	   Poisson	  distribution	   was	   simulated	   as	  𝑃𝑜(𝑥|𝑚) = !!!  !!!! ,	   where	  𝑥	  is	   the	  observed	  number	  of	  SNPs	  per	  cell	  and	  𝑚	  is	  the	  average	  number	  of	  preSNPs	  per	  cell.	  The	  negative	  binomial	  model	  was	  simulated	  as	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𝑁𝐵𝑖(𝑥|𝑝, 𝑟) = !(!!!)!(!)!! 𝑝!(1 − 𝑝)! ,	   where	   Γ	   denotes	   the	   Gamma	  function,	   	  𝑝	  is	   the	   probability	   of	   getting	   a	   preSNP	   if	   these	   were	  homogeneously	   distributed	   across	   cells	   and	   𝑟 	  is	   the	   average	  number	   of	   cells	   that	   have	   to	   be	   examined	   before	   obtaining	   a	  preSNP.	  Therefore	  𝑟	  measures	   the	  degree	  of	  preSNP	  aggregation.	  For	   each	   distribution,	   the	   observed	   number	   of	   preSNPs	   per	   cell	  was	   used	   to	   fit	   the	  model	   by	  maximum	   likelihood.	   Similarly,	  we	  found	   that	   the	   number	   of	   preSNPs	   per	   isolated	   cell	   showed	   a	  significant	   over-­‐dispersion	   compared	   to	   the	  Poisson	  distribution	  since	   the	   variance-­‐to-­‐mean	   ratio	   was	   2.92	   (Figure	   20),	   thus	  rejecting	   a	   scenario	   of	   a	   Poisson	   distribution	   of	   preSNPs	  (Kolmogorov-­‐Smirnov	   test,	   p	   <	   0.001).	   Therefore,	   a	   negative	  binomial	   distribution	   fitted	   better	   our	   results,	   suggesting	   spatial	  aggregation	  of	  the	  number	  of	  preSNPs	  per	  isolated	  cells.	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Figure	   20.	  Distribution	   of	   the	   number	   of	   preSNPs	   per	   isolated	   single-­‐cell.	  The	  distribution	  of	  the	  62	  preSNPs	  is	  represented	  for	  the	  350	  single-­‐cells	   isolated	   (log-­‐scale).	  The	  observed	  distribution	   is	   compated	   to	   two	  statistical	  models:	  a	  Poisson	  (blue)	  model	  that	  assumed	  random	  spatial	  distribution	  of	  infectious	  particles,	  and	  a	  negative	  binomial	  (red)	  model	  that	   accommodates	   putative	   spatial	   aggregation	   of	   infectious	   particles.	  Both	   circles	   above	   the	  histogram	   represent	   the	   assumption	  underlying	  each	  model.	  The	  Poisson	  model	  was	  rejected	  by	  a	  Kolmogorov-­‐Smirnov	  test	   (p	   <	   0.001),	   whereas	   the	   binomial	  model	   fitted	   better	   our	   results	  (log-­‐likelihood:	  -­‐	  log	  L	  =	  389.84	  for	  Poisson,	  -­‐log	  L	  =	  281.16	  for	  negative	  binomial).	  Adapted	  from	  Combe	  et	  al.	  (submitted).	  	  	   The	  spatial	  aggregation	  of	  viral	  particles	  within	   the	  same	  infectious	   unit	   is	   supported	   by	  microscopy	   studies	   showing	   that	  individual	   PFUs	   can	   be	   constituted	   by	   aggregates	   of	   virions	  (Bussereau	  and	  Flamand,	  1978;	  Libersou	  et	  al.,	  2010).	  For	  Sindbis	  virus,	   it	  has	  been	  shown	  that	  virions	  are	  able	  to	   form	  aggregates	  at	   the	   cell	   surface	   within	   cytoplasmic	   vacuoles	   (Boehme	   et	   al.,	  2000).	   Also,	   plant	   viruses,	   such	   that	   Potato	   virus	   X	   (Cruz	   et	   al.,	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1996),	   Tomato	   Golden	   Mosaic	   virus	   (Rushing	   et	   al.,	   1987)	   and	  Bamboo	  Mosaic	  virus	  (Lin	  and	  Chen,	  1991),	  are	  able	  to	  form	  large	  and	   fibrillar	   aggregates	   of	   virions	   within	   infected	   cells.	  Additionally,	   a	   recent	   study	   showed	   that	   enteroviruses	   are	  transmitted	   from	   cell-­‐to-­‐cell	   inside	   lipid	   vesicles	   harboring	  multiple	  viral	  particles	  (Chen	  et	  al.,	  2015).	  Therefore,	  despite	  the	  low	  MOI	  used	  to	  infect	  the	  cultures,	  single	  cells	  were	  not	  infected	  by	   a	   single	   infectious	   particle,	   but	   rather	   by	   a	   pool	   of	   multiple,	  genetically	  non-­‐identical	  infectious	  particles	  contained	  within	  the	  same	  PFU.	  Also,	  our	  results	  provided	  a	  quantitative	  estimation	  of	  the	  diversity	  of	  these	  multiple	  infectious	  particles	  since	  we	  found	  an	   average	   of	   2.56	   alleles	   delivered	   to	   each	   cell.	   However,	   this	  estimate	  was	  based	  on	  SNPs	  occurring	  in	  multiple	  cells	  only,	  and	  thus	   the	   actual	   number	   might	   be	   higher	   because	   we	   could	   not	  discard	  that	  some	  of	  the	  SNPs	  occurring	  in	  only	  one	  cell	  were	  also	  pre-­‐existing.	  
	   2.4.2	  Intra-­‐PFU	  genetic	  complementation	  	  
	   During	   transmission	   between	   their	   hosts,	   viruses	  experience	   strong	   population	   bottlenecks	   where	   the	   genetic	  diversity	   is	   lost.	   Such	   bottlenecks	   have	   been	   thought	   to	   have	  negative	   consequences	   on	   viral	   fitness,	   but	   this	   view	   can	   be	  questioned	   if	   even	   the	   smallest	   infectious	   unit	   (i.e.	   PFU)	   can	  deliver	   viral	   genetic	   diversity	   to	   individual	   cells.	   Also,	   after	   co-­‐infection	  of	  a	  cell	  with	  two	  or	  more	  viruses,	  viral	  products	  can	  be	  shared,	  thus	  allowing	  the	  genetic	  complementation	  of	  deleterious	  alleles	  (Novella	  et	  al.,	  2004).	  For	  Dengue	  virus	  it	  has	  been	  shown	  that	   this	   process	   can	   persist	   in	   vivo	   for	   multiple	   generations	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(Aaskov	   et	   al.,	   2006).	   Here,	   we	   found	   that	   9	   of	   the	   285	   SNPs	  produced	  a	  premature	  stop	  codon	   in	   the	  matrix	  protein	   (M),	   the	  surface	   glycoprotein	   (G)	   and	   the	   polymerase	   protein	   (L),	   thus	  being	   obviously	   lethal	   for	   the	   virus	   (Table	   6),	   suggesting	   intra-­‐PFU	   genetic	   complementation.	   Moreover,	   since	   6	   of	   these	   stop	  codons	   were	   found	   in	   multiple	   plaques	   (between	   2-­‐10	   copies)	  within	   a	   cell,	   and	   3	   were	   scored	   in	   several	   cells	   (between	   2-­‐3	  cells),	  they	  could	  not	  be	  attributed	  to	  sequencing	  bias.	  	  
Table	  6.	  Premature	  stop	  codons	  found	  in	  single-­‐cell	  SNPs.	  For	  each	  stop	  codon,	  the	  cell	  number	  and	  the	  number	  of	  copies	  within	  each	  cell	  where	  it	  occurred	  are	  indicated.	  	  	  
Mutation	   Cells	   Plaques	   Protein	   Codon	  change	  U2330A	   36,	  46	   10,	  9	   M	   TAT	  -­‐>	  TAA	  U2330G	   24,	  62,	  63	   10,	  9,	  8	   M	   TAT	  -­‐>	  TAG	  G3414U	   83	   2	   G	   GAA	  -­‐>	  TAA	  U4552A	   4	   2	   G	   TTA	  -­‐>	  TAA	  U4965G	   19,	  71	   1,	  3	   L	   TTA	  -­‐>	  TGA	  C4971A	   47	   1	   L	   TCA	  -­‐>	  TAA	  G5834U	   49	   1	   L	   GGA	  -­‐>	  TGA	  G9290U	   57	   1	   L	   GGA	  -­‐>	  TGA	  U9682A	   59	   5	   L	   TAT	  -­‐>	  TAA	  	  	  Site-­‐directed	   mutagenesis	   studies	   using	   infectious	  molecular	   clones	   of	   VSV	   and	   other	   RNA	   viruses	   showed	   that	  viruses	   are	   extremely	   sensitive	   to	   the	   introduction	   of	   single-­‐
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nucleotide	   substitutions,	  with	   up	   to	   40%	  being	   effectively	   lethal	  (Sanjuán	  et	   al.,	   2004).	  Therefore,	   the	   fact	   that	   these	   stop	   codons	  were	   detected	   despite	   their	   lethal	   effect	   for	   the	   virus	   suggested	  that	   genetic	   trans-­‐complementation	   occurred	   within	   infected	  cells.	   As	   a	   consequence,	   we	   proposed	   that	   the	   genetic	   diversity	  delivered	  to	  individual	  cells	  by	  multiple,	  genetically	  non-­‐identical,	  infectious	   particles	   within	   the	   same	   PFU	   may	   confer	   greater	  robustness	  against	  the	  effects	  of	  deleterious	  mutations	  than	  it	  was	  previously	   thought.	   Related	   to	   this,	   it	   has	   been	   shown	   using	  poliovirus	   that	   the	   fitness	   of	   a	   particular	   viral	   genotype	   is	  determined	   by	   cooperative	   interactions	   established	   among	  genotypes,	   suggesting	   thus	   that	   viral	   fitness	   is	   a	   property	   of	   the	  entire	   viral	   population,	   rather	   than	   an	   individual	   property	  (Vignuzzi	   et	   al.,	   2006).	   Therefore,	   in	   agreement	   with	   previous	  microscopy	   studies,	   our	   results	   showed	   that	   infectious	   particles	  might	  allow	  the	  co-­‐transmission	  of	  pools	  of	  variants	  to	  individual	  cells,	   allowing	   intra-­‐cellular	   genetic	   complementation	   and	  conferring	  greater	  robustness	  to	  viral	  populations.	  
	   2.4.3	  Co-­‐transmission	  of	  SNPs	  within	  the	  same	  	  PFU	  Since	  the	  above	  results	  suggested	  that	  multiple	   infectious	  particles	  might	   have	   been	   delivered	   to	   cells	   as	   part	   of	   the	   same	  PFU,	   we	   thought	   to	   perform	   an	   extra	   and	   complementary	  experiment	  to	  check	  this	  finding.	  To	  do	  so,	  BHK-­‐21	  cells	  were	  co-­‐infected	   with	   the	   wild-­‐type	   (WT)	   VSV	   virus	   and	   a	   monoclonal	  antibody-­‐resistant	  (MAR)	  mutant	  (input	  ratio	  1:1)	  at	  a	  MOI	  of	  20	  PFU/cell.	  After	  24	  h	  of	  incubation,	  the	  supernatant	  was	  plated	  on	  confluent	   BHK	   monolayers,	   20	   individual	   plaques	   (PFUs)	   were	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picked,	  amplified	  and	  then	  used	  for	  a	  second	  plaque	  assay	   in	  the	  presence/absence	   of	   monoclonal	   antibody.	   If	   these	   PFUs	   were	  initially	   constituted	   by	   a	   single	   infectious	   particle,	   they	   should	  show	  clones	  of	  either	  full	  WT	  or	  fully	  MAR	  phenotype.	  However	  if	  variants	   co-­‐transmitted	   within	   the	   same	   PFU,	   these	   plaques	  would	  show	  both	  phenotypes.	  In	  agreement	  with	  our	  finding,	  this	  experiment	   confirmed	   the	   co-­‐transmission	  of	  multiple	   infectious	  particles	   since	  10/20	  PFUs	   showed	  a	  WT	  phenotype,	  4/20	  PFUs	  behaved	   as	   MAR	   phenotype,	   whereas	   6/20	   PFUs	   showed	   both	  phenotypes	  (Figure	  21).	  	  By	   examinating	   the	   sequence	   of	   several	   clones	   (between	  15-­‐19	  clones)	  from	  5	  WT	  PFUs,	  we	  observed	  that	  9/15	  and	  2/19	  clones	   had	   the	   MAR-­‐conferring	   mutations	   (Combe	   and	   Sanjuán,	  2014b).	  Whilst	   the	  MAR	  mutations	  were	  present	   in	   these	  clones,	  they	   did	   not	   allow	   the	   growth	   of	   the	   virus	   in	   the	   presence	   of	  monoclonal	   antibody,	   suggesting	   that	   they	   behaved	   as	   recessive	  alleles.	   One	   explanation	   could	   be	   that	   they	   were	   neutralized	   by	  the	  WT	   sequence	   located	  within	   the	   same	  PFU.	   Therefore,	   these	  results	   suggested	   that	   the	   phenotype	   of	   a	   given	   mutation	   is	  determined	   collectively	   by	   a	   pool	   of	   variants	   co-­‐transmitted	  whithin	  the	  same	  multi-­‐particle	  infectious	  units.	  Finally,	   we	   investigated	   if	   SNPs	   could	   be	   co-­‐transmitted	  over	  time.	  Two	  PFUs	  showing	  both	  phenotypes	  (i.e.	  WT	  and	  MAR)	  were	  passaged	  (ratio	  1:1)	  at	   low	  MOI	   (0.02	  PFU/cell)	   in	  BHK-­‐21	  cells.	   The	   plaque	   purification	   and	   plaque	   assays	   were	   repeated.	  Here	   again	  we	  observed	   that	   individual	  PFUs	   showed	  both	  MAR	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and	  WT	   phenotypes,	   indicating	   that	   SNPs	   co-­‐transmisison	   could	  last	  for	  several	  generations.	   	  
	  
	  
Figure	   21.	   Co-­‐transmission	   of	  MAR-­‐mutant	   and	  wild-­‐type	  VSV	   viruses	  within	  the	  same	  infectious	  particle.	  BHK-­‐21	  cells	  were	   infected	  with	  an	  input	  ratio	  1:1	  of	  MAR:WT	  viruses,	  at	  a	  MOI	  of	  20	  PFU/cell	  that	  allowed	  co-­‐infection.	  After	   release	   of	   viral	   progeny,	   20	   individual	   plaques	  were	  picked	  and	  tested	  for	  the	  MAR	  phenotype.	  On	  the	  plot,	  the	  proportion	  of	  MAR	  viruses	  within	  each	  PFU	  is	  shown	  in	  red	  whereas	  the	  proportion	  of	  WT	  viruses	   is	  represented	   in	  dark	  grey.	  Then,	  15-­‐19	  clones	   from	  5	  WT	  phenotype	   plaques	   were	   sequenced.	   Clones	   with	   the	   MAR-­‐conferring	  mutation,	  although	  they	  behaved	  recessively	  in	  the	  phenotype	  assay,	  are	  represented	   by	   red	   dots.	   In	   parallel,	   two	   plaques	   with	   a	   mixed	  phenotype	  were	  passaged	  in	  fresh	  cells,	  and	  the	  plaque	  purification	  and	  MAR	  phenotype	  assay	  were	  repeated.	   In	  both	  cases	  mixing	  of	  MAR	  and	  WT	   phenotypes	   was	   still	   evident	   after	   this	   transfer.	   Adapted	   from	  Combe	  et	  al.	  (submitted).	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As	   a	   result	   of	   co-­‐transmission	  within	   the	   same	   infectious	  units,	  we	  hypothesized	  that	  some	  SNPs	  may	  be	  found	  in	  the	  same	  cells	   as	   other	   SNPs,	   and	   thus	   spatially	   co-­‐localize.	   To	   test	   this	  scenario,	  we	  focused	  on	  the	  62	  preSNPs	  and	  we	  observed	  that	  12	  pairs	   co-­‐localized	   in	   two	   cells,	   whereas	   3	   pairs	   co-­‐localized	   in	  three	   cells	   (substitutions	   A6757G/A7573G,	   U3894A/A7573G,	  G1790A/U3894A),	   and	   1	   pair	   co-­‐localized	   in	   four	   cells	  (substitutions	   A2925C/C6712U,	   Figure	   22).	   However,	   although	  these	   SNPs	   co-­‐localized	   within	   the	   same	   cell,	   they	   were	   not	  systematically	   found	   together	   in	   all	   plaques	   sequenced.	   This	  observation	  suggested	  that	  the	  coupling	  of	  these	  SNPs	  within	  the	  same	   cell	   was	   not	   the	   result	   of	   genetic	   linkage,	   but	   rather	  supported	   their	   co-­‐transmission	   within	   the	   same	   PFU.	   This	   co-­‐transmission	  might	  have	  allowed	  particle	  reassortment	  during	  the	  release	  of	  new	  PFUs	  by	  each	  cell,	  thus	  explaining	  the	  observation	  of	   some	   preSNPs	   within	   the	   same	   plaque	   after	   sequencing.	  Indeed,	   in	   PFUs	   released	   from	   each	   cell	   SNPs	   might	   belong	   to	  different	   virion	   sequences	   contained	   in	   each	   PFU	   (Figure	   23).	  Despite	  the	  fact	  that	  virion	  reassortment	  or	  recombination	  within	  PFU	  should	  have	  resulted	  in	  the	  same	  number	  of	  SNPs	  per	  plaque,	  
Mononegavirales	  such	  as	  VSV	  show	  extremely	  low	  recombination	  rates	   (Han	   and	   Worobey,	   2011),	   and	   thus	   the	   possibility	   that	  virion	  recombination	  within	  PFUs	  occurred	  was	  excluded.	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Figure	   23.	   Virion	   reassortment	   versus	   recombination	   within	   PFUs.	  Within	   each	   infecting	   PFU,	   aggregates	   of	   infectious	   particles	   are	  represented.	   Coloured	   dots	   within	   each	   infectious	   particle	   represent	  variability,	   e.g.	  preSNPs.	  After	   replication,	  PFUs	  are	   released	   from	  each	  single	  cell	  as	  a	  new	  pool	  of	  variants	  able	  to	  infect	  another	  cell.	  A	  scenario	  of	   virion	   reassortment	   as	   well	   as	   virion	   recombination	  within	   PFUs	   is	  indicated.	   Then	   these	   PFUs,	   also	   called	   individual	   plaques,	   were	  sequenced	   and	   SNPs	   scored	   in	   each	   PFU	   were	   attributed	   to	   the	  corresponding	  plaque.	  Therefore,	  the	  final	  picture	  of	  the	  number	  of	  SNPs	  per	  plaque	  we	  got	   is	   identical	   if	   reassortment	  or	   recombination	  within	  PFUs	  occurred.	  However,	  since	  Mononegavirales	  such	  as	  VSV	  show	  very	  low	   recombination	   rates	   (Han	   and	   Worobey,	   2011)	   we	   proposed	   a	  scenario	  of	  virion	  reassortment	  rather	  than	  recombination.	  	  
2.5	  Production	  of	  spontaneous	  mutations	  in	  single-­‐cells	  and	  per-­‐cell	  
burst	  size	  
	   Our	   approach	   allowed	   us	   to	   measure	   the	   de	   novo	  production	  of	  spontaneous	  mutations	  in	  90	  individual	  cells.	  To	  do	  so,	   we	   had	   to	   discard	   SNPs	   that	   were	   likely	   to	   pre-­‐exist	   in	   the	  
Virion reassortment Virion recombination 
 Single cell replication 
 Infecting PFU 
 Plaque released 
 SNPs calling 
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inoculum,	  such	  as	  the	  62	  preSNPs	  found	  in	  multiple	  cells,	  but	  also	  SNPs	   found	   in	   single	   cells	   but	   as	   multiple	   intra-­‐cellular	   copies.	  Indeed,	   since	   we	   were	   not	   able	   to	   determine	   if	   these	   multiple-­‐copy	   SNPs	   came	   from	   de	   novo	   spontaneous	   mutation	   occurring	  during	  genome	  replication	  within	  a	  cell	  or	  were	  pre-­‐existing	  and	  thus	  delivered	  to	  the	  cell	  by	  infectious	  particles,	  we	  removed	  both	  types	   of	   SNPs.	   Therefore,	   we	   focused	   on	   SNPs	   that	   occurred	   as	  single-­‐copies	  only	  (scSNPs).	  Of	  the	  90	  cells	  analysed,	  we	  scored	  a	  total	   of	   91	   scSNPs,	   and,	   by	   computing	   the	   frequency	   of	   each	  scSNPs	   (between	   7-­‐10	   plaques	   examined	   per	   cell),	   we	   found	   an	  average	  mutation	   frequency	  of	   0.104	   scSNPs	  per	  plaque	  per	   cell	  (Figure	  24A).	  Then,	  by	  counting	  how	  many	  cells	   showed	  at	   least	  one	  scSNP,	  we	  determined	  the	  rate	  of	  spontaneous	  mutation	  per	  round	  of	  copying	  (U),	  which	  has	  already	  been	  demonstrated	  to	  be	  robust	   to	   selection	   acting	   on	   deleterious	   mutations	   and	  independent	   on	   the	   replication	   mode	   (Sanjuán	   et	   al.,	   2010).	  According	  to	  this	  method,	  U	  =	  -­‐	  ln	  (P0/N),	  where	  P0	  is	  the	  fraction	  of	   cells	   showing	  no	   scSNPs	   (40	   out	   of	   90	   cells	   examined)	   and	  N	  the	   number	   of	   plaques	   sequenced	   per	   cell	   (between	   7-­‐10	  depending	   on	   the	   cell).	  We	   found	   that	   the	  mutation	   rate	   ranged	  from	  U	  =	  0.081	   (10	  plaques	   sequenced)	   to	  U	  =	  0.116	   (7	  plaques	  sequenced).	  By	  considering	  the	  mutational	  target	  size	  (T	  =	  11,161	  bp),	   this	  gave	  µ	  =	  7.26	  ×	  10-­‐6	  and	  µ	  =	  1.04	  ×	  10-­‐5	  substitution	  per	  nucleotide	  per	  round	  of	  copying	  (s/n/r),	  respectively.	  This	  range	  is	   in	   good	   agreement	   with	   our	   previous	   estimates	   obtained	   by	  scoring	   the	   appearance	   of	   spontaneous	   MAR	  mutants	   using	   the	  Luria-­‐Delbrück	   fluctuation	   test	   (see	   “Chapter	   1”),	   therefore	  
	   107	  
confirming	  that	  scSNPs	  are	  convenient	  for	  the	  analysis	  of	  de	  novo	  spontaneous	  mutations.	  	   The	   accumulation	   of	   spontaneous	  mutation	   within	   a	   cell	  depends	   on	   their	   probability	   of	   appearance,	   but	   also	   on	   the	  number	  of	   rounds	  of	  genome	  copying.	   It	  has	  been	  proposed	   that	  viruses	   grow	   exponentially	  within	   infected	   cells,	   leading	   to	   high	  viral	   yields	   (Cuevas	   et	   al.,	   2005).	   Also,	   although	   it	   has	   been	  suggested	  that	  most	  RNA	  viruses	  might	  replicate	  their	  genome	  via	  the	  “stamping-­‐machine”	  model,	  in	  which	  progeny	  genomes	  are	  all	  synthesized	   from	   the	   same	   initital	   template	   (García-­‐Villada	   and	  Drake,	   2012;	   Chao	   et	   al.,	   2002;	   French	   and	   Stenger,	   2003;	  Martinez	   et	   al.,	   2011;	   Safari	   and	   Roossinck,	   2014),	   indirect	  evidence	  with	  VSV	   (Sanjuán	  et	  al.,	  2010)	  and	  poliovirus	   (Schulte	  et	   al.,	   2015)	   suggested	   multiple	   rounds	   of	   genome	   copying	   per	  cell,	   with	   stochastic	   variation	   from	   cell-­‐to-­‐cell.	   Therefore,	  although	  undergoing	  multiple	  rounds	  of	  genome	  copying	  per	  cell	  allows	  the	  production	  of	  higher	  viral	  yields,	  it	  comes	  at	  the	  cost	  of	  a	  greater	  load	  of	  mutations,	  suggesting	  thus	  that	  there	  might	  be	  a	  trade-­‐off	   between	   the	   efficiency	   and	   the	   fidelity	   of	   viral	  replication	   at	   the	   single-­‐cell	   level.	   To	   test	   for	   this	   trade-­‐off,	   we	  determined	  the	  BS	  for	  each	  of	  the	  90	  cells	  analysed.	  We	  found	  that	  BS	  varied	  amply	  between	  cells	  and	  ranged	  from	  195	  to	  5,840	  with	  an	   average	   of	   1,160	   PFU/cell	   (Figure	   24B).	   Moreover,	   BS	   was	  positively	  correlated	   to	   the	   frequency	  of	   scSNPs	  per	  genome	  per	  cell	   (Pearson	   correlation:	   r	   =	   0.914,	   P	   =	   0.011),	   suggesting	   that	  increased	  progeny	  production	  was	  accompanied	  by	  a	  greater	  load	  of	  mutations	  (Figure	  24C).	  This	  result	  was	  supported	  by	  previous	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studies	   that	   showed	   that	   increased	   polymerase	   fidelity	   reduced	  fitness	   (measured	   as	   the	   BS)	   in	   both	   T4	   and	   VSV	   (Mansky	   and	  Cunningham,	   2000;	   Furió	   et	   al.,	   2005).	   Under	   a	   scenario	   where	  the	   dynamics	   of	   intra-­‐cellular	   viral	   particles	   positively	   correlate	  with	   the	   load	   of	   mutations,	   more	   mutations	   will	   accumulate	   in	  fewer	   infection	   cycles,	   thus	   accelerating	   adaptation.	   This	   has	  implications	  for	  the	  elaboration	  of	  attenuated	  live	  virus	  vaccines,	  where	  each	  additional	  passage	  of	  the	  clonal	  stock	  might	  generate	  an	   exponential	   increase	   of	   more	   robust	   and/or	   more	   virulent	  variants	   (Wimmer	   et	   al.,	   1993),	   but	   also	   for	   disease	   emergence,	  where	  more	   advantageous	  mutations	  will	   be	   generated	   in	   burst,	  accelerating	  thus	  host-­‐to-­‐host	  successful	  transmission.	  	  
	  
	  
Figure	   24.	   Viral	   production	   and	   frequency	   of	   SNPs	   in	   single-­‐cells.	   A,	  distribution	  of	  scSNP	  frequencies	  in	  the	  viral	  progeny	  of	  each	  single-­‐cell;	  B,	   burst	   size	   between	   single-­‐cells;	   C,	   relationship	   between	   scSNP	  frequency	  and	  burst	  size	  (Pearson	  correlation:	  r	  =	  0.914,	  P	  =	  0.011).	  For	  each	  category	  of	  scSNP	  frequency	  the	  average	  burst	  size	  is	  represented.	  	  
2.6	  Low-­‐frequency	  variants	  with	  a	  mutator	  phenotype	  	   Among	   the	   881	   plaques	   analyzed,	   670	   were	   mutated	  (76%)	   with	   389	   plaques	   (58%)	   accumulating	   more	   than	   one	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mutation	  in	  burst.	  Previous	  work	  suggested	  that	  viral	  populations	  should	   be	   composed	   of	   subpopulations	   with	   different	   mutation	  frequencies,	   (Schubert	   et	   al.,	   1984;	   Ninio,	   1991;	   Drake	   et	   al.,	  2005),	   as	   clearly	   demonstrated	   for	   Spleen	   Necrosis	   Virus	   (SNV)	  where	  a	  single	  provirus	  showed	  a	  mutation	  rate	  1,000-­‐fold	  higher	  than	  the	  rate	  determined	  for	  the	  virus	  population	  because	  of	   the	  accumulation	   of	   multiple	   mutations	   in	   its	   genome	   (Pathak	   and	  Temin,	   1990).	   Moreover,	   the	   occurrence	   of	   low-­‐frequency	  variants	   with	   multiple	   mutations	   has	   been	   proposed	   to	   be	   a	  common	   phenomenon	   in	   viral	   populations	   (Parthasarathi	   et	   al.,	  1995;	  Tromas	  and	  Elena,	  2010;	  García-­‐Villada	  and	  Drake,	  2012),	  as	   recorded	   for	  poliovirus	  populations	   (de	   la	  Torre	  et	   al.,	   1992),	  for	  the	  bacteriophage	  T4	  gene	  (Bebenek	  et	  al.,	  2001),	  but	  also	  for	  TMV	   (Tobacco	  mosaic	   virus),	   CMV	   (Cucumber	  mosaic	   virus)	   and	  CCMV	   (Cowpea	  chlorotic	  mottle	  virus)	   (Schneider	   and	  Roossinck,	  2000).	   In	   bacteria,	   low-­‐frequency	  mutators	   have	   been	   shown	   to	  significantly	   contribute	   to	   population	   adaptability	   and	   virulence	  (Gonzalez	  et	  al.,	  2008;	  Jolivet-­‐Gougeon	  et	  al.,	  2011;	  LeClerc	  et	  al.,	  1996;	  Sniegowski	  et	  al.,	  1997).	  For	  viruses,	  one	  could	  hypothesize	  that	   whereas	   single	   SNPs	   might	   be	   neutral	   or	   deleterious,	   they	  could	  become	  advantageous	  when	  combined	   together	  within	   the	  same	  infectious	  particle	  (Drake,	  2005),	  as	  exemplified	  above	  with	  the	  hijacking	  of	  the	  lethal	  effect	  of	  stop	  codons	  for	  the	  virus.	  Also,	  in	  terms	  of	  adaptability,	  the	  occurrence	  of	  multiple	  mutations	  in	  a	  single	   replication	   cycle	   might	   confer	   a	   selective	   advantage	   for	  successful	   cross-­‐species	   transmission	   and	   adaptation	   to	   new	  environments	  (Stech	  et	  al.,	  1999;	  Kuiken	  et	  al.,	  2006).	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   To	   determine	   if	   low-­‐frequency	   mutator	   variants	   could	  underly	  the	  variability	  between	  cells	  in	  the	  de	  novo	  production	  of	  genetic	   diversity,	   we	   measured	   the	   mutation	   rate	   of	   individual	  plaques	   picked	   from	   distinct	   cells	   using	   the	   Luria-­‐Delbrück	  fluctuation	   test	   (see	  section	  4.1	   in	   “Materials	  and	  Methods”).	  We	  selected	   three	   plaques	   from	   a	   cell	   showing	   a	   high	   genetic	  diversity,	   such	   as	   cell	   36	  with	   10	   SNPs,	   and	   two	  plaques	   from	   a	  less	  diverse	  cell,	  such	  as	  cell	  81	  with	  2	  SNPs	  (Table	  7).	  From	  cell	  36,	  plaques	  36.1	  and	  36.9	  had	  replacements	   in	  residues	  446	  and	  447	  of	  the	  polymerase	  (L	  protein),	  but	  they	  did	  not	  map	  to	  any	  of	  the	   six	   functionally	   relevant	   conserved	   regions	   (CRs)	   of	   this	  protein.	  However,	   plaque	   36.2	   had	   an	   additional	   replacement	   in	  residue	  957,	  thus	  mapping	  to	  CRIV,	  a	  concerved	  domain	  that	  is	  a	  key	   structural	   component	  of	   the	   replicase	   ring	  domain	   (Rahmeh	  et	  al.,	  2010).	  Finally,	  from	  cell	  81,	  plaques	  81.9	  and	  81.10	  did	  not	  have	  any	  amino	  acid	  replacement	  in	  the	  genome.	  Therefore	  these	  plaques	   provided	   the	   wild-­‐type	   mutation	   rate.	   We	   found	  differences	   in	   the	  mutation	   rate	   to	   the	  MAR	  phenotype	  between	  individual	  plaques	  (one-­‐way	  ANOVA,	  p	  =	  0.002),	  with	  plaque	  36.2	  showing	  a	  significant	  3.6-­‐fold	  increase	  compared	  to	  the	  other	  four	  plaques	  (Tukey’s	  post-­‐hoc	  test,	  p	  <	  0.05).	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Table	  7.	  Mutation	  rate	  to	  the	  MAR	  phenotype	  determined	  by	  the	  Luria-­‐Delbrück	   fluctuation	   test	   for	   viral	   plaques	   picked	   from	   single-­‐cells.	  Following	  the	  amino	  acid	  (AA)	  change,	   the	  protein	   in	  which	  the	  change	  occurred	  is	  indicated,	  as	  the	  conserved	  region	  in	  the	  polymerase.	  	  	  
Cell	   Plaque	   Mutation	   AA	  change	   MARa	  ×	  10–5	  
36	   1	  
C4636A	   None	  
1.08	  ±	  0.28	  A6069G	   E446G	  (L)	  A6070G	   E446G	  (L)	  C6071Ub	   L447F	  (L)	  
36	   2	  
C2833U	   S195F	  (M)	  
4.03	  ±	  2.02	  
G3485U	   None	  A6069G	   E446G	  (L)	  A6070G	   E446G	  (L)	  C6071U	   L447F	  (L)	  A7601Gb	   M957V	  (L:	  CRIV)	  
36	   9	   A3620C	   None	   1.27	  ±	  0.20	  C6071U	   L447F	  81	   9	   None	   None	   1.20	  ±	  0.46	  81	   10	   None	   None	   0.91	  ±	  0.15	  a	  MAR	  refers	  to	  mutation	  rate	  (m)	  to	  the	  MAR	  phenotype,	  expressed	  as	  substitutions	  per	  nucleotide	  per	  round	  of	  copying	  (s/n/r).	  b	  A	  non-­‐expressed	  stop	  codon	  mutation	  (U2330A)	  was	  also	  found	  in	  these	  plaques.	  	   Our	  results	  suggested	   that	   the	  variability	   in	   the	  mutation	  rate	   between	   individual	   plaques	   released	   from	   a	   cell	   could	  contribute	   to	  explaining	  differences	   in	   the	  viral	   genetic	  diversity	  observed	   between	   cells.	   Since	   progeny	   released	   from	   cells	   with	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different	  genetic	  diversity	  showed	  similar	  mutation	  rates	  (plaques	  36.1,	   36.9	   and	  plaques	  81.9,	   81.10),	   but	   that	   progeny	  within	   the	  same	   cell	   had	   different	   mutation	   rates	   (plaques	   36.1,	   36.9	   and	  plaque	  36.2),	  we	  proposed	  that	  the	  production	  of	  genetic	  diversity	  between	  cells	  might	  be	  the	  result	  of	  mixed	  stochastic	  cellular	  and	  viral	  effects,	  such	  that	  a	  small	  fraction	  of	  the	  progeny	  accumulated	  multiple	   mutations	   and	   showed	   a	   mutator	   phenotype,	   whereas	  other	  plaques	  had	  only	  few	  or	  no	  mutations.	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Chapter	  3.	  Norwalk	  virus	  mutation	  rate	  	  	   Human	   noroviruses	   are	   highly	   genetically	   diverse,	   and	  viral	   populations	   co-­‐circulating	   change	   between	   and	   within	  outbreaks	   (Siebenga	   et	   al.,	   2007).	   Variation	   at	   the	   genome	   level	  can	   result	   in	   silent	   mutations	   (i.e.	   homologous	   amino	   acid	  substitutions)	   or	   in	   amino	   acid	   substitutions	   that	   change	   the	  properties	   of	   virus	   binding	   or	   the	   immunogenicity	   of	   virus	  epitopes,	  and	  thus	  lead	  to	  the	  generation	  of	  variants	  with	  altered	  tropism	   or	   antibody-­‐escape	   mutants	   (Gallimore	   et	   al.,	   2007).	  Because	   the	   success	   of	   these	   variants	   is	   either	   due	   to	   immune	  escape	   or	   changes	   in	   receptor	   binding,	   the	   high	   diversity	   and	  exposed	   structure	   of	   the	   P2	   domain	   of	   the	   capsid	   (VP1)	   protein	  has	   lead	   to	   the	   asumption	   that	   receptor	   binding	   sites	   and	   key	  antigenic	  determinants	  should	  be	   localised	   in	   this	   region	  (Cao	  et	  al.,	  2007;	  Tan	  et	  al.,	  2003).	  	   The	   cell	   tropism	   of	   human	   noroviruses	   and	   the	  development	   of	   an	   in	   vitro	   infection	   model	   remain	   elusive,	  restricting	   thus	   considerably	   their	   study.	   Recently	   a	   cell	   culture	  system	   has	   been	   developed	   with	   the	   discovery	   of	   B	   cells	   as	   a	  cellular	   target	   of	   human	   GII-­‐4	   norovirus	   strain	   and	   histo-­‐blood	  group	   antigen	   (HBGA)	   expressed	   by	   enteric	   bacteria	   being	  necessary	   for	   norovirus	   susceptibility	   and	   infection	   (Jones	   et	   al.,	  2014).	  Human	  B	  cells	  possess	  three	  members	  of	  the	  ADAR	  family:	  ADAR1	   and	   ADAR2	   that	   are	   functional	   deaminases	   (Bass	   and	  Weintraub,	  1988;	  Kim	  et	  al.,	  1994)	  and	  ADAR3,	  which	  do	  not	  have	  a	   known	   enzymatic	   function	   (Chen	   et	   al.,	   2000).	   Recently,	   DNA	  and	  mRNA	  sequences	  from	  B	  cell	  cultures	  were	  examined	  by	  deep	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sequencing	  and	   the	   results	   showed	  extensive	  ADAR-­‐mediated	  A-­‐to-­‐G	  editing	   sites	   in	  premature	  and	  mature	  mRNAs	  as	  well	   as	   in	  long	   noncoding	   RNAs	   (Wang	   et	   al.,	   2013).	   However,	   no	   studies	  have	   focused	   on	   the	   effect	   of	   ADAR	   on	   norovirus	   genome	  replication	  in	  human	  cells.	  	   Noroviruses	  replicate	  quickly	  and	  are	  expected	   to	  exhibit	  high	   rates	  of	  mutation	   (Dingle,	   2004),	   although	   there	   is	  no	   clear	  information	   yet	   about	   the	   rate	   at	   which	   spontaneous	  mutations	  accumulate	   in	   the	   norovirus	   genome.	   The	   only	   available	  information	   comes	   from	   studies	   where	   mutations	   were	   scored	  after	  several	  weeks	  of	  virus	  shedding,	  reflecting	  thus	  substitution	  rates	   rather	   than	  mutation	   rates.	   Nilsson	   et	   al.	   (2003)	   found	   32	  amino	   acid	   changes	   in	   the	   capsid	   protein	   of	   a	   norovirus	   shed	  chronically	   over	   one	   year	   by	   an	   immunocompromised	   patient,	  whereas	  Dingle	   (2004)	   sequenced	  49	  viruses	   from	  22	  outbreaks	  and	   observed	   a	   high	   mutation	   frequency	   (4	   point	   mutations	   in	  3,255	  nt	  sequenced).	  	  	   Because	   of	   the	   impact	   of	   norovirus-­‐associated	  gastroenteritis	  outbreaks	  in	  the	  human	  population,	  it	  is	  necessary	  to	   have	   a	   better	   understanding	   about	   the	   type	   and	   frequency	   of	  spontaneous	  mutations	  in	  noroviruses.	  Here	  we	  measured	  the	  NV	  mutational	   spectrum	   after	   transfection	   of	   HEK293T	   cells.	   Also,	  because	   of	   its	   essential	   function	   in	   cell	   binding	   and	   neutralizing	  antibodies	   (Lochridge	   et	   al.,	   2005),	   we	   focused	   on	   spontaneous	  mutations	   arising	   in	   the	   VP1	   gene.	   Finally,	   since	   the	   cellular	  expression	   of	   ADAR	   in	   the	   human	   HEK293T	   cells	   has	   been	  demonstrated	  before	  (Maas	  et	  al.,	  1996;	  Maas	  et	  al.,	  2001;	  Clerzius	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et	   al.,	   2009;	   Li	   et	   al.,	   2010),	   this	   allowed	   us	   to	   estimate	   the	  potential	  effect	  of	  the	  ADAR	  editing	  on	  viral	  mutation	  rates.	  
3.1	  Transfection	  of	  NV	  cDNA	  into	  HEK293T	  cells	  and	  amplification	  
efficiency	  	   Norwalk	  virus	  cDNA	  (pNV)	  was	  transfected	  into	  HEK293T	  cells	   previously	   infected	   with	   the	   recombinant	   vaccinia	   vTF7-­‐3	  virus	  to	  allow	  the	  primary	  transcription	  of	  the	  cDNA	  clone.	  After	  5	  h	   incubation,	   replication	   of	   any	   remaining	   vaccinia	  was	   blocked	  and	   transcribed	  NV	   RNA	   should	   replicate	   then	   by	   itself	   into	   the	  cytoplasm	  of	   the	  cells.	  Because	  NV	  is	  not	  able	  to	   infect	  HEK293T	  cells,	  we	  scored	  spontaneous	  mutation	  after	  only	  one	  cycle	  of	  cell	  infection.	   This	   allowed	   us	   to	   avoid	   the	   effect	   of	   selection	   or	   to	  score	   the	   accumulation	   of	   mutations	   over	   several	   generations.	  Three	   transfections	   were	   performed	   (NV1,	   NV2,	   NV3)	   and	   (-­‐)-­‐strands	   RNA	   from	   supernatants	   and	   from	   cells	   were	   RT-­‐PCR	  amplified	  using	  strand-­‐specific	  primers	   in	   the	  RT	  step.	  However,	  since	   we	   got	   a	   weak	   PCR	   amplification	   from	   supernatants,	   only	  RNA	  extracted	  from	  cells	  was	  used	  for	  subsequent	  experiments.	  	  	   	  Positive	   and	   negative	   strands	   RNA	   were	   amplified	   from	  these	   three	   transfection	   samples	   using	   strand-­‐specific	   primers	  (see	   section	   8.2	   in	   “Materials	   and	   Methods”)	   and	   purified	   PCR	  products	  were	  used	   for	  molecular	   clone	   sequencing	   (see	   section	  5.2	   in	   “Materials	   and	  Methods”)	   of	   the	   full	   VP1	   gene	   (ORF2).	   In	  order	   to	   verify	   that	   the	   treatment	   of	   the	   samples	   with	   DNase	   I,	  RNase-­‐free	  endonucleases	  have	  eliminated	  all	  remaining	  template	  DNA,	   and	   thus	   that	   positive	   RT-­‐PCRs	   were	   not	   due	   to	   DNA	  amplification,	  PCRs	  of	  each	  transfection	  were	  performed	  without	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reverse-­‐transcription.	  The	  results	  showed	  no	  amplification,	  whilst	  the	   positive	   control	   (i.e.	   with	   cDNA)	   was	   efficiently	   amplified.	  Mutations	  scored	  in	  (+)-­‐strands	  were	  used	  to	  correct	  for	  mutation	  frequency	  of	  (-­‐)-­‐strands	  RNA.	  Indeed,	  because	  of	  the	  large	  amount	  of	  cDNA	  template	  inoculated	  to	  transfect,	  most	  mutations	  found	  in	  (+)-­‐strands	   RNA	   might	   have	   been	   introduced	   by	   T7	   RNA	  polymerase,	   whereas	   mutations	   in	   (-­‐)-­‐strands	   RNA	   should	   have	  been	  generated	  by	  the	  NV	  polymerase	  during	  replication.	  
3.2	  Norwalk	  virus	  mutational	  spectrum	  and	  mutation	  frequency	  	  	   In	  (+)-­‐strands	  RNA,	  a	  total	  of	  10	  mutations	  were	  observed	  among	   296,412	   nucleotides	   analysed,	   with	   6	   base	   substitutions	  and	  4	  indels	  (Table	  8).	  Among	  these	  base	  substitutions,	  we	  found	  3	   transitions	   and	   3	   transversions.	   In	   parallel,	   clones	   of	   negative	  polarity	   synthesized	   during	   NV	   self-­‐replication	   were	   also	  sequenced.	   A	   total	   of	   35	   mutations	   were	   observed	   among	   the	  272,064	  bases	  examined,	  with	  30	  base	  substitutions	  and	  5	  indels	  (Table	   8).	   These	   results	   indicated	   that	   (-­‐)-­‐strands	   RNA	  accumulated	   significantly	  more	  mutations	   than	   (+)-­‐strands	   RNA	  (Fisher’s	   exact	   test,	   p	   =	   1.5	   ×	   10–5),	   confirming	   that	   mutations	  found	   in	   (+)-­‐strands	   might	   have	   been	   generated	   by	   T7	   RNA	  polymerase,	  whereas	  most	  mutations	  found	  in	  (-­‐)-­‐strands	  should	  have	  been	  introduced	  by	  the	  NV	  polymerase.	  Also,	  we	  observed	  a	  bias	   towards	  transition	  mutations,	  with	  a	   transition:transversion	  ratio	  of	  26:4.	  	  	   The	   above	   results	   allowed	   us	   to	   determine	   the	  mutation	  frequency	  f	  of	  (+)-­‐	  and	  (-­‐)-­‐strands	  RNA.	  We	  found	  f	  =	  2.02	  ×	  10–5	  for	   (+)-­‐strands	  and	   f	  =	  1.1	  ×	  10–4	   for	   (-­‐)-­‐strands	  RNA.	  Therefore,	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after	  correction	  for	  T7-­‐induced	  mutations	  in	  (-­‐)-­‐strands	  RNA,	  we	  found	   f	  =	   9	   ×	   10–5.	   Since	   only	   one	   cycle	   of	   cell	   infection	   elapsed	  mutation	   frequency	   and	   mutation	   rate	   were	   similar	   in	   this	  experiment	   (µ	   =	   9	   ×	   10-­‐5	   s/n/c).	   These	   results	   provide	   a	   first	  quantification	  of	  the	  NV	  rate	  of	  spontaneous	  mutation,	  and	  shows	  that	  mutations	   accumulate	   quickly,	   similar	   to	   other	  RNA	  viruses	  (Sanjuán	  et	  al.,	  2010).	  	  
Table	  8.	  Mutations	  found	  in	  (+)-­‐	  and	  (-­‐)-­‐strands	  RNA.	  	  	  
Type	  of	  Mutation	   (+)-­‐strand	  RNA	   (-­‐)-­‐strand	  RNA	  Clones	  sequenced	   138	   128	  Bases	  analyzed	   296,412	   272,064	  Total	  mutations	   10	   35	  Base	  substitutions	   6	   30	  Indels	   4	   5	  Transitions	   3	   26	  Transversions	   3	   4	  Synonymous	   1	   13	  Nonsynonymous	   5	   17	  	  
3.3	  Hypermutated	  NV	  sequences	  	   Of	   the	   30	   base	   substitutions	   observed	   23	   were	   T	   -­‐>	   C	  transitions	  (Figure	  25).	  Close	  examination	  of	  the	  sequences	  of	  the	  128	   clones	   sequenced	   showed	   two	   clones	   with	   several	   T	   -­‐>	   C	  mutations.	  Clone	  M1.8	  had	  6	  T	  -­‐>	  C	  changes	  in	  a	  region	  composed	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of	   452	   bases,	   such	   that	   these	   hypermutations	   appeared	   at	   a	  frequency	   of	   1.3	   ×	   10–2,	  whereas	   clone	  NV2.5	   showed	   16	   T	   -­‐>	   C	  substitutions	   in	  a	  region	  composed	  of	  456	  nucleotides,	   such	   that	  at	  a	  frequency	  of	  3.5	  ×	  10–2	  (Table	  9).	  These	  results	  suggested	  that,	  during	   genome	   replication,	   a	   small	   fraction	   (1.5%)	   of	   the	   NV	  sequences	  were	   hypermutated.	   Since	   sequences	  were	   compared	  against	   the	   plus-­‐strand	   reference	   genome,	   these	   T	   -­‐>	   C	  hypermutations	   actually	   correspond	   to	   A	   -­‐>	   G	   mutations	  occurring	  in	  the	  (-­‐)-­‐strands	  RNA	  used	  for	  RT-­‐PCR.	  	  

















Transitions Transversions 	  	  
Figure	   25.	   Frequency	   of	   each	   type	   of	   base	   substitution	   found	   in	   (-­‐)-­‐strands	  RNA.	  Among	  transitions	  T	  -­‐>	  C	  changes	  were	  significantly	  more	  abundant	  than	  other	  types	  of	  mutation	  (Fisher’s	  exact	  test,	  p	  =	  0.0007).	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   Because	   of	   the	   small	   fraction	   of	   clones	   that	   were	  hypermutated,	   and	   the	   very	   high	   frequency	   at	   which	   these	  hypermutations	  occured,	  we	  hypothesized	  that	  they	  might	  be	  the	  results	   of	   the	   editing	   of	   cellular	   enzymes,	   such	   as	   adenosine	  deaminases	   of	   the	   ADAR	   family	   (Valente	   and	   Nishikura,	   2005),	  rather	   than	   being	   generated	   by	   the	  NV	   polymerase.	   Since	   ADAR	  editing	   can	   occur	   on	   either	   the	   genome	   or	   antigenome	   (Samuel,	  2011),	   this	   supported	   that	   adenosine	   deamination	   to	   guanosine	  occurred	  in	  (-­‐)-­‐strands	  RNA.	  Whilst	  ADAR	  editing	  has	  been	  shown	  to	  affect	  several	  RNA	  viruses,	   this	  cellular	  enzyme	   is	  also	  known	  to	  require	  dsRNA	  as	  template	  (see	  section	  3.2.1	  in	  “Introduction”).	  One	   hypothesis	   could	   be	   that	   ADAR-­‐like	   mutations	   tend	   to	  accumulate	  in	  folded	  regions	  of	  the	  NV	  RNA.	  Alternatively,	  ADAR	  might	  have	  hit	  on	  intermediate	  dsRNAs	  produced	  by	  the	  NV	  RdRp	  during	  genome	  replication,	  as	  it	  is	  widely	  assumed	  for	  (+)-­‐strand	  RNA	   viruses	   (Jacobs	   and	   Langland,	   1996;	   Weber	   et	   al.,	   2006).	  However,	  under	  this	  latter	  scenario	  A	  -­‐>	  G	  hypermutations	  should	  also	  be	  observed	  in	  (+)-­‐strands	  RNA.	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Table	  9.	  Mutations	  in	  the	  VP1	  gene	  of	  (-­‐)-­‐strands	  RNA	  clones.	  Insertions	  are	  symbolized	  by	  a	  “+”	  and	  deletions	  by	  a	  “-­‐”	  symbol.	  “AA”	  means	  amino	  acid.	  	  
	  
Clone	   Mutation	   AA	  change	   Codon	  change	  M6.2	   G5406A	   Gly	  -­‐>	  Ser	   GGC	  -­‐>	  AGC	  M6.6	   C5868T	   His	  -­‐>	  Tyr	   CAT	  -­‐>	  TAT	  M6.1	   +6014T	   -­‐	   -­‐	  M6.16	   T6523C	   Leu	  -­‐>	  Pro	   CTT	  -­‐>	  CCT	  M6.2	   C6747A	   Pro	  -­‐>	  Thr	   CCT	  -­‐>	  ACT	  M6.3	   T6841A	   Leu	  -­‐>	  Gln	   CTG	  -­‐>	  CAG	  NV3.5	   -­‐5696A	   -­‐	   -­‐	  NV3.5	   -­‐5697G	   -­‐	   -­‐	  NV3.5	   -­‐5698C	   -­‐	   -­‐	  NV3.5	   -­‐5699T	   -­‐	   -­‐	  NV3.14	   G6091T	   Arg	  -­‐>	  Leu	   CGT	  -­‐>	  CTT	  NV3.12	   -­‐6094C	   -­‐	   -­‐	  M1.8	   T5732C	   Val	  -­‐>	  Val	   GTT	  -­‐>	  GTC	  M1.8	   T5804C	   Ile	  -­‐>	  Ile	   ATT	  -­‐>	  ATC	  M1.8	   T5840C	   Pro	  -­‐>	  Pro	   CCT	  -­‐>	  CCC	  M1.8	   T5860C	   Val	  -­‐>	  Ala	   GTT	  -­‐>	  GCT	  M1.29	   -­‐5874A	   -­‐	   -­‐	  M1.29	   -­‐5875A	   -­‐	   -­‐	  M1.29	   -­‐5876T	   -­‐	   -­‐	  M1.8	   T5911C	   Met	  -­‐>	  Thr	   ATG	  -­‐>	  ACG	  M1.8	   T6184C	   Leu	  -­‐>	  Pro	   CTG	  -­‐>	  CCG	  M1.4	   -­‐6222A	   -­‐	   -­‐	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M1.33	   A6320G	   Pro	  -­‐>	  Pro	   CCA	  -­‐>	  CCG	  NV2.5	   T5956C	   Phe	  -­‐>	  Ser	   TTT	  -­‐>	  TCT	  NV2.5	   T6134C	   Asn	  -­‐>	  Asn	   AAT	  -­‐>	  AAC	  NV2.5	   T6150C	   Phe	  -­‐>	  Leu	   TTC	  -­‐>	  CTC	  NV2.5	   T6167C	   Cys	  -­‐>	  Cys	   TGT	  -­‐>	  TGC	  NV2.5	   T6250C	   Val	  -­‐>	  Ala	   GTA	  -­‐>	  GCA	  NV2.5	   T6284C	   Phe	  -­‐>	  Phe	   TTT	  -­‐>	  TTC	  NV2.5	   T6315C	   Phe	  -­‐>	  Leu	   TTT	  -­‐>	  CTT	  NV2.5	   T6332C	   Gly	  -­‐>	  Gly	   GGT	  -­‐>	  GGC	  NV2.5	   T6335C	   Cys	  -­‐>	  Cys	   TGT	  -­‐>	  TGC	  NV2.5	   T6339C	   Trp	  -­‐>	  Arg	   TGG	  -­‐>	  CGG	  NV2.5	   T6344C	   His	  -­‐>	  His	   CAT	  -­‐>	  CAC	  NV2.5	   T6368C	   His	  -­‐>	  His	   CAT	  -­‐>	  CAC	  NV2.5	   T6371C	   Ser	  -­‐>	  Ser	   TCT	  -­‐>	  TCC	  NV2.5	   T6384C	   Tyr	  -­‐>	  His	   TAT	  -­‐>	  CAT	  NV2.5	   T6391C	   Val	  -­‐>	  Ala	   GTA	  -­‐>	  GCA	  NV2.5	   T6412C	   Phe	  -­‐>	  Ser	   TTT	  -­‐>	  TCT	  M2.35	   T6248A	   Thr	  -­‐>	  Thr	   ACT	  -­‐>	  ACA	  	  
3.4	  ADAR-­‐like	  mutations	  revealed	  by	  deep	  sequencing	  	   Although	   the	   mutations	   observed	   here	   might	   have	   been	  introduced	  by	  the	  editing	  of	  cellular	  enzymes	  such	  as	  ADAR,	  only	  few	   clones	  were	   analyzed	   by	   Sanger	   and	   among	   these	   only	   two	  sequences	   showed	   ADAR-­‐like	   mutations.	   To	   further	   investigate	  this	   finding	   we	   set	   up	   a	   protocol	   based	   on	   a	   nested	   PCR	  amplification	   that	   allows	   us	   to	   amplify	   ADAR-­‐edited	   RNA	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sequences	   using	   degenerated	   primers	   (see	   section	   8.3	   in	  “Materials	   and	   Methods”)	   and	   the	   454	   deep-­‐sequencing	  technology.	  	   We	  focused	  on	  ADAR-­‐like	  mutations	  and	  thus	  when	  more	  than	  two	  T	  -­‐>	  C	  or	  A	  -­‐>	  G	  changes	  occurred	  in	  a	  specific	  read,	  we	  considered	   the	   read	   as	   possibly	   hypermutated.	   Interestingly,	  we	  observed	   both	   types	   (i.e.	   T	   -­‐>	   C	   and	   A	   -­‐>	   G)	   of	   ADAR-­‐like	  mutations,	   in	   contrast	   to	   the	   above	   results	   from	   Sanger	   where	  only	   T	   -­‐>	   C	   hypermutations	   occurred	   (Table	   10).	   However,	  significantly	   less	  A	  -­‐>	  G	  changes	  were	  scored	  by	  454	  sequencing,	  compared	  to	  the	  number	  of	  T	  -­‐>	  C	  hypermutations	  (Fisher’s	  exact	  test:	  p	  <	  0.001).	  Therefore	  it	  might	  be	  that	  because	  of	  their	  lower	  frequency	   A	   -­‐>	   G	   hypermutations	   were	   missed	   by	   Sanger.	   This	  finding	   suggested	   thus	   that:	   (i)	   the	   NV	   RNA	   might	   have	   been	  edited	   by	   the	   cellular	   enzyme	   ADAR	   during	   genome	   replication,	  thus	   confirming	   its	   expression	   in	   HEK293T	   cells	   (Maas	   et	   al.,	  1996;	  Maas	  et	  al.,	  2001;	  Clerzius	  et	  al.,	  2009;	  Li	  et	  al.,	  2010),	  (ii)	  A	  -­‐>	   G	   hypermutations	   occurred	   in	   (-­‐)-­‐strands	   RNA	   RT-­‐PCR	  amplified	  (remember	  that	  T	  -­‐>	  C	  changes	  were	  scored	  in	  strands	  of	  positive	  polarity	  sequenced	  whilst	  strands	  of	  negative	  polarity	  were	   amplified),	   and	   (iii)	   some	   A	   -­‐>	   G	   hypermutations	   also	  occurred	  in	  (+)-­‐strands	  RNA.	  	  	   Whilst	  2	  out	  of	  128	  clones	  analysed	  by	  Sanger	  (frequency	  of	  1.5	  ×	  10–2)	  were	  hypermutated,	  the	  frequency	  of	  hypermutated	  reads	  ranged	  between	  3	  ×	  10–3	  and	  1.7	  ×	  10–2	   for	  T	  -­‐>	  C	  changes,	  and	   between	   2.4	   ×	   10–4	  and	   2	   ×	   10–3	   for	   A	   -­‐>	   G	   changes.	   These	  results	  confirmed	  that	  during	  genome	  replication	  within	  the	  host	  
	   123	  
cell,	  a	  fraction	  of	  the	  sequences	  synthesized	  by	  the	  RdRp	  showed	  several	   ADAR-­‐like	   mutations.	   This	   finding	   suggests	   that	   the	  variability	  in	  RNA	  virus	  mutation	  rates	  might	  be	  explained	  in	  part	  by	  host	  factors	  that	  lead	  to	  the	  production	  of	  hypermutated	  viral	  genomes.	   For	   instance,	   one	   could	   extrapolate	   that	   host	   factors	  such	   as	   ADAR	   could	   also	   explain	   differences	   in	   mutation	   rates	  between	   mammalian	   and	   plant	   viruses	   that	   seem	   to	   lack	   the	  immune	   pathway	   responsible	   for	   the	   activation	   of	   ADAR	   (Wang	  and	  Garmichael,	  2004).	  	  
Table	  10.	  Hypermutated	  reads	  for	  each	  region	  of	  the	  VP1	  gene	  analysed	  by	   454	   deep	   sequencing.	   For	   each	   transfection	   sample,	   region	   1	   and	  region	  2	   sequenced	  are	   indicated,	   as	  well	   as	   the	   total	  number	  of	   reads	  generated	   by	   the	   454	   technology.	   The	   number	   of	   reads	   potentially	  hypermutated	   (i.e.	   >	   2	   T	   -­‐>	   C	   or	   A	   -­‐>	   G)	   is	   indicated	   with	   the	  corresponding	  frequency	  of	  hypermutated	  reads.	  	  




T	  -­‐>	  C	  
Frequency	  
Reads	  
A	  -­‐>	  G	  
Frequency	  
NV1	   1	   11,703	   35	   3	  ×	  10–3	   24	   2	  ×	  10–3	  2	   16,636	   63	   3.8	  ×	  10–3	   4	   2.4	  ×	  10–4	  
NV2	   1	   8,332	   143	   1.7	  ×	  10–2	   3	   3.6	  ×	  10–4	  2	   5,384	   56	   1	  ×	  10–2	   8	   1.5	  ×	  10–3	  
NV3	   1	   9,986	   139	   1.4	  ×	  10–2	   2	   4	  ×	  10–4	  2	   36,612	   268	   7.3	  ×	  10–3	   13	   3.5	  ×	  10–4	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   Independently	   of	   the	   type	   of	   changes	   observed,	  significantly	  more	   hypermutated	   reads	  were	   scored	   in	   region	   1,	  which	   is	   composed	   of	   only	   266	   bp	   as	   opposed	   to	   405	   bases	   in	  region	  2	  (Fisher’s	  exact	  test:	  p	  <	  0.001	  for	  T	  -­‐>	  C	  and	  p	  =	  0.035	  for	  A	   -­‐>	   G).	   It	   has	   been	   proposed	   that	   the	   structure	   of	   the	   RNA	  substrate,	  rather	  than	  its	  sequence,	  might	  determine	  selectivity	  of	  ADAR	  (defined	  as	   the	   fraction	  of	  modified	  adenosines	   in	  an	  RNA	  substrate)	  (Lehmann	  and	  Bass,	  1999).	  For	  instance,	  RNAs	  that	  are	  completely	   double-­‐stranded	   are	   deaminated	   non-­‐selectively	   (i.e.	  approx.	   50%	   of	   adenosines	   deaminated)	   whereas	   whose	   base-­‐paired	   structures	   that	   are	   interrupted	   by	  mismatches,	   bulges	   or	  internal	   loops	   are	   deaminated	   selectively	   and	   thus	   show	   less	  deamination.	   To	   check	   for	   this	   finding	   as	   explaining	   the	   higher	  level	  of	  hypermutations	  in	  region	  1	  compared	  to	  region	  2,	  ADAR-­‐like	   mutations	   found	   in	   reads	   with	   more	   than	   10	   of	   these	  mutations	   were	   mapped	   to	   the	   predicted	  minimum	   free	   energy	  (MFE)	   RNA	   secondary	   structure	   of	   each	   region,	   which	   was	  obtained	   using	   the	   RNAfold	   program	   online	  (rna.tbi.univie.ac.at/cgi-­‐bin/RNAfold/cgi)	   (Figure	   26).	   After	  closely	  looking	  at	  both	  stuctures	  in	  terms	  of	  internal	  loops,	  bulges	  and	   hairpins,	   we	   observed	   that	   region	   1	   shows	   a	   long	   stem	   in	  which	  most	  of	  the	  ADAR-­‐like	  mutations	  (26	  out	  of	  44	  mutations)	  were	  scored.	  This	  finding	  suggests	  that	  region	  1	  might	  have	  been	  more	   promiscuously	   deaminated	   by	   ADAR,	   whereas	   region	   2	  could	   have	   been	  more	   selectively	  modified,	   thus	   explaining	  why	  region	  1	  shows	  more	  ADAR-­‐like	  mutations.	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   In	  addition	   to	   selectivity,	   it	  has	  been	  proposed	   that	   in	  an	  RNA	  substrate	  ADAR	  has	  also	  preferences,	  such	  that	  an	  adenosine	  is	  more	  efficienctly	  deaminated	  when	   it	  has	  as	  5’	  neighbor	  As	  or	  Us,	  mainly	  because	  of	  their	  effect	  on	  base	  flipping	  (Nishikura	  et	  al.,	  1991;	   Kuttan	   and	   Bass,	   2012).	   Indeed,	   AU	   or	   UA	   base	   pair	   (the	  underscore	   shows	   the	   5’	   neighbor	   of	   the	   deaminated	   base)	   are	  optimal	   whereas	   GC	   or	   CG	   base	   pair	   should	   reduce	   binding	   to	  ADAR	   and	   thus	   lower	   the	   frequency	   of	   deamination	   at	   the	  adjacent	   adenosine	   (Polson	   and	   Bass,	   1994).	   Irrespective	   of	   the	  RNA	  structure,	  we	  screened	   the	  sequences	  of	   these	  reads	  with	  >	  10	  ADAR-­‐like	  mutations	  for	  the	  5’	  neighbor	  of	  the	  As	  deaminated	  in	  the	  (-­‐)-­‐strand	  RNA	  (Table	  11).	  For	  region	  1	  as	  well	  as	  for	  region	  2	   significantly	  more	  5’	  neighbor	  As	  or	  Us	  were	  observed	  next	   to	  the	  deamination	  site,	  whereas	  in	  contrast	  more	  Gs	  or	  Cs	  preceded	  a	  non-­‐deaminated	  base	  (Fisher’s	  exact	  test,	  p	  =	  2.4	  ×	  10–4	  and	  p	  =	  9.6	  ×	  10–7,	  respectively).	  In	  agreement	  with	  previous	  studies,	  our	  results	  show	  that	  ADAR	  has	  preferences	  for	  those	  adenosines	  that	  have	  as	  5’	  neighbor	  As	  or	  Us.	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Table	  11.	  Preference	  for	  5’	  neighbor	  As	  or	  Us	  next	  to	  ADAR	  deaminated	  site.	  For	  each	  region,	  the	  5’	  neighbor	  A,	  T,	  G	  or	  C	  counts	  are	  indicated	  for	  deaminated	  As	  as	  well	  as	  unmodified	  As	  in	  (-­‐)-­‐strand	  RNA.	  	  
	   Region	  1	   Region	  2	  	   A	   T	   G	   C	   A	   T	   G	   C	  Deaminated	  As	   16	   12	   4	   7	   23	   15	   7	   11	  Unmodified	  As	   7	   1	   11	   12	   10	   1	   14	   28	  	  	   Interestingly,	   region	   2	   falls	   in	   the	   P2	   hypervariable	  domain	   of	   the	   VP1	   gene,	   responsible	   for	   host	   interaction	   and	  antigen	   recognition	   (Cao	   et	   al.,	   2007;	   Prasad	   et	   al.,	   1999).	  Although	  previous	  studies	  from	  mammals	  and	  bacteria	  suggested	  that	   host-­‐pathogen	   interaction	   loci	   showed	   a	   hypermutation	  response	  (Metzgar	  and	  Wills,	  2000;	  Rando	  and	  Verstrepen,	  2007;	  Teng	   and	   Papavasiliou,	   2007;	   Moxon	   et	   al.,	   2006),	   the	   opposite	  scenario	   has	   been	   proposed	   for	   HIV-­‐1,	   where	   fewer	   mutations	  accumulated	   in	   the	   region	   of	   the	   envelope	   protein	   that	   contains	  most	   antibody	   targets	   and	   determines	   cell	   tropism	   (personal	  communication	  from	  Geller	  et	  al.,	  manuscript	  under	  submission).	  Whilst	   more	   sites	   of	   the	   NV	   genome	   have	   to	   be	   screened,	   our	  results	   suggest	   that	   different	   regions	   of	   the	   viral	   genome	  might	  exhibit	  different	  affinity	   for	   the	  antiviral	   cellular	  enzymes	   to	  act.	  Focusing	  on	   these	  particular	   regions	  could	  help	  determining	  key	  viral-­‐host	  mechanisms	  underlying	  variability	  in	  mutation	  rates.	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General	  Discussion	  
	   Riboviruses	   are	   the	   causative	   agents	   of	   important	  infectious	  diseases.	  Wilst	   the	  mortality	   rates	  and	  economic	  costs	  associated	   to	   these	   infectious	   pathogens	   are	   considerable	   in	  developing	   countries	   (Holmes,	   2009),	   only	   few	  of	   these	  diseases	  can	   be	   efficiently	   controlled	   by	   vaccination	   or	   antiviral	   drugs.	  Indeed,	   these	   strategies	   are	   counterbalanced	   by	   the	   quick	  emergence	  of	  new	  riboviral	  pathogens	  or	  drug-­‐resistant	  variants	  (Domingo,	  2010;	  Pepin	  et	  al.,	  2010).	  A	  key	  feature	  that	  confers	  to	  riboviruses	   an	   extensive	   genetic	   diversity,	   allowing	   them	   to	  quickly	   adapt	   to	   changing	   environments,	   is	   their	   extremely	   high	  mutation	  rates	  (Duffy	  et	  al.,	  2008;	  Sanjuán	  et	  al.,	  2010;	  Combe	  and	  Sanjuán,	  2014a).	  Whilst	   several	  virus-­‐encoded	   factors	  have	  been	  shown	  to	  play	  an	  important	  role	  in	  the	  evolution	  of	  RNA	  viruses,	  only	   few	   studies	   have	   focused	   on	   host	   factors	   underlying	   the	  variability	   in	   the	  production	  of	  viral	  genetic	  diversity,	  neither	  on	  whether	   this	   variability	   could	   be	   heterogeneously	   distributed	  among	  individual	  cells.	  	  	   When	  this	  PhD	  started,	  the	  effect	  of	  the	  cell	  metabolism	  on	  viral	   mutation	   rates	   was	   reported	   for	   retroviruses	   (Diamond	   et	  al.,	   2004;	   Bebenek	   et	   al.,	   1992;	   Julias	   and	   Pathak,	   1998)	   and	  hepatitis	   C	   virus	   (Seronello	   et	   al.,	   2011)	   only.	   No	   studies	   have	  investigated	   the	   differences	   in	   the	   rate	   at	   which	   mutations	  accumulate	   in	   both	   hosts	   of	   arthropod-­‐borne	   viruses	   as	   an	  alternative	   explanation	   for	   their	   slow	   evolution	   and	   thus	   fitness	  trade-­‐offs	   only	  were	   assumed	   to	   drive	   this	   evolution	   (Jenkins	   et	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al.,	  2002;	  Woelk	  and	  Holmes,	  2002;	  Hicks	  and	  Duffy,	  2014).	  Also,	  although	   recent	   advances	   in	   deep	   sequencing	   technologies	  allowed	   a	   better	   exploration	   of	   viral	   genetic	   diversity,	   no	   study	  have	  focused	  on	  the	  variability	  in	  the	  production	  of	  this	  diversity	  among	  single	  cells	  (Acevedo	  et	  al.,	  2014).	  However	  the	  extensive	  cell-­‐to-­‐cell	  variation	   in	   terms	  of	  metabolism,	  physiological	   status	  or	  gene	  expression	  patterns	  has	  obviously	  major	  implications	  for	  the	  outcome	  of	  viral	  infection	  (Pathak	  and	  Temin,	  1990;	  Monk	  et	  al.,	  1992).	  Finally,	  although	   the	  expression	  of	  cellular	  genes	  such	  as	  APOBEC3G	  cytidine	  deaminases	  or	  RNA-­‐dependent	  adenosine	  deaminase	   (ADAR)	   were	   known	   to	   edit	   hypermutation	   in	  riboviruses,	   the	   impact	   of	   these	   cellular	   enzymes	   on	   norovirus	  mutation	   rates	   has	   not	   been	   quantified	   before.	   Because	   viruses	  are	   obligate	   parasites	   and	   that	   the	   interactions	   with	   their	   host	  (cell)	   are	   finely	   adjusted	   to	   allow	   their	   efficient	   replication	   and	  transmission,	   the	   variability	   and	   host-­‐dependency	   in	   viral	  mutation	  rates	  had	  to	  be	  investigated.	  	  	   In	  chapter	  1,	  we	   looked	  at	   the	  effects	  of	   the	  cell	   type	  and	  host	   species	   in	   which	   the	   virus	   replicates	   on	   the	   mutation	   rate	  using	   the	   Luria-­‐Delbrück	   fluctuation	   test.	   Because	   previous	  estimates	   have	   been	   obtained	   in	   BHK-­‐21	   cells,	   an	   immortalized	  cell	  line,	  we	  investigated	  the	  effect	  of	  cellular	  immortalization	  and	  other	   changes	   leading	   to	   a	   tumoral	   cell	   by	   testing	   mammalian	  cells	   of	   various	   origins,	   but	   also	   under	   different	   oxygen	   levels.	  However,	   our	   results	   suggested	   that	   VSV	   was	   not	   sensitive	   to	  differences	  in	  metabolic	  and	  mitotic	  activity,	  but	  rather	  replicated	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with	   similar	   fidelity	   in	   these	   different	   mammalian	   cell	   types.	  Moreover,	  the	  fact	  that	  this	  virus	  was	  not	  affected	  by	  the	  aberrant	  metabolism	  of	  cancerous	  cells,	  neither	  by	  the	  lower	  oxygen	  levels	  encountered	  in	  these	  cells	  (1%	  02),	  suggested	  that	  VSV	  should	  be	  a	   good	   candidate	   for	   the	   field	   of	   oncolytic	   virotherapy,	   as	  previously	   proposed	   (Breitbach	   et	   al.,	   2011).	   Interestingly	  when	  comparing	   the	   host	   species	   involved	   in	   the	   lifecycle	   of	   VSV,	   we	  found	   a	   3.9-­‐fold	   decrease	   in	   mutation	   rate	   in	   insect	   cells	  compared	   to	   mammalian	   cells.	   Arboviruses	   such	   as	   VSV	   are	  known	   to	   evolve	  more	   slowly	   than	   directly	   transmitted	   viruses,	  and	   this	   is	   commonly	   explained	   in	   terms	   of	   fitness	   trade-­‐offs.	  Since	  only	  few	  studies	  on	  arboviruses	  focused	  on	  both	  insect	  and	  mammal	   hosts,	   our	   results	   offer	   a	   new	   possible	   explanation	   for	  the	   relatively	   slow	   arboviral	   evolution,	   based	   on	   lower	   rates	   of	  mutation	  in	  the	  insect	  reservoir.	  	  	  	   In	   chapter	   2,	   we	   focused	   on	   the	   viral	   genetic	   diversity	  released	   by	   single-­‐cells	   infected	   with	   VSV	   using	  micromanipulation	  and	  deep	  sequencing	  approaches.	  We	  showed	  that	   single-­‐cells	   exhibit	   extensive	   viral	   genetic	   diversity,	   with	  most	  progeny	  plaques	  released	  by	  each	  cell	  being	  mutated,	  whilst	  this	  diversity	   is	  not	  homogeneously	  allocated	  by	   individual	   cells.	  Interestingly,	   this	   approach	   allowed	   us	   to	   demonstrate	   for	   the	  first	   time	   that	   single	   PFUs	   co-­‐transmit	   several	   and	   genetically	  diverse	   variants,	   thus	   delivering	   genetic	   diversity	   to	   each	   cell.	  This	   co-­‐transmission	   allows	   (i)	   the	   genetic	   complementation	   of	  lethal	   alleles	   (premature	   stop	   codons)	   between	   variants	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belonging	   to	   the	   same	   PFU	   and	   (ii)	   the	   hitchhiking	   of	   beneficial	  alleles	   (MAR	   mutant	   which	   is	   beneficial	   in	   the	   presence	   of	  antibody)	   suggesting	   that	   the	   effect	   of	   a	   given	   mutation	   is	  determined	   collectively	   by	   other	   variants	   during	   their	   co-­‐transmission,	   a	   process	   that	   could	   last	   for	   several	   generations.	  The	   co-­‐transmission	   of	   genetic	   diversity	   within	   the	   same	  infectious	  unit	  has	  important	  implications	  for	  viral	  evolution:	  first,	  it	   promotes	   the	   maintenance	   of	   genetic	   diversity	   during	   strong	  population	   bottlenecks	   (such	   as	   during	   host-­‐to-­‐host	  transmission),	  and	  thus	  the	  negative	  effect	  of	  such	  bottlenecks	  on	  viral	   fitness	   has	   to	   be	   revised.	   Second,	   it	   creates	   a	   spatial	  association	  between	  alleles	  and	  thus	  questions	  the	  selection	  unit.	  Third,	   it	   confers	   a	   greater	   robustness	   against	   the	   effect	   of	  deleterious	  mutations.	   Finally,	  we	   showed	   that	   the	   variability	   in	  the	   amount	   of	   diversity	   produced	   per	   cell	   was	   positively	  correlated	   to	   the	   viral	   yield.	   These	   results	   suggested	   a	   trade-­‐off	  between	   the	  efficiency	  and	   the	   fidelity	  of	  viral	   replication,	  which	  may	   be	   driven	   by	   geometric	   replication	   of	   viral	   genomic	   RNA	  within	  some	  infected	  cells	  (Safari	  and	  Roossinck,	  2014).	  Although	  this	  type	  of	  replication	  fosters	  the	  appearance	  of	  new	  mutations,	  it	  also	   increases	   the	   viral	   genetic	   load.	   Counterbalancing,	   variants	  with	   a	   mutator	   phenotype	   might	   be	   encountered	   at	   a	   low	  frequency	   in	   viral	   populations,	   as	   supported	   by	   the	   similar	  mutation	   rate	   of	   the	   VSV	   viral	   population	   used	   to	   infect	   single-­‐cells	  (see	  “Chapter	  1”)	  and	  non-­‐mutator	  plaques,	  whereas	  the	  rate	  of	  spontaneous	  mutations	  was	  higher	  for	  plaque	  36.2	  that	  showed	  a	  mutator	  phenotype.	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In	   chapter	   3,	  we	   scored	  NV	   spontaneous	  mutations	   after	  transfection	  of	  HEK293T	  cells	  and	  focused	  on	  the	  VP1	  gene,	  which	  is	  composed	  of	  both	  conserved	  and	  more	  variable	  (P2)	  domains.	  The	   mutational	   spectrum	   provided	   a	   first	   estimate	   of	   the	  mutation	   rate	   for	   NV	   of	   µ	   =	   9	   ×	   10–5	   s/n/c,	   which	   is	   high	   and	  consistent	   with	   previously	   published	   estimates	   for	   RNA	   viruses	  (Sanjuán	  et	  al.,	  2010).	   Interestingly,	  we	  observed	   that,	  out	  of	   the	  128	  clones	  of	  negative	  polarity	  sequenced	  by	  Sanger	  two	  showed	  several	  A	   -­‐>	  G	  hypermutations	  at	  a	  very	  high	   frequency	  (>	  10–2).	  By	   allowing	   the	   amplification	   of	   hypermutated	   NV	   sequences	  using	   degenerated	   primers	   and	   analyzing	   them	   with	   deep	  sequencing	   we	   confirmed	   the	   high	   frequency	   of	   A	   -­‐>	   G	  hypermutated	   sequences,	   with	   the	   majority	   being	   located	   in	  region	  1.	  Our	   results	   suggested	   that	   a	   fraction	   of	  NV	  RNA	  might	  have	   been	   edited	   by	   the	   cellular	   enzyme	   ADAR	   during	   genome	  replication	   within	   the	   cytoplasm	   of	   HEK293T	   cells.	   Moreover,	  different	  regions	  of	  the	  genome	  might	  be	  either	  promiscuously	  or	  selectively	   edited	   by	   ADAR,	   depending	   on	   the	   structure	   of	   the	  RNA	  substrate	  (such	  as	   long	  stems)	  as	  well	  as	   the	  5’	  neighbor	  of	  the	   modified	   adenosine.	   These	   findings	   suggested	   thus	   that	   the	  variability	   in	   mutation	   rates	   might	   also	   be	   explained	   by	   the	  editing	  of	  cellular	  enzymes.	  	  The	   experiments	   performed	   during	   this	   PhD	   present	   a	  unifying	   framework	   that	   helps	   to	   better	   appreciate	   and	   explain	  the	   variability	   in	   viral	   mutation	   rates	   as	   well	   as	   its	   host-­‐dependency.	   Whilst	   mutation	   rates	   are	   similar	   in	   different	  mammalian	   cells	   in	   Chapter	   1,	  we	   showed	   in	  Chapter	   2	   that	   the	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genetic	   diversity	   is	   heterogeneously	   distributed	   between	  individual	   cells,	   suggesting	   thus	   that	   this	   constancy	   in	  mutation	  rates	   is	   likely	   due	   to	   the	   averaging	   effect	   of	   cell	   cultures.	   In	  Chapter	  2	  we	  demonstrate	  for	  the	  first	  time	  the	  variability	  in	  the	  level	  of	  genetic	  diversity	  during	  the	  course	  of	  a	  cell	  infection:	  first,	  infecting	   PFUs	   deliver	   a	   pool	   of	   variants	   to	   each	   cell.	   Then,	   in	  addition	  to	  this	  pre-­‐existing	  variability,	  each	  cell	  releases	  different	  levels	  of	  genetic	  diversity	  as	  a	  new	  pool	  of	  variants	  able	  to	  infect	  another	   cell.	   Finally,	   within	   a	   cell	   each	   individual	   plaque	   show	  different	  mutation	   rates,	   also	   explaining	   the	  variability	  observed	  between	  cells.	  These	   findings	  allow	  us	   to	  better	  understand	  how	  RNA	   viruses	   deal	   with	   high	   rates	   of	   mutation	   and	   the	   resulting	  genetic	   load.	   We	   propose	   that	   RNA	   virus	   populations	   might	  cluster	   their	   genetic	  diversity	   in	   a	   subset	   of	   cells,	   such	   that	   they	  exist	   as	   a	   dynamic	   equilibrium	   between	   the	   fast	   appearance	   of	  low-­‐frequency	  mutator	  variants	  accelerating	  adaptation	  and	  their	  elimination	  by	  out-­‐competition	  of	  less	  diverse	  viruses	  preserving	  their	   genetic	   integrity.	   Moreover,	   Chapter	   1	   proposes	   an	  alternative	  explanation	  for	  the	  slow	  evolution	  rate	  of	  arboviruses,	  based	   on	   their	   lower	   mutation	   rates	   in	   the	   insect	   host.	   These	  differences	  between	  insects	  and	  mammals	  could	  be	  explained	  by	  a	  trade-­‐off	  between	  replication	  efficiency	  and	   fidelity,	   as	  proposed	  in	   Chapter	   2.	   Finally,	   the	   results	   obtained	   in	   Chapter	   3	   improve	  our	   knowledge	   on	   the	   effect	   of	   cellular	   editing	   enzymes	   such	   as	  ADAR	  on	  the	  production	  of	  genetic	  diversity	  and	  suggests	  that	  this	  host-­‐mediated	   editing	   may	   play	   a	   major	   role	   in	   explaining	  variability	  in	  RNA	  virus	  mutations	  rates.	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The	   results	   obtained	   through	   this	   PhD	   offer	   several	  possible	  future	  lines	  of	  research:	  	  
§ Whilst	   Chapter	   1	   showed	   that	   VSV	   exhibits	   significantly	  lower	   mutation	   rates	   in	   the	   insect	   reservoir,	   more	  experiments	  with	   other	   arboviruses	  will	   be	   necessary	   to	  elucidate	   the	   generality	   of	   our	   findings.	   One	   possible	  explanation	  to	  higher	  mutation	  rates	  in	  mammals	  could	  be	  that	   arboviruses	   replicate	   more	   quickly	   in	   mammalian	  cells	  than	  in	  insect	  cells	  (Rozen-­‐Gagnon	  et	  al.,	  2014).	  Then,	  if	   as	   suggested	   in	  Chapter	  2,	   there	   is	   a	   trade-­‐off	  between	  replication	  efficiency	  and	  fidelity,	  increased	  viral	  yield	  will	  also	   correlate	   with	   more	   mutations	   that	   accumulate	   in	  fewer	   replication	   cycles.	   Since	   the	  effect	  of	  differences	   in	  host	   temperature	   as	   well	   as	   in	   our	   sensitivity	   to	   detect	  MAR	  mutants	   on	   the	   lower	   viral	   yield	   in	   insect	   cells	  was	  discarded,	   future	   studies	   will	   have	   to	   clarify	   the	   cellular	  host	  factors	  implicated	  or	  missing	  in	  these	  host	  cell	  lines.	  	  
§ The	   results	   of	   Chapter	   2	   showed	   that	   cell	   cultures	   are	  definitely	   not	   homogeneous	   environments	   and	   thus	   to	  better	  understand	   the	   virus-­‐host	  mechanisms	  underlying	  high	  genetic	  diversity	  among	  RNA	  viruses,	  as	  well	  as	  their	  efficient	   transmission,	   this	   diversity	   has	   to	   be	   studied	   at	  the	   single-­‐cell	   level.	   The	   micromanipulation	   approach	  developed	  here	  could	  be	  used	  for	  the	  study	  of	  other	  RNA	  viruses,	   such	   that	   for	   those	   viruses	   for	   which	   no	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phenotypic	   markers	   are	   available.	   Moreover,	   since	   we	  found	   a	   trade-­‐off	   between	   replication	   efficiency	   and	  fidelity,	   the	   mode	   by	   which	   RNA	   viruses	   replicate	   their	  genome	   should	   be	   investigated	   in	   more	   details.	   Finally,	  because	  of	  the	  major	  implications	  of	  virus	  co-­‐transmission	  within	   single	   PFUs	   on	   viral	   evolution,	   it	   could	   be	  interesting	   to	   have	   a	   better	   quantification	   of	   the	   level	   of	  genetic	  diversity	  delivered	  to	  individual	  cells.	  	  
§ Whilst	   in	   Chapter	   3	   ADAR-­‐like	   hypermutations	   were	  observed	   from	   transfected	   samples,	   we	   propose	   that	  future	   experiments	   should	   attempt	   to	   generalize	   this	  finding	   by	   analysing	   the	   genetic	   diversity	   of	   norovirus	  isolates	   from	   stool	   samples.	   Since	   these	   hypermutations	  occurred	  at	  a	  high	  frequency	  they	  might	  play	  an	  important	  role	  in	  the	  production	  of	  genetic	  diversity	  during	  genome	  replication	  within	  the	  host	  and	  thus	  might	  strongly	  impact	  viral	   mutation	   rates.	   Therefore,	   future	   studies	   should	  focus	   on	   (i)	   the	   strength	   of	   this	   cellular	   editing	   on	   viral	  mutation	   rates	   and	   (ii)	   the	   variability	   in	   cellular	   editing	  between	   different	   regions	   of	   the	   viral	   genome,	   and	  most	  notably	   between	   those	   involved	   in	   virus-­‐host	   reconition	  and	  receptor	  binding	  sites.	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FINAL	  CONCLUSIONS	  	  
Looking	  at	  the	  effect	  of	  the	  cell	  type	  and	  the	  host	  species	  on	  viral	  mutation	  rates:	  	  
§ The	   mutation	   rate	   of	   VSV	   was	   homogeneous	   between	  mammalian	  cells	  of	  various	  origins,	  such	  as	  BHK-­‐21,	  MEFs	  and	  MEFs	  p53-­‐/-­‐,	  CT26	  and	  Neuro-­‐2a,	  suggesting	  that	  the	  fidelity	  of	  viral	  replication	  was	  not	  affected	  by	  differences	  in	   metabolic	   and	   mitotic	   activities	   between	   mammalian	  cells.	  	  
	  
§ VSV	  was	  not	  sensitive	  to	  different	  oxygen	  levels,	  since	  the	  mutation	   rate	  was	   similar	  under	  normoxia	   (20%	  02)	   and	  hypoxia	  (1%	  02).	  
	  
§ When	  comparing	  phylogenetically	  more	  distant	  hosts,	  VSV	  showed	   a	   mutation	   rate	   3.9-­‐fold	   lower	   in	   insect	   cells	  compared	  to	  mammalian	  cells.	  This	  finding	  suggests	  a	  new	  explanation	   for	   the	   lower	   evolutionary	   rates	   of	  arboviruses	  compared	  to	  directly	  transmitted	  viruses.	  	  
	  Focusing	  at	  the	  viral	  genetic	  diversity	  released	  by	  single-­‐cells:	  
	  
§ Single-­‐cells	  showed	  extensive	  viral	  genetic	  diversity.	  As	  a	  consequence	   of	   this	   high	   intra-­‐cellular	   genetic	   diversity,	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most	   progeny	   plaques	   released	   by	   each	   cell	   should,	   on	  average,	  be	  mutated.	  	  
§ Infectious	   particles	   delivered	   viral	   genetic	   diversity	   to	  individual	   cells	   by	   co-­‐transmission	   of	   pools	   of	   variants.	  This	  might	  promote	   the	  maintenance	  of	   genetic	  diversity	  during	   strong	   population	   bottlenecks,	   and	   allow	   the	  genetic	   complementation	   of	   alleles	   within	   infected	   cells.	  These	  findings	  also	  question	  the	  selection	  unit,	  and	  confer	  a	  greater	  robustness	  to	  deleterious	  mutations.	  	  
§ Increased	   viral	   yield	   per	   cell	   was	   accompanied	   by	   a	  greater	   load	  of	  mutations,	  suggesting	  a	  trade-­‐off	  between	  the	   efficiency	   and	   the	   fidelity	   of	   viral	   replication,	   which	  may	  be	  driven	  by	  the	  geometric	  model.	  	  
§ Within	  some	  individual	  cells	  plaques	  with	  increased	  rates	  of	   spontaneous	  mutations	   contributed	   to	   the	   production	  of	   genetic	   diversity,	   thus	   explaining	   the	   variability	  observed	  between	  cells.	  	  
§ To	   counterbalance	   the	   genetic	   load	   associated	   to	  geometric	   replication,	   these	   mutator	   variants	   should	   be	  maintained	  at	  low	  frequency	  in	  viral	  populations.	  	  Determining	  norovirus	  mutation	  accumulation	  and	  the	   impact	  of	  cellular	  editing	  enzymes	  such	  as	  ADAR	  on	  mutation	  rates:	  	  
	   139	  
§ We	  have	  provided	  an	  estimate	  of	  the	  mutation	  rate	  of	  NV	  in	  transfected	  HEK293T	  cells.	  	  
§ The	  NV	  mutational	  spectrum	  showed	  a	  small	  fraction	  of	  A	  -­‐>	  G	  hypermutated	   sequences,	   a	   finding	   that	  was	   further	  confirmed	  by	  deep	  sequencing.	  These	  hypermutations	  are	  reminiscent	  of	  ADAR	  edition,	  suggesting	   that	   this	  cellular	  enzyme	  might	   impact	   the	  production	  of	   genetic	  diversity	  and	   thus	   contribute	   to	   explaining	   the	   variability	   in	  mutation	  rates	  among	  RNA	  viruses.	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Supplementary	  1.	  Fluctuation	  tests	  of	  VSV	  in	  mammalian,	  insect	  and	  mosquito	  cells.	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Fluctuation	  tests	  in	  wild-­‐type	  MEFs	  	  







	   Test	  1	   Test	  2	   Test	  3	  
Ni	  (pfu)	   439	  ±	  94	   124	  ±	  15	   160	  ±	  11	  
Nf	  (pfu)	   49812	  ±	  5985	   12000	  ±	  2021	   36075	  ±	  3162	  Total	  cultures	   24	   24	   24	  With	  no	  MAR	   15	   21	   14	  With	  1	  MAR	   5	   3	   10	  With	  2	  MARs	   2	   0	   0	  With	  >2	  MARs	   2	   0	   0	  Fraction	  no	  MAR	  (P0)	   0.625	   0.875	   0.583	  Plating	  efficiency	  (z)a	   0.94	  ±	  0.04	   0.94	  ±	  0.04	   0.94	  ±	  0.04	  Corrected	  P0	  (Q0)	   0.607	   0.868	   0.564	  Mutation	  rate	  (m)	   1.01	  ×	  10–5	   1.20	  ×	  10–5	   1.60	  ×	  10–5	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Fluctuation	  tests	  in	  p53-­‐/-­‐	  MEFs	  	  
a:	   relative	   to	   fluctuation	   tests	   performed	   in	   BHK-­‐21	   cells	   (z	   =	   1	  was	  used).	  	  	  	  	  	  	  	  	  
	   Test	  1	   Test	  2	   Test	  3	  
Ni	  (pfu)	   33	  ±	  10	   368	  ±	  38	   160	  ±	  11	  
Nf	  (pfu)	   40929	  ±	  6820	   9725	  ±	  1619	   40650	  ±	  2602	  Total	  cultures	   24	   24	   24	  With	  no	  MAR	   20	   21	   19	  With	  1	  MAR	   4	   2	   3	  With	  2	  MARs	   0	   1	   2	  With	  >2	  MARs	   0	   0	   0	  Fraction	  no	  MAR	  (P0)	   0.833	   0.875	   0.792	  Plating	  efficiency	  (z)a	   1.01	  ±	  0.02	   1.01	  ±	  0.02	   1.01	  ±	  0.02	  Corrected	  P0	  (Q0)	   0.833	   0.875	   0.792	  Mutation	  rate	  (m)	   4.46×	  10–6	   1.43	  ×	  10–5	   5.77	  ×	  10-­‐6	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Fluctuation	  tests	  in	  CT26	  colon	  cancer	  cells	  











	   Test	  1	   Test	  2	   Test	  3	  
Ni	  (pfu)	   465	  ±	  52	   33	  ±	  10	   123	  ±	  15	  
Nf	  (pfu)	   42375	  ±	  5214	   6675	  ±	  1217	   134700	  ±	  4435	  Total	  cultures	   24	   24	   24	  With	  no	  MAR	   22	   23	   19	  With	  1	  MAR	   2	   1	   3	  With	  2	  MARs	   0	   0	   1	  With	  >2	  MARs	   0	   0	   1	  Fraction	  no	  MAR	  (P0)	   0.917	   0.958	   0.792	  Plating	  efficiency	  (z)a	   0.29	  ±	  0.05	   0.29	  ±	  0.05	   0.29	  ±	  0.05	  Corrected	  P0	  (Q0)	   0.741	   0.863	   0.447	  Mutation	  rate	  (m)	   7.16	  ×	  10–6	   2.23	  ×	  10–5	   5.99	  ×	  10–6	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Fluctuation	  tests	  in	  Neuro-­‐2a	  neuroblastoma	  cells	  










	   Test	  1	   Test	  2	   Test	  3	  
Ni	  (pfu)	   124	  ±	  15	   160	  ±	  11	   215	  ±	  36	  
Nf	  (pfu)	   28913	  ±	  4339	   61275	  ±	  3417	   29513	  ±	  3244	  Total	  cultures	   24	   24	   24	  With	  no	  MAR	   16	   16	   20	  With	  1	  MAR	   3	   2	   4	  With	  2	  MARs	   1	   6	   0	  With	  >2	  MARs	   4	   0	   0	  Fraction	  no	  MAR	  (P0)	   0.667	   0.667	   0.833	  Plating	  efficiency	  (z)a	   0.85	  ±	  0.06	   0.85	  ±	  0.06	   0.85	  ±	  0.06	  Corrected	  P0	  (Q0)	   0.621	   0.621	   0.807	  Mutation	  rate	  (m)	   1.65×	  10–5	   7.80	  ×	  10–6	   7.34	  ×	  10–6	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  Fluctuation	  tests	  in	  BHK-­‐21	  cells	  under	  hypoxia	  (1%	  O2)	  	  







	   Test	  1	   Test	  2	   Test	  3b	  
Ni	  (pfu)	   355	  ±	  35	   267	  ±	  18	   267	  ±	  18	  
Nf	  (pfu)	   49875	  ±	  175	   19625	  ±	  1735	   20750	  ±	  1652	  Total	  cultures	   24	   24	   24	  With	  no	  MAR	   15	   19	   16	  With	  1	  MAR	   4	   4	   6	  With	  2	  MARs	   3	   0	   2	  With	  >2	  MARs	   2	   1	   0	  Fraction	  no	  MAR	  (P0)	   0.625	   0.792	   0.667	  Plating	  efficiency	  (z)a	   0.51±	  0.04	   0.51±	  0.04	   0.51±	  0.04	  Corrected	  P0	  (Q0)	   0.398	   0.633	   0.452	  Mutation	  rate	  (m)	   1.90	  ×	  10–5	   2.36	  ×	  10–5	   3.88	  ×	  10–5	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  Fluctuation	  tests	  in	  S2	  cells	  










	   Test	  1	   Test	  2	   Test	  3	  
Ni	  (pfu)	   358	  ±	  11	   358	  ±	  11	   322	  ±	  10	  
Nf	  (pfu)	   19025	  ±	  898	   6775	  ±	  724	   13080	  ±	  593	  Total	  cultures	   24	   24	   24	  With	  no	  MAR	   23	   23	   23	  With	  1	  MAR	   1	   1	   0	  With	  2	  MARs	   0	   0	   0	  With	  >2	  MARs	   0	   0	   1	  Fraction	  no	  MAR	  (P0)	   0.96	   0.96	   0.96	  Plating	  efficiency	  (z)a	   1.07	  ±	  0.07	   1.07	  ±	  0.07	   1.07	  ±	  0.07	  Corrected	  P0	  (Q0)	   0.958	   0.958	   0.958	  Mutation	  rate	  (m)	   2.28	  ×	  10–6	   6.63	  ×	  10–6	   3.34	  ×	  10–6	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Fluctuation	  tests	  in	  sf21	  cells	  	  











	   Test	  1	   Test	  2	   Test	  3	  
Ni	  (pfu)	   295	  ±	  12	   223	  ±	  26	   312	  ±	  32	  
Nf	  (pfu)	   6970	  ±	  174	   14400	  ±	  898	   17033	  ±	  652	  Total	  cultures	   24	   24	   24	  With	  no	  MAR	   23	   22	   22	  With	  1	  MAR	   1	   2	   1	  With	  2	  MARs	   0	   0	   1	  With	  >2	  MARs	   0	   0	   0	  Fraction	  no	  MAR	  (P0)	   0.958	   0.917	   0.917	  Plating	  efficiency	  (z)a	   1.09	  ±	  0.04	   1.09	  ±	  0.04	   1.09	  ±	  0.04	  Corrected	  P0	  (Q0)	   0.958	   0.917	   0.917	  Mutation	  rate	  (m)	   6.38	  ×	  10–6	   6.14	  ×	  10–6	   5.20	  ×	  10–6	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Fluctuation	  tests	  in	  C6/36	  cells	  	  










	   Test	  1	   Test	  2	   Test	  3	  
Ni	  (pfu)	   295	  ±	  12	   223	  ±	  26	   312	  ±	  32	  
Nf	  (pfu)	   10100	  ±	  410	   9800	  ±	  546	   10833	  ±	  499	  Total	  cultures	   24	   24	   24	  With	  no	  MAR	   22	   23	   22	  With	  1	  MAR	   1	   0	   2	  With	  2	  MARs	   1	   1	   0	  With	  >2	  MARs	   0	   0	   0	  Fraction	  no	  MAR	  (P0)	   0.916	   0.958	   0.916	  Plating	  efficiency	  (z)a	   0.88	  ±	  0.02	   0.88	  ±	  0.02	   0.88	  ±	  0.02	  Corrected	  P0	  (Q0)	   0.906	   0.953	   0.906	  Mutation	  rate	  (m)	   1.01	  ×	  10–5	   5.01	  ×	  10–6	   9.32	  ×	  10–6	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Supplementary	   2.	   Specific	   primers	   used	   to	   PCR-­‐amplify	   and	  sequence	  molecular	  clones	  of	  VSV	  from	  BHK-­‐21	  cells.	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Supplementary	   3.	   Sequence	   and	  orientation	  of	   specific	  primers	  used	  to	  PCR-­‐amplify	  VSV	  plaques	  sequenced	  by	  SOLID.	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Supplementary	  5.	  List	  of	  all	  SNPs	  found	  in	  the	  90	  cells.	  The	  type	  of	  mutation	   is	   indicated	   for	   each	   cell,	   as	   the	   number	   of	   plaques	  sharing	  the	  mutation.	  Non-­‐coding	  mutations	  are	  indicated	  by	  a	  “-­‐“	  symbol.	   Stop	   codons	   are	   symbolized	   by	   “*”.	   Cells	   17,	   45,	   60,	   65	  and	  90	  with	  no	  mutations	  are	  not	  indicated	  in	  this	  table.	  	  	  




change	  1	   T1832G	   4	   P	   GTT	  -­‐>	  GGT	   V146G	  T3894A	   10	   G	   TCA	  -­‐>	  ACA	   S273T	  
2	  
T930C	   6	   N	   TAT	  -­‐>	  TAC	   Y289Y	  A6150C	   9	   L	   AAT	  -­‐>	  ACT	   N473T	  A6757G	   2	   L	   GGA	  -­‐>	  GGG	   G675G	  A7573G	   2	   L	   GTA	  -­‐>	  GTG	   V947V	  C7794T	   6	   L	   ACT	  -­‐>	  ATT	   T1021I	  T8038C	   4	   L	   ACT	  -­‐>	  ACC	   T1102T	  A8608G	   2	   L	   ACA	  -­‐>	  ACG	   T1292T	  C8932T	   1	   L	   TTC	  -­‐>	  TTT	   F1400F	  A8962C	   2	   L	   AGA	  -­‐>	  AGC	   R1410S	  A8965C	   2	   L	   GCA	  -­‐>	  GCC	   A1411A	  G9284T	   7	   L	   GTC	  -­‐>	  TTC	   V1518F	  3	   T2952C	   10	   -­‐	   -­‐	   -­‐	  
4	   T4552A	   2	   G	   TTA	  -­‐>	  TAA	   L492*	  A4553T	   2	   G	   TTA	  -­‐>	  TTT	   L492F	  A4567C	   2	   G	   AAA	  -­‐>	  ACA	   K497T	  G11041A	   4	   L	   GAG	  -­‐>	  GAA	   E2103E	  
5	  
T930C	   6	   N	   TAT	  -­‐>	  TAC	   Y289Y	  G1790A	   4	   P	   GGA	  -­‐>	  GAA	   G132E	  A2243G	   4	   M	   -­‐	   -­‐	  T2327C	   2	   M	   CCT	  -­‐>	  CCC	   P26P	  T3894A	   10	   G	   TCA	  -­‐>	  ACA	   S273T	  T7846C	   1	   L	   ACT	  -­‐>	  ACC	   T1038T	  A7978G	   6	   L	   TCA	  -­‐>	  TCG	   S1082S	  T8038C	   4	   L	   ACT	  -­‐>	  ACC	   T1102T	  C9074T	   3	   L	   CCA	  -­‐>	  TCA	   P1448S	  T9926C	   4	   L	   TAT	  -­‐>	  CAT	   Y1732H	  	  	   T2184C	   2	   P	   TAT	  -­‐>	  TAC	   Y263Y	  A2711G	   2	   M	   GTA	  -­‐>	  GTG	   V154V	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6	  	  	  	  
A5161G	   5	   L	   AAA	  -­‐>	  AAG	   K143K	  C5621T	   1	   L	   CTG	  -­‐>	  TTG	   L297L	  A8608G	   2	   L	   ACA	  -­‐>	  ACG	   T1292T	  A9695G	   3	   L	   ATA	  -­‐>	  GTA	   I1655V	  A10184G	   5	   L	   ACG	  -­‐>	  GCG	   T1818A	  
7	   G1790A	   4	   P	   GGA	  -­‐>	  GAA	   G132E	  T3894A	   10	   G	   TCA	  -­‐>	  ACA	   S273T	  A7978G	   6	   L	   TCA	  -­‐>	  TCG	   S1082S	  G9984A	   2	   L	   GGC	  -­‐>	  GAC	   G1751D	  
8	  
C3506A	   1	   G	   GTC	  -­‐>	  GTA	   V143V	  T3894A	   10	   G	   TCA	  -­‐>	  ACA	   S273T	  G5557A	   1	   L	   GTG	  -­‐>	  GTA	   V275V	  A6757G	   2	   L	   GGA	  -­‐>	  GGG	   G675G	  A7573G	   2	   L	   GTA	  -­‐>	  GTG	   V947V	  T10000C	   4	   L	   ATT	  -­‐>	  ATC	   I1756I	  
9	  
T930C	   6	   N	   TAT	  -­‐>	  TAC	   Y289Y	  A2925C	   1	   M	   AGC	  -­‐>	  CGC	   S226R	  C5621T	   1	   L	   CTG	  -­‐>	  TTG	   L297L	  C6712T	   2	   L	   AAC	  -­‐>	  AAT	   N660N	  C8308T	   2	   L	   CCC	  -­‐>	  CCT	   P1192P	  
10	  
A2925C	   1	   M	   AGC	  -­‐>	  CGC	   S226R	  T3894A	   10	   G	   TCA	  -­‐>	  ACA	   S273T	  G6523A	   3	   L	   GCG	  -­‐>	  GCA	   A597A	  C6712T	   2	   L	   AAC	  -­‐>	  AAT	   N660N	  A7573G	   2	   L	   GTA	  -­‐>	  GTG	   V947V	  	  11	   C1743T	   2	   P	   GAC	  -­‐>	  GAT	   D116D	  G1790A	   3	   P	   GGA	  -­‐>	  GAA	   G132E	  T2384C	   5	   M	   TAT	  -­‐>	  TAC	   Y45Y	  T4701G	   1	   G	   -­‐	   -­‐	  
	  12	  
C1368T	   3	   N	   -­‐	   -­‐	  T1927G	   3	   P	   TAT	  -­‐>	  GAT	   Y178D	  A2736C	   1	   M	   AAT	  -­‐>	  CAT	   N163H	  G4151A	   1	   G	   AGG	  -­‐>	  AGA	   R358R	  C4804T	   1	   L	   TTC	  -­‐>	  TTT	   F24F	  G10240A	   4	   L	   ATG	  -­‐>	  ATA	   M1836I	  
13	   C2405T	   1	   M	   GAC	  -­‐>	  GAT	   D52D	  A4152C	   2	   G	   ATG	  -­‐>	  CTG	   M359L	  A10813G	   2	   L	   TCA	  -­‐>	  TCG	   S2027S	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14	   C2966A	   1	   M	   -­‐	   -­‐	  T6728C	   2	   L	   TCA	  -­‐>	  CCA	   S666P	  15	   T8218C	   1	   L	   TCT	  -­‐>	  TCC	   S1162S	  
16	  
G297A	   2	   N	   AAG	  -­‐>	  AAA	   K78K	  T2580C	   1	   M	   TTG	  -­‐>	  CTG	   L111L	  C2758T	   10	   M	   ACG	  -­‐>	  ATG	   T170M	  A4752G	   1	   L	   GAG	  -­‐>	  GGG	   E7G	  A4967C	   1	   L	   ACA	  -­‐>	  CCA	   T79P	  A6150C	   9	   L	   AAT	  -­‐>	  ACT	   N473T	  18	   T5901C	   9	   L	   CTT	  -­‐>	  CCT	   L390P	  T7081G	   1	   L	   CGT	  -­‐>	  CGG	   R783R	  
19	   C3506A	   1	   G	   GTC	  -­‐>	  GTA	   V143V	  T4965G	   2	   L	   TTA	  -­‐>	  TGA	   L78*	  A4966C	   1	   L	   TTA	  -­‐>	  TTC	   L78F	  A10234G	   1	   L	   GTA	  -­‐>	  GTG	   V1834V	  20	   A6251G	   1	   L	   AAA	  -­‐>	  GAA	   K507E	  21	   T10131A	   7	   L	   TTT	  -­‐>	  TAT	   F1800Y	  
22	   G2812T	   1	   M	   AGG	  -­‐>	  ATG	   R188M	  G5129A	   1	   L	   GGC	  -­‐>	  AGC	   G133S	  A6757G	   1	   L	   GGA	  -­‐>	  GGG	   G675G	  A10499G	   5	   L	   AGA	  -­‐>	  GGA	   R1923G	  23	   A2353G	   4	   M	   TAT	  -­‐>	  TGT	   Y35C	  
24	   A2329G	   10	   M	   TAT	  -­‐>	  TGT	   Y27C	  T2330G	   10	   M	   TAT	  -­‐>	  TAG	   Y27*	  A10869G	   1	   L	   CAA	  -­‐>	  CGA	   Q2046R	  
25	   T1338C	   6	   N	   -­‐	   -­‐	  T4485G	   3	   G	   TTT	  -­‐>	  GTT	   F470V	  A4714G	   1	   -­‐	   -­‐	   -­‐	  T7423G	   3	   L	   CTT	  -­‐>	  CTG	   L897L	  
26	  
T2184C	   5	   P	   TAT	  -­‐>	  TAC	   Y263Y	  A2711G	   5	   M	   GTA	  -­‐>	  GTG	   V154V	  T2866C	   6	   M	   TTA	  -­‐>	  TCA	   L206S	  A2857G	   2	   M	   GAG	  -­‐>	  GGG	   E203G	  T4485G	   3	   G	   TTT	  -­‐>	  GTT	   F470V	  T5671A	   10	   L	   CAT	  -­‐>	  CAA	   H313Q	  27	   T1338C	   6	   N	   -­‐	   -­‐	  G1790A	   2	   P	   GGA	  -­‐>	  GAA	   G132E	  T3894A	   10	   G	   TCA	  -­‐>	  ACA	   S273T	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28	  
A2370G	   8	   M	   ATT	  -­‐>	  GTT	   I41V	  A2771C	   1	   M	   ACA	  -­‐>	  ACC	   T174T	  T3894A	   10	   G	   TCA	  -­‐>	  ACA	   S273T	  A4714G	   1	   -­‐	   -­‐	   -­‐	  A6757G	   1	   L	   GGA	  -­‐>	  GGG	   G675G	  A7573G	   2	   L	   GTA	  -­‐>	  GTG	   V947V	  
29	  
C1747A	   1	   P	   CAT	  -­‐>	  AAT	   H118N	  A2925C	   1	   M	   AGC	  -­‐>	  CGC	   S226R	  A5549G	   1	   L	   AAA	  -­‐>	  GAA	   K273E	  C6712T	   1	   L	   AAC	  -­‐>	  AAT	   N660N	  T8426C	   2	   L	   TCT	  -­‐>	  CCT	   S1232P	  G8737A	   4	   L	   TCG	  -­‐>	  TCA	   S1335S	  T10429C	   4	   L	   ATT	  -­‐>	  ATC	   I1899I	  
30	  
T1510G	   1	   P	   TTG	  -­‐>	  GTG	   L39V	  A2925C	   1	   M	   AGC	  -­‐>	  CGC	   S226R	  T3071C	   7	   G	   -­‐	   -­‐	  T3894A	   10	   G	   TCA	  -­‐>	  ACA	   S273T	  T5996C	   4	   L	   TTT	  -­‐>	  CTT	   F422L	  C6712T	   1	   L	   AAC	  -­‐>	  AAT	   N660N	  T6847A	   2	   L	   ACT	  -­‐>	  ACA	   T705T	  A8023G	   2	   L	   ACA	  -­‐>	  ACG	   T1097T	  
31	   G359A	   9	   N	   GGG	  -­‐>	  GAG	   G99E	  C1132T	   4	   N	   CCA	  -­‐>	  TCA	   P357S	  T2831C	   1	   M	   AAT	  -­‐>	  AAC	   N194N	  32	   C447T	   5	   N	   AGC	  -­‐>	  AGT	   S128S	  T3878C	   1	   G	   CCT	  -­‐>	  CCC	   P267P	  T9811C	   3	   L	   AGT	  -­‐>	  AGC	   S1693S	  
33	  
T786C	   1	   N	   TCT	  -­‐>	  TCC	   S241S	  T4542G	   1	   G	   TGC	  -­‐>	  GGC	   C489G	  A5390C	   7	   L	   AAG	  -­‐>	  CAG	   K220Q	  T5401C	   1	   L	   GAT	  -­‐>	  GAC	   D223D	  A6931C	   2	   L	   TTA	  -­‐>	  TTC	   L733F	  T9815G	   2	   L	   TTA	  -­‐>	  GTA	   L1695V	  T10210C	   5	   L	   TTT	  -­‐>	  TTC	   F1826F	  A10979C	   1	   L	   ATC	  -­‐>	  CTC	   I2083L	  34	   G360A	   7	   N	   GGG	  -­‐>	  GGA	   G99G	  G361A	   8	   N	   GAT	  -­‐>	  AAT	   D100N	  T1044A	   1	   N	   CTT	  -­‐>	  CTA	   L327L	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C3683A	   1	   G	   ATC	  -­‐>	  ATA	   I202I	  C3740A	   2	   G	   TTC	  -­‐>	  TTA	   F221L	  C4245A	   4	   G	   CTG	  -­‐>	  ATG	   L390M	  C8349A	   1	   L	   TCT	  -­‐>	  TAT	   S1206Y	  
35	  
C5984T	   2	   L	   CAT	  -­‐>	  TAT	   H418Y	  A6069C	   7	   L	   GAA	  -­‐>	  GCA	   E446A	  A6070C	   5	   L	   GAA	  -­‐>	  GAC	   E446D	  T10210C	   5	   L	   TTT	  -­‐>	  TTC	   F1826F	  T10532A	   9	   L	   TAT	  -­‐>	  AAT	   Y1934N	  
36	  
T2330A	   10	   M	   TAT	  -­‐>	  TAA	   Y27*	  C2833T	   8	   M	   TCT	  -­‐>	  TTT	   S195F	  G3485T	   3	   G	   ACG	  -­‐>	  ACT	   T136T	  A3620C	   1	   G	   ACA	  -­‐>	  ACC	   T181T	  C4636A	   1	   G	   -­‐	   -­‐	  C5738A	   1	   L	   CAT	  -­‐>	  AAT	   H336N	  A6069G	   4	   L	   GAA	  -­‐>	  GGA	   E446G	  A6070G	   5	   L	   GAA	  -­‐>	  GAG	   E446E	  C6071T	   8	   L	   CTT	  -­‐>	  TTT	   L447F	  A7601G	   1	   L	   ATG	  -­‐>	  GTG	   M957V	  
37	  
T2184C	   5	   P	   TAT	  -­‐>	  TAC	   Y263Y	  G4249A	   9	   G	   AGG	  -­‐>	  AAG	   R391K	  C4968A	   9	   L	   ACA	  -­‐>	  AAA	   T79K	  A7595G	   1	   L	   ATC	  -­‐>	  GTC	   I955V	  A8671G	   9	   L	   TCA	  -­‐>	  TCG	   S1313S	  G8737A	   4	   L	   TCG	  -­‐>	  TCA	   S1335S	  
38	   G4025A	   10	   G	   GTG	  -­‐>	  GTA	   V316V	  T5223C	   1	   L	   TTA	  -­‐>	  TCA	   L164S	  C8547T	   4	   L	   ACG	  -­‐>	  ATG	   T1272M	  
39	  
C3506A	   1	   G	   GTC	  -­‐>	  GTA	   V143V	  A6190T	   2	   L	   AAA	  -­‐>	  AAT	   K486N	  T6507C	   1	   L	   TTG	  -­‐>	  TCG	   L592S	  T6695G	   1	   L	   TTG	  -­‐>	  GTG	   L655V	  C8837T	   5	   L	   CTA	  -­‐>	  TTA	   L1369L	  
40	   A5390C	   7	   L	   AAG	  -­‐>	  CAG	   K220Q	  C6071T	   5	   L	   CTT	  -­‐>	  TTT	   L447F	  C8547A	   2	   L	   ACG	  -­‐>	  AAG	   T1272K	  	  	   A123G	   3	   N	   GCA	  -­‐>	  GCC	   A20A	  G599A	   3	   N	   CGT	  -­‐>	  CAT	   R179H	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41	   A5303G	   3	   L	   AGA	  -­‐>	  GGA	   R191G	  T5671A	   9	   L	   CAT	  -­‐>	  CAA	   H313Q	  T8038C	   1	   L	   ACT	  -­‐>	  ACC	   T1102T	  G9371A	   3	   L	   GAG	  -­‐>	  AAG	   E1547K	  A10945G	   2	   L	   TCA	  -­‐>	  TCG	   S2071S	  42	   C5495A	   1	   L	   CTG	  ATG	   L255M	  G5806T	   4	   L	   TGG	  -­‐>	  TGT	   W358C	  
43	   T3894A	   8	   G	   TCA	  -­‐>	  ACA	   S273T	  T4505G	   1	   G	   ATT	  -­‐>	  ATG	   I476M	  A7639T	   7	   L	   GTA	  -­‐>	  GTT	   V969V	  G10591A	   1	   L	   CCG	  -­‐>	  CCA	   P1953P	  
44	   G1422A	   1	   P	   GAG	  -­‐>	  GAA	   E9E	  C5119A	   1	   L	   ACC	  -­‐>	  ACA	   T129T	  G6280T	   2	   L	   AAG	  -­‐>	  AAT	   K513N	  A7700C	   1	   L	   ATA	  -­‐>	  CTA	   I990L	  
46	  
T576C	   1	   N	   TTT	  -­‐>	  TTC	   F171F	  T2330A	   9	   M	   TAT	  -­‐>	  TAA	   Y27*	  C4070T	   1	   G	   GTC	  -­‐>	  GTT	   V331V	  C4137A	   7	   G	   CCA	  -­‐>	  ACA	   P354T	  A4983C	   4	   L	   AAT	  -­‐>	  ACT	   N84T	  C5473A	   3	   L	   TCC	  -­‐>	  TCA	   S247S	  A6070C	   1	   L	   GAA	  -­‐>	  GAC	   E446D	  A7109G	   1	   L	   AGA	  -­‐>	  GGA	   R793G	  
47	  
G361A	   5	   N	   GAT	  -­‐>	  AAT	   D100N	  A2552G	   2	   M	   AAA	  -­‐>	  AAG	   K101K	  A3040G	   1	   -­‐	   -­‐	   -­‐	  G4896T	   3	   L	   AGG	  -­‐>	  ATG	   R55M	  C4971A	   2	   L	   TCA	  -­‐>	  TAA	   S80*	  C5126A	   1	   L	   CGC	  -­‐>	  AGC	   R132S	  A6069G	   7	   L	   GAA	  -­‐>	  GGA	   E446G	  A7038C	   2	   L	   CAA	  -­‐>	  CCA	   Q769P	  
	  48	  
G1051T	   10	   N	   GCA	  -­‐>	  TCA	   A330S	  C2780T	   8	   M	   ATC	  -­‐>	  ATT	   I177I	  C4668A	   2	   G	   -­‐	   -­‐	  C4968A	   9	   L	   ACA	  -­‐>	  AAA	   T79K	  A4983C	   4	   L	   AAT	  -­‐>	  ACT	   N84T	  A6070G	   7	   L	   GAA	  -­‐>	  GAG	   E446E	  T7285C	   1	   L	   GAT	  -­‐>	  GAC	   D851D	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A10615C	   2	   L	   GCA	  -­‐>	  GCC	   A1961A	  
49	  
A1362G	   6	   N	   -­‐	   -­‐	  T3894A	   8	   G	   TCA	  -­‐>	  ACA	   S273T	  G4249A	   2	   G	   AGG	  -­‐>	  AAG	   R391K	  A5629G	   9	   L	   AAA	  -­‐>	  AAG	   K299K	  G5834T	   1	   L	   GGA	  -­‐>	  TGA	   G368*	  G6380A	   1	   L	   GAA	  -­‐>	  AAA	   E550K	  T8762C	   1	   L	   TAT	  -­‐>	  CAT	   Y1344H	  T10383C	   2	   L	   TTG	  -­‐>	  TCG	   L1884S	  50	   C5476A	   1	   L	   ATG	  -­‐>	  ATA	   M248I	  
51	   T5446C	   2	   L	   ATT	  -­‐>	  ATC	   I238I	  A8962C	   10	   L	   AGA	  -­‐>	  AGC	   R1410S	  A8965C	   10	   L	   GCA	  -­‐>	  GCC	   A1411A	  
52	   T4803C	   4	   L	   TTC	  -­‐>	  TCC	   F24S	  G7879A	   1	   L	   AGG	  -­‐>	  AGA	   R1049R	  A8631G	   1	   L	   AAG	  -­‐>	  AGG	   K1300R	  53	   C102T	   3	   N	   GTC	  -­‐>	  GTT	   V13V	  G2618A	   1	   M	   TTG	  -­‐>	  TTA	   L123L	  	   A4628C	   3	   G	   -­‐	   -­‐	  
54	   A1149G	   1	   N	   GGA	  -­‐>	  GGG	   G362G	  C2405T	   1	   M	   GAC	  -­‐>	  GAT	   D52D	  G7420T	   1	   L	   TTG	  -­‐>	  TTT	   L896F	  G10549T	   1	   L	   TCG	  -­‐>	  TCT	   S1939S	  
55	  
T1694C	   2	   P	   GTG	  -­‐>	  GCG	   V100A	  T2330C	   1	   M	   TAT	  -­‐>	  TAC	   Y27Y	  A4966C	   1	   L	   TTA	  -­‐>	  TTC	   L78F	  A4967C	   3	   L	   ACA	  -­‐>	  CCA	   T79P	  G6003A	   1	   L	   AGT	  -­‐>	  AAT	   S424N	  A6150C	   4	   L	   AAT	  -­‐>	  ACT	   N473T	  A8754G	   2	   L	   AAA	  -­‐>	  AGA	   K1341R	  A9950G	   1	   L	   AGG	  -­‐>	  GGG	   R1740G	  56	   A522G	   1	   N	   AGA	  -­‐>	  AGG	   R153R	  A6190T	   1	   L	   AAA	  -­‐>	  AAT	   K486N	  
57	   C752A	   5	   N	   ACA	  -­‐>	  AAA	   T230K	  A4628C	   3	   G	   -­‐	   -­‐	  A8545G	   1	   L	   GCA	  -­‐>	  GCG	   A1271A	  G9290T	   1	   L	   GGA	  -­‐>	  TGA	   G1520*	  	   T2371A	   1	   M	   ATT	  -­‐>	  AAT	   I41N	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58	   A4969C	   1	   L	   ACA	  -­‐>	  ACC	   T79T	  A5629G	   9	   L	   AAA	  -­‐>	  AAG	   K299K	  
59	  
A1362G	   6	   N	   -­‐	   -­‐	  A4983C	   4	   L	   AAT	  -­‐>	  ACT	   N84T	  G5969A	   2	   L	   GGA	  -­‐>	  AGA	   G413R	  T6223G	   1	   L	   ACT	  -­‐>	  ACG	   T497T	  G8543A	   3	   L	   GCA	  -­‐>	  ACA	   A1271T	  T9682A	   5	   L	   TAT	  -­‐>	  TAA	   Y1650*	  
61	   A1904G	   1	   P	   AAG	  -­‐>	  AGG	   K170R	  C5313A	   1	   L	   TCT	  -­‐>	  TAT	   S194Y	  G8737A	   6	   L	   TCG	  -­‐>	  TCA	   S1335S	  
62	   A2329G	   8	   M	   TAT	  -­‐>	  TGT	   Y27C	  T2330G	   9	   M	   TAT	  -­‐>	  TAG	   Y27*	  C2768T	   4	   M	   CTC	  -­‐>	  CTT	   L173L	  
63	  
G360A	   4	   N	   GGG	  -­‐>	  GGA	   G99G	  T2330G	   8	   M	   TAT	  -­‐>	  TAG	   Y27*	  T2869G	   1	   M	   ATG	  -­‐>	  AGG	   M207R	  T3894A	   9	   G	   TCA	  -­‐>	  ACA	   S273T	  C6637T	   9	   L	   ATC	  -­‐>	  ATT	   I635I	  A10182G	   9	   L	   AAG	  -­‐>	  AGG	   K1817R	  C11006T	   7	   L	   CGG	  -­‐>	  TGG	   R2092W	  64	   A6190T	   5	   L	   AAA	  -­‐>	  AAT	   K486N	  C6616T	   8	   L	   TTC	  -­‐>	  TTT	   F628F	  
66	   C3029A	   2	   -­‐	   -­‐	   -­‐	  T7639C	   7	   L	   GTT	  -­‐>	  GTA	   V969V	  G7870A	   3	   L	   AAG	  -­‐>	  AAA	   K1046K	  
67	   A6775G	   1	   L	   GAA	  -­‐>	  GAG	   E681E	  T8769C	   1	   L	   TTA	  -­‐>	  TCA	   L1346S	  C9246T	   1	   L	   TCA	  -­‐>	  TTA	   S1505L	  A10032G	   2	   L	   GAT	  -­‐>	  GGT	   D1767G	  
68	   G361A	   5	   N	   GAT	  -­‐>	  AAT	   D100N	  A6069C	   3	   L	   GAA	  -­‐>	  GCA	   E446A	  C6071T	   9	   L	   CTT	  -­‐>	  TTT	   L447F	  
69	   G359A	   5	   N	   GGG	  -­‐>	  GAG	   G99E	  T3894A	   10	   G	   TCA	  -­‐>	  ACA	   S273T	  A6989G	   1	   L	   ATA	  -­‐>	  GTA	   I753V	  70	   C1353T	   1	   N	   -­‐	   -­‐	  G3350T	   10	   G	   CCG	  -­‐>	  CCT	   P91P	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71	  
G359A	   4	   N	   GGG	  -­‐>	  GAG	   G99E	  T3071C	   2	   G	   -­‐	   -­‐	  T4965G	   3	   L	   TTA	  -­‐>	  TGA	   L78*	  C5398T	   1	   L	   CTC	  -­‐>	  CTT	   L222L	  C7134A	   6	   L	   ACC	  -­‐>	  AAC	   T801N	  72	   T5671A	   8	   L	   CAT	  -­‐>	  CAA	   H313Q	  
73	  
A249G	   2	   N	   GGA	  -­‐>	  GGG	   G62G	  A1317G	   1	   N	   TCA	  -­‐>	  TCG	   S418S	  A2329G	   10	   M	   TAT	  -­‐>	  TGT	   Y27C	  A6070G	   7	   L	   GAA	  -­‐>	  GAG	   E446E	  C8547A	   4	   L	   ACG	  -­‐>	  AAG	   T1272K	  G9430T	   1	   L	   GTG	  -­‐>	  GTT	   V1566V	  A9681T	   10	   L	   TAT	  -­‐>	  TTT	   Y1650F	  74	   G5323T	   6	   L	   ACG	  -­‐>	  ACT	   T197T	  C7135A	   3	   L	   ACC	  -­‐>	  ACA	   T801T	  
75	  
T1044A	   1	   N	   CTT	  -­‐>	  CTA	   L327L	  G4249A	   7	   G	   AGG	  -­‐>	  AAG	   R391K	  C5832T	   1	   L	   ACT	  -­‐>	  ATT	   T367I	  T6728C	   2	   L	   TCA	  -­‐>	  CCA	   S666P	  C8308T	   4	   L	   CCC	  -­‐>	  CCT	   P1192P	  A8671G	   3	   L	   TCA	  -­‐>	  TCG	   S1313S	  
76	  
G535A	   4	   N	   GAT	  -­‐>	  AAT	   D158N	  A1224G	   1	   N	   AGA	  -­‐>	  AGG	   R387R	  G2601A	   7	   M	   GCC	  -­‐>	  ACC	   A118T	  C2896G	   7	   M	   GCA	  -­‐>	  GGA	   A216G	  A4969C	   2	   L	   ACA	  -­‐>	  ACC	   T79T	  T7406C	   4	   L	   TTG	  -­‐>	  CTG	   L892L	  G8593T	   4	   L	   TGG	  -­‐>	  TGT	   W1287C	  
77	  
G3350A	   10	   G	   CCG	  -­‐>	  CCA	   P91P	  A3870G	   2	   G	   AGA	  -­‐>	  GGA	   R265G	  A5239G	   6	   L	   TTA	  -­‐>	  TTG	   L169L	  A8714G	   1	   L	   ACA	  -­‐>	  GCA	   T1328A	  T10830C	   4	   L	   ATC	  -­‐>	  ACC	   I2033T	  	  78	   C1146T	   4	   N	   ACC	  -­‐>	  ACT	   T361T	  G1318A	   2	   N	   GAA	  -­‐>	  AAA	   E419K	  T10532A	   9	   L	   TAT	  -­‐>	  AAT	   Y1934N	  	  	   A1407C	   9	   P	   CTA	  -­‐>	  CTC	   L4L	  G3699A	   2	   G	   GAC	  -­‐>	  AAC	   D208N	  
	   196	  
79	   G3871A	   1	   G	   AGA	  -­‐>	  AAA	   R265K	  T4964G	   1	   L	   TTA	  -­‐>	  GTA	   L78V	  G7591A	   1	   L	   CTG	  -­‐>	  CTA	   L953L	  G8551T	   1	   L	   TTG	  -­‐>	  TTT	   L1273F	  	   T1438C	   5	   P	   TCT	  -­‐>	  CCT	   S15P	  
80	   A6787G	   1	   L	   CAA	  -­‐>	  CAG	   Q685Q	  G8548A	   1	   L	   ACG	  -­‐>	  ACA	   T1272T	  T10407C	   1	   L	   ATT	  -­‐>	  ACT	   I1892T	  81	   C7135A	   3	   L	   ACC	  -­‐>	  ACA	   T801T	  G8548T	   1	   L	   ACG	  -­‐>	  ACA	   T1272T	  
82	   C5315A	   2	   L	   CAT	  -­‐>	  AAT	   H195N	  A5973C	   2	   L	   GAC	  -­‐>	  GCC	   D414A	  C8552T	   3	   L	   CTC	  -­‐>	  TTC	   L1274F	  A10146G	   3	   L	   GAA	  -­‐>	  GGA	   E1805G	  
83	  
G3414T	   2	   G	   GAA	  -­‐>	  TAA	   E113*	  A5549G	   1	   L	   AAA	  -­‐>	  GAA	   K273E	  G6935A	   1	   L	   GGT	  -­‐>	  AGT	   G735S	  G7501A	   1	   L	   CTG	  -­‐>	  CTA	   L923L	  C8308T	   4	   L	   CCC	  -­‐>	  CCT	   P1192P	  
84	   A123G	   4	   N	   GCA	  -­‐>	  GCC	   A20A	  G4249A	   7	   G	   AGG	  -­‐>	  AAG	   R391K	  C5302A	   2	   L	   GTC	  -­‐>	  GTA	   V190V	  T7586G	   2	   L	   TCT	  -­‐>	  GCT	   S952A	  
85	  
A242T	   4	   G	   TTC	  -­‐>	  TAC	   F221Y	  T1438C	   5	   P	   TCT	  -­‐>	  CCT	   S15P	  G5150A	   1	   L	   GAA	  -­‐>	  AAA	   E140K	  A5627G	   1	   L	   AAA	  -­‐>	  GAA	   K299E	  A7573G	   2	   L	   GTA	  -­‐>	  GTG	   V947V	  C8547T	   3	   L	   ACG	  -­‐>	  ATG	   T1272M	  86	   A4462G	   1	   G	   AAG	  -­‐>	  AGG	   K462R	  T8602C	   7	   L	   AGT	  -­‐>	  AGC	   S1290S	  
87	  
A123G	   4	   N	   GCA	  -­‐>	  GCC	   A20A	  C1368T	   9	   N	   -­‐	   -­‐	  G1672A	   6	   P	   GAT	  -­‐>	  AAT	   D93N	  A4983C	   2	   L	   AAT	  -­‐>	  ACT	   N84T	  A5152G	   1	   L	   GAA	  -­‐>	  GAG	   E140E	  A5240G	   5	   L	   ATC	  -­‐>	  GTC	   I170V	  G5794A	   2	   L	   TCG	  -­‐>	  TCA	   S354S	  
	   197	  
T7736G	   1	   L	   TTC	  -­‐>	  GTC	   F1002V	  A8546G	   1	   L	   ACG	  -­‐>	  GCG	   T1272A	  C8837T	   6	   L	   CTA	  -­‐>	  TTA	   L1369L	  88	   C2416T	   1	   M	   CCG	  -­‐>	  CTG	   P56L	  
89	  























	  	  	  
